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Executive Summary
Electronic Reporting of Laboratory Data for Public Health: 
Meeting Report and Recommendations
On March 24-25, 1997, a meeting was held to provide a forum for discussing barriers to
implementing effective laboratory reporting standards and to seek creative, practical approaches
to moving forward.  The meeting was co-sponsored by the Centers for Disease Control and
Prevention (CDC), the Council of State and Territorial Epidemiologists (CSTE), and the
Association of State and Territorial Public Health Laboratory Directors (ASTPHLD). 
Three main perspectives were represented among meeting participants:  the views of federal
public health agencies, the views of state epidemiologists and public health laboratorians, and the
views of the private sector (both laboratories and laboratory software vendors). 
This report summarizes discussions during the meeting and presents preliminary recommendations
in three main areas:
Flow—where, when, and how data should move to and from users.
  
Format—the mechanics of data transfer, including the use of Health Level Seven
(HL7) messages and/or other reporting formats, and ways to ensure security. 
Content—the determination of which data elements should be included in an
electronic reporting system for clinical laboratories.
Recommendations in each category are summarized below.  
Summary of Flow Recommendations
CDC/Association of State and Territorial Health Officials (ASTHO)/CSTE/ASTPHLD
should coordinate a unified approach to electronic reporting of clinical laboratory data,
designating specific staff and resources to approach large laboratories and laboratory
software vendors.
The unified approach would specify: the standard HL7 message and, through a set of
tables, reportable diseases and conditions by state (and large jurisdictions); data elements;
and specific laboratory tests (and codes) that should be reported (described in content and
format recommendations).
A standard approach with daily reporting (as data are verified by laboratories) should be
specified.
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Summary of Format Recommendations
CDC/CSTE/ASTHO/ASTPHLD should issue a joint statement that:
all state and territorial laboratories and health departments should accept standard
HL7 2.3 Observation Results Unsolicited (ORU) messages, and
all newly established laboratory reporting systems should use HL7.
CDC should have primary responsibility for ensuring access to a generic HL7 reader that
parses messages from HL7.  Because of variation at the state level in the ability to make
use of these data, CDC should provide the option of forward-translating for potential
merge-matching into STD-MIS, TB SURVS, NETSS, PHLIS, HARS, and other CDC
data systems.  (Decisions about merging and matching will occur at the state level.)
CDC surveillance systems should develop the capacity to accept HL7 messages, as well as
other formats, where appropriate (such as ASCII and .DBF).
LOINC coding conventions for electronic reporting of laboratory data should be adopted
for the OBX3 segment of the HL7 message.  SNOMED coding conventions should be
adopted for the OBX5 segment for organism name.
The draft HL7 specification (Appendix C, Table I) should be revised to allow 
incorporation of laboratory data relevant for chronic diseases and environmental health
(e.g., blood lead levels).
Summary of Content Recommendations
CSTE, with CDC and ASTPHLD should develop and maintain an Internet-accessible list
of reportable diseases and conditions by state (and indicate whether positive and negative
results are to be reported).  A process for periodic updates should be specified.
CDC, CSTE, and ASTPHLD should develop collaboratively a table of required and
desired demographics and other information for notifiable conditions (state-specific, if
necessary).  (This information is embedded in the HL7 message.  See Appendix C).  A
process for periodic updates should be specified.
(Name reporting of HIV test results warrants special consideration, to recognize states
that use unique identifiers.) 
CDC, ASTPHLD, and CSTE should arrange to maintain a table of specific tests reported
by disease and condition, expanding the case definitions document to include the
reportable laboratory tests.  A process for periodic updates should be specified.
The public health system that first receives laboratory data should ensure an
auditing/monitoring role to identify problems with completeness and timeliness of data,
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and ensure corrective action.
Before adjourning, participants identified a short list of actions that could be taken immediately: 
 Share the key meeting recommendations with attendees of upcoming CSTE,
ASTHO and ASTPHLD meetings.  Seek input on approach and recommendations,
and ultimately endorsement, by these organizations.
Finalize the tables recommended by the Content group and obtain review and
endorsement by participating organizations.
Secure needed approvals, funding, space, and staffing for a coordinating
“intermediary” office.  
Designate a group of representatives from CDC, CSTE, ASTHO, and ASTPHLD
to approach major reference laboratories and software vendors with a unified
message.
  Valdiserri RO.  Temples of the future: an historical overview of the laboratory’s role in public health1
practice.  Ann Rev Public Health 1992; 14:635-48.
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I. Background
ver a century ago, Louis Pasteur described laboratories as the “temples of the future.”   O 1Technical advances in the scope and accuracy of laboratory tests have fulfilled Pasteur’s
vision, yet laboratory reporting to public health lags behind other applications of state-of-the-art
technology.  In part, this is because existing electronic formats are not standardized or connected. 
In some cases, reports that could be transmitted, received, and sorted electronically are still
moved from one location to another on paper by mail or fax machines.  In addition to being
inefficient for the laboratories themselves, current laboratory reporting practices limit use of these
data by public health agencies.  
Uses of Laboratory and Surveillance Data 
Table 1, below, summarizes the various uses of surveillance data by local, state, and federal public
health agencies.  It is important to note that effective surveillance relies on clinical data from both
the laboratory and the physician; thus, laboratory functions are but one component of a more
comprehensive approach.  This distinction is important to take into account when considering the
recommendations described in this report, since they address only electronic laboratory-based
reporting and not the entire surveillance infrastructure that complements it.  For this reason, this
report refers to electronic laboratory-based reporting, as distinct from surveillance.
The characteristics of data required for various surveillance functions are driven by the different
needs and emphases of each component of the public health system.  For example, personal
identifying information is critical for local health department investigations, but generally needs to
be excluded from data transmitted to federal public health agencies.  On the other hand, in order
to evaluate the impact of a new diagnostic test on case counts, a database would need to include,
not just whether a result for a given disease was positive, but also what the test was—an item
likely to be more important to disease-specific specialists at the federal level than to local health
department staff.  These differing uses contribute to the complexity inherent in designing an
approach to laboratory reporting that is useful throughout public health, without being
inordinately cumbersome to the providers of information.  
In general, laboratory data specify the results of specific tests, not clinical impressions.  In this
sense, test results constitute “hard data.”  However, since laboratory test results still may require
additional interpretation in a clinical or epidemiologic context, their utility for surveillance
purposes varies from disease to disease.  For some diseases, a laboratory result essentially defines
a case (e.g., positive culture from normally sterile sites for invasive bacterial pathogens).  For
others, such as distinguishing between the incidence and prevalence of tuberculosis, hepatitis B, or
cancer, laboratory results must be supplemented by clinical information. 
  Categories adapted from Teutsch SM. Considerations in planning a surveillance system. In Teutsch SM2
and Churchill RE, editors. Principles and Practice of Public Health Surveillance.  New York:  Oxford University
Press, 1994:18-9.
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Table 1:
Public Health Uses of Surveillance Data 2
Public Health System
Components and Emphases 
(  = greatest emphasis)
Local State Federal
Identification of cases for investigation and follow-up
Estimate the magnitude of a health problem; 
follow trends in incidence and distribution
Detect outbreaks or epidemics to trigger interventions
Evaluate control and prevention measures
Monitor changes in infectious agents (e.g., antibiotic resistance,
clinical spectrum)
Facilitate epidemiologic and laboratory research; 
formulate prevention strategies; formulate hypotheses
Detect changes in health practice (e.g., impact of use of new
diagnostic methods on case counts)
Facilitate planning (e.g., allocation of program resources, policy
development)
Even when clinical laboratory results are useful for surveillance purposes, the sentiment within
each component of the public health system is that these results could be far more useful if they
conveyed more complete information with each transfer.   For example, in many situations, it
would be useful to know not only positive test results but negative ones as well.  In addition,
more complete demographic detail could enhance the uses of laboratory results for surveillance
purposes (although this detail is not always required).  Justifiable concerns about excessive
reporting burden have constituted one set of obstacles to more complete reporting—a set of
obstacles that may be addressed by technological improvements and efficiencies.  Although
technology may be used to minimize burden, concerns about privacy and confidentiality may
become more pronounced as broader use of demographic identifiers is contemplated.  The issues
of how much information should be reported and how far the “granularity” (or detail) of the data
should be preserved are important considerations for any laboratory reporting blueprint.
  CSTE ad hoc Working Group on ELS.  Recommendations on electronic reporting of laboratory data to3
public health authorities. [Draft] January 1997.
  HL7 provides a standard format for the structure of electronic messages; it describes what part of the4
message contains information about the sending laboratory, the patient, the tests performed, and the results.  More
information on HL7 is available from the following web site: http://www.mcis.duke.edu/standards/hl7/hl7.htm. 
 Health Level Seven Specifications for Electronic Laboratory-based reporting of Public Health5
Information, Version 1.1, October 9, 1996. DBMD, NCID, CDC. DRAFT DOCUMENT
  Washington State Department of Health.  A prototype reader for electronic laboratory-based reporting 6
-- interim progress report on the development of a versatile Health Level Seven translator/parser for the
Washington state department of health.  2/20/97.
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Efforts to Improve Electronic Laboratory-Based Reporting
The benefits and obstacles inherent in moving toward electronic reporting of clinical laboratory
data have been the subject of work group deliberations, position papers, and demonstration
projects in numerous states.  The Council of State and Territorial Epidemiologists (CSTE) has
convened an ad hoc Working Group on Electronic Laboratory Surveillance (ELS), which
represents epidemiologists from states with ongoing ELS pilot projects.  This group has drafted a
set of recommendations on electronic reporting of laboratory data.   In addition, specifications for3
electronic laboratory-based reporting using Health Level Seven (HL7) messages , have been4
developed by CDC   and refined by Washington state (one of the pilot states)  , working closely5           6
with the CSTE ad hoc Working Group and others.
Through these ongoing efforts, the key technical elements required for electronic laboratory-
based reporting have been outlined.  The next steps are to secure agreements, endorsements, and
cooperation from the many interested parties.  These parties include clinical, pathology,
environmental, and public health laboratories, large reference laboratories, laboratory information
system vendors, managed care organizations, as well as state, local, and federal public health
agencies—each with its own set of needs and priorities.
To stimulate progress, the Centers for Disease Control and Prevention (CDC), the Council of
State and Territorial Epidemiologists (CSTE), and the Association of State and Territorial Public
Health Laboratory Directors (ASTPHLD) co-sponsored a meeting to discuss the remaining
barriers to implementing effective laboratory reporting standards and to seek creative, practical
approaches to moving forward.  This report summarizes discussions during the meeting and
presents preliminary recommendations.  The report will be circulated and presented at upcoming
professional meetings to obtain feedback on the recommendations.
This meeting was held in Atlanta, Georgia on March 24-25, 1997.  Three main perspectives were
represented among meeting participants: the views of federal public health agencies, the views of
state epidemiologists and public health laboratorians, and the views of the private sector (both
laboratories and laboratory software vendors).  Except for the meeting’s co-sponsors, participants
were asked to attend because of their individual areas of expertise, rather than as representatives
of any organization.  A complete list of participants is provided in Appendix A. 
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II. Meeting Objectives
 
The meeting was designed to accomplish four objectives:  
define the goals for electronic reporting of clinical laboratory data for public health
surveillance
identify barriers to implementation of electronic laboratory-based reporting 
identify potential solutions to address major barriers
recommend specific next steps for CDC, states, private organizations, and others.
The agenda (see Appendix B) allowed for both large and small group discussions in order to
provide participants ample opportunity to share their knowledge and perceptions.  An outside
facilitator helped focus the discussion and ensure that participants could freely express their
views.  Group discussions and recommendations are summarized below.
III. Goals for Electronic Reporting of Laboratory Data
To prepare for a discussion on goals of electronic laboratory-based reporting, participants were
asked to independently complete a short worksheet that asked two questions:
1. What do you hope will be accomplished through electronic reporting of data from
clinical laboratories?  Who will benefit from these accomplishments (e.g., local or
state health departments, CDC, private laboratories, vendors)?
2. What impact would successful electronic reporting of clinical laboratory data
have?  How would you know if such reporting were successful?
Responses were generally consistent, describing benefits that could accrue to public health
surveillance overall, to health departments, and to laboratories.  In addition, participants described
some desired attributes of electronic reporting protocols.   In terms of surveillance and its
functions, meeting participants envisioned an electronic reporting structure for clinical laboratory
data that would lead to:
prompt and appropriate public health action in response to timely, accurate reports
(or, as one participant noted, fulfillment of the surveillance functions described in
Table 1, “Public Health Uses of Surveillance Data”)
improved sensitivity of surveillance
expanded reporting of chronic diseases and environmental health data, as well as
infectious diseases
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improved ability to address more diseases and conditions as gains in timeliness,
accuracy, and efficiency free up resources at laboratories and health agencies
improved ability to measure the impact of public health interventions, using
laboratory indicators
improved ability to compare rates for diseases and conditions across populations
expanded options to generate new hypotheses with more data available
electronically
strengthened partnerships with managed care and other organizations that also
utilize data from clinical laboratories.  
For local health departments, some participants expressed concerns about increases in the
workload of agencies that already may be understaffed; they doubted the capacity of either local
or state health departments to absorb and fully utilize more data (potentially generated by more
comprehensive laboratory reporting).  On the other hand, some participants hoped for widespread
efficiency gains from the adoption of consistent electronic reporting formats, including reductions
in clerical time currently used to sort or enter printed laboratory results.
Participants also mentioned efficiency gains for laboratories that would result from streamlined
electronic reporting protocols.  In addition, participants hoped for quality improvements, such
as clearer, unambiguous reporting of laboratory test results.
In terms of desired attributes of an electronic reporting process, participants noted that it should:
protect individuals’ privacy and confidentiality, and be widely perceived as doing
so
be dynamic—i.e., able to adjust readily to changes in reporting requirements
be relatively simple and flexible (especially for use by smaller laboratories and less
electronically sophisticated health departments)
be transparent to both producers and consumers of information. 
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IV. Barriers and Recommended Solutions 
To launch the discussion of barriers and solutions, three broad categories of electronic reporting
issues were described:
Flow—where, when, and how data should move to and from users.
  
Format—the mechanics of data transfer, including the use of Health Level Seven
(HL7) messages and/or other reporting formats, and ways to ensure security. 
Content—the determination of which data elements should be included in an
electronic reporting system for clinical laboratories.
In addition to these three categories, the group considered confidentiality to be an issue that
applied to flow, format, and content.   In the summaries below, it should be noted that the word
“confidentiality” refers to the types of personal identifying information that can be linked to a test
result, while the word “security” refers to ensuring the existence of barriers to unauthorized
access to the information.
The participants broke into smaller groups to consider each of these topics in greater detail.  A
spokesperson from each group then presented the group’s recommendations to the larger group,
for further review and modification.  Summaries of the small group discussions and specific
recommended solutions for each category are provided below.
A. Barriers and Solutions Related to Data Flow
In the current flow of laboratory test result reporting, some laboratories and clinicians must report
various diseases to multiple jurisdictions, with varying types of information accompanying the
results. The group discussed how technological advances would allow for the possibility of a
unified waystation.  In this arrangement, data would flow from laboratories to a central
waystation or waystations, where they would be accessible to various data users (with appropriate
security and confidentiality protections in place).  This approach was viewed as the best technical
solution, since it streamlined the reporting responsibilities for laboratories while allowing timely
and customized access to the data by federal and state agencies.  
Despite these advantages, many participants agreed that such a plan would not be widely
accepted, since regulatory obstacles and jurisdictional disputes would make it impractical.  A
unified waystation also would raise concerns about a centralized repository of (and thus, the
potential for more widespread access to) confidential clinical test results.  
The group discussed additional barriers related to the flow of data.  A key barrier involves the
authority to make decisions about which data flow to whom first, how they are reviewed at each
level, and similar issues.  Given the range of motivations and organizations potentially involved in
both the private and public sectors, agreement on who should have this authority could be
difficult.  Another set of barriers involves the technological aspects of data flow, including the
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translation from HL7 readers.  These were considered by the format group.  Indeed, many format
and content decisions depend on the flow scheme.  
A technologic issue that was implicit during the meeting, but not widely discussed, was the use of
the Internet as the mechanism for transmitting data.
As a compromise between a more centralized flow of data through waystations and decentralized
flow from laboratories to multiple public health jurisdictions (much like the status quo), meeting
participants suggested a modification that would draw upon the strengths of each approach, while
minimizing its potential drawbacks.  This would be accomplished by CDC and state health
departments together developing and endorsing a fully described set of specifications for reporting
from laboratories to public health, including HL7 message specifications, and tables describing 1)
diseases and conditions reportable in each state and jurisdiction, 2) data elements, and 3) specific
tests and their codes.  (These are described in greater detail in the format and content discussions,
below.)  A designated group of representatives from CDC and state health departments would
approach large laboratories and laboratory software vendors with this set of specifications for
electronic laboratory-based reporting.  The proposed approach is shown below:
This approach has several advantages.  First, it allows progress in the areas on which there already
is general agreement, without precluding movement towards other models in the future, if they
become more feasible or desirable.  It decreases the vulnerability of public health agencies to
vendors who might be tempted to take advantage of inconsistent levels of knowledge or
sophistication.  The unified approach also builds in an incentive for CDC and other federal health
agencies to support state efforts.  States could still choose to use the data in different ways (in
fact, tables would specify the state-specific reporting requirements), although states would be
asked, for the sake of consistency, to accept specifications for data even if a specific data element
were not of interest to them.  
In addition to the advantages it offers to public health agencies, a unified approach could be
efficient for laboratories as well—especially if laboratories could discharge their reporting
responsibilities by meeting the specifications outlined in this approach.
Draft Meeting Report — 8
SUMMARY OF FLOW RECOMMENDATIONS
CDC/ASTHO/CSTE/ASTPHLD should coordinate a unified approach to electronic
reporting of clinical laboratory data, designating specific staff and resources to
approach large laboratories and laboratory software vendors. [For the
recommendations in this report, the term laboratory data refers to results of tests on
specimens from humans from clinical laboratories or pathology departments.]
The unified approach would specify: the standard HL7 message and, through a set of
tables, reportable diseases and conditions by state (and large jurisdictions); data
elements; and specific laboratory tests (and codes) that should be reported (described
in content and format recommendations).
A standard approach with daily reporting (as data are verified by laboratories) should
be specified.
B. Barriers and Solutions Related to Message Format
The format discussion centered on the use of HL7 for sending reportable findings to appropriate
local, state, territorial, and federal agencies—whether this was feasible, given existing variations
by state and by agency, and, if so, how movement toward this standard could be achieved with a
minimum of disruption.  Several state participants noted that CDC’s program-specific softwares
do not allow standard importing and exporting of data (including using HL7 readers), often
requiring entering data into state databases and again into CDC databases.  Like the other groups,
the format group discussed relevant confidentiality concerns.
The group strongly supported movement toward an HL7 format for a variety of reasons.  First,
HL7 includes laboratory data of interest.  While other standards for electronic messaging exist,
they are used primarily for business-related purposes, such as billing.  HL7 is the leading private
laboratory industry standard for the transmission of clinical data; consequently, laboratory
information system vendors are capable of supporting it.  HL7 also maintains the desired level of
detail (or granularity) of data.  Overall, adopting HL7 as a standard offers the fastest route to
standardized laboratory reporting.
Another format issue raised during the discussion was whether to support the adoption of LOINC
(Laboratory Observation Identifier Names and Codes) and/or SNOMED (Systemized
Nomenclature for Medicine) codes within the HL7 message (in particular, the OBX3 segment).  
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SUMMARY OF FORMAT RECOMMENDATIONS
CDC/CSTE/ASTHO/ASTPHLD should issue a joint statement that:
all state and territorial laboratories and health departments should accept
standard HL7 2.3 Observation Results Unsolicited (ORU) messages, and
all newly established laboratory reporting systems should use HL7.
CDC should have primary responsibility for ensuring access to a generic HL7 reader
that parses messages from HL7.  Because of variation at the state level in the ability
to make use of these data, CDC should provide the option of forward-translating for
potential merge-matching into STD-MIS, TB SURVS, NETSS, PHLIS, HARS, and
other CDC data systems.  (Decisions about merging and matching will occur at the
state level.)
CDC’s surveillance systems should develop the capacity to accept HL7 messages, as
well as other formats, where appropriate (such as ASCII and .DBF).
LOINC coding conventions for electronic reporting of laboratory data should be
adopted for the OBX3 segment of the HL7 message.  SNOMED coding conventions
should be adopted for the OBX5 segment for organism name.
The draft HL7 specification (Appendix C) should be revised to allow  incorporation
of laboratory data relevant for chronic diseases and environmental health (e.g., blood
lead levels).
C. Barriers and Solutions Related to Message Content
To make decisions about message content, meeting participants struggled to balance the need for
comprehensive, uniform data collection with the more variable capabilities of individual states and
laboratories.  For example, in considering which data elements should be included in a reporting
protocol, the choices range from a minimum set, to a larger set, to all variables.  Another issue
discussed during the meeting was whether all results (positive and negative) should be required
for some diseases, or only positive results.  Similarly, decisions must be made regarding which
demographic data should accompany reportable cases. 
Specifying different data elements raises the question of “requirements.”  Technically, a
“required” field means that the entire transmission would be rejected if a required field is missing. 
To avoid the rejection of useful but incomplete data, the designation of “send if available” has
been developed.  These distinctions are important in terms of the wording of recommendations
and specifications, and were considered by the group.  However, many fields not technically
required for transmission are required for effective public health surveillance (e.g., age, address,
sex).  Further deliberations are warranted on how best to obtain needed data as uniformly and
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SUMMARY OF CONTENT RECOMMENDATIONS
CSTE, with CDC and ASTPHLD, should develop and maintain an Internet-accessible
list of reportable diseases and conditions by state (and indicate whether positive and
negative results are to be reported).  A process for periodic updates should be
specified.
CDC, CSTE, and ASTPHLD, should develop collaboratively a table of required and
desired demographics and other information for notifiable conditions (state-specific, if
necessary).  (This information is embedded in the HL7 message. See Appendix C).  A
process for periodic updates should be specified.
(Name reporting of HIV test results warrants special consideration, to recognize
states that use unique identifiers.) 
CDC, ASTPHLD, and CSTE, should arrange to maintain a table of specific tests
reported by disease and condition, expanding the case definitions document to include
the reportable laboratory tests.  A process for periodic updates should be specified.
The public health system that first receives laboratory data should ensure an
auditing/monitoring role to identify problems with completeness and timeliness of
data, and assure corrective action.
comprehensively as possible.
In order to obtain uniform content, agreement must be reached regarding case definitions (and
how they are determined), updating and maintenance of definitions, and audit functions
(particularly, who is or should be responsible for reviewing data elements for completeness). 
Fortunately, the basis for agreement on message content exists in the form of previously drafted
tables of notifiable diseases and conditions by state, findings reportable with LOINC and
SNOMED codes, required demographics, and optional data elements that can be sent on an “if
available” basis.  In its recommendations, the group suggested that these tables be updated,
finalized (i.e., endorsed by the relevant groups), and disseminated.
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V. Next Steps
Before adjourning, participants identified a short list of actions that could be taken immediately: 
 Share the key meeting recommendations with attendees of upcoming CSTE,
ASTHO and ASTPHLD meetings.  Seek input on approach and recommendations,
and ultimately endorsement, by these organizations.
Finalize the tables recommended by the Content group and obtain review and
endorsement by participating organizations.
Secure needed approvals, funding, space, and staffing for a coordinating
“intermediary” office.  
Designate representatives from CDC, CSTE, ASTHO, and ASTPHLD to
approach major reference laboratories and software vendors with a unified
message.
The meeting sponsors jointly agreed to pursue these next steps as expeditiously as possible and to
keep the group informed of progress.  They closed the meeting by thanking participants for their
significant contributions and encouraging continued pursuit of their efforts, both individually and
collectively.  
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Agenda
Meeting on Electronic Reporting of Clinical Laboratory Data
March 24-25, 1997 — Holiday Inn Airport North
MONDAY, MARCH 24
8:30 - 9:15 Opening Remarks and Introductions










 10:30 - 10:45 BREAK
10:45 - 11:45 Delineation of Goals
11:45 - 12:30 LUNCH
12:30 - 1:30 Issues and Barriers (Brainstorming Session)
1:30 - 3:00 Solutions Discussions (Breakout Groups)
3:00 - 3:15 BREAK
3:15 - 5:30 Reports from Breakout Groups and Discussion
5:30 Adjourn for Day 1
TUESDAY, MARCH 25
8:30 - 9:15 Review of Monday’s Discussions
9:15 - 10:30 Implementation/Next Steps 
10:30 - 10:45 BREAK
10:45 - 1:00 Implementation Discussion, continued
1:00 Adjourn
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Health Level Seven Specifications for Electronic 
Laboratory-Based Reporting of Public Health Information
Document Summary
This document is a guide for implementing electronic communication of reportable information from
laboratories to public health agencies using Health Level 7 (HL7).  HL7 is an accredited, nationally-
recognized standard for electronic data exchange in healthcare environments.  HL7 is not a commercial
software or data transfer package, but instead is a defined set of rules for sending simple text characters
in groups that represent patient identifiers, clinician identifiers, laboratory test information, test results,
and other clinical and administrative data.  The standard allows communication between separate and
different types of information systems.  The implementation guide directly follows the specifications
described in the HL7 Standard version 2.3 and  focuses on one type of HL7 message, the Observational
Report - Unsolicited (ORU).  While HL7 has described the order and structure of data fields for sharing
test results, it has not stipulated which coding system or dictionary of descriptive terms should be used to
unambiguously identify specific tests and findings; this is the responsibility of the parties sharing the
information.  For sharing laboratory-based reports of public health findings, two coding systems are
recommended: 1) Logical Observation Identifier Names and Codes (LOINC) for specific laboratory
procedure names, and 2) the Systematized Nomenclature for Human and Veterinary Medicine
(SNOMED) for descriptions of findings, notably organism names.  The guide gives a description of the
utility and requirement of each data field in the ORU message with some specific comments for cancer
registry reporting, provides examples of complete messages, and provides tables of recommended




Monitoring the occurrence of diseases is a cornerstone of public health decision-making.  This
monitoring, referred to as public health surveillance, can be used to trigger case or outbreak
investigations, follow trends, evaluate the effect of prevention measures such as immunizations, and
suggest public health priorities.  Because disease trends have the potential to shift rapidly, especially
with infectious diseases, surveillance needs to be ongoing, timely, and complete.  
Each state and territory has requirements for laboratories to report certain findings to health officials.  In
the past, these reports were written by hand on forms provided by health departments and mailed to
appropriate offices.  With computerization of laboratories, it has become possible for laboratories to send
reportable data to health departments electronically.
This guide contains the specifications for sending laboratory-reportable findings to appropriate state,
territorial, and federal health agencies using Health Level 7 (HL7) messages.  The message is not
specific to any pathogen or reportable condition and is applicable for most laboratory-reportable findings
in the National Public Health Surveillance System (NPHSS) as defined by the Council of State and
Territorial Epidemiologists (CSTE).  The message is also applicable for pilot-testing of laboratory
reporting of anatomic pathology results to cancer registries in accordance with the North American
Association of Central Cancer Registries (NAACCR).  The specifications given in this guide have been
reviewed and revised with the assistance of Clement MacDonald, MD,  of the Regenstrief Institute and
Co-Chair of HL7 Chapters 4 and 7, Hans Buitendijk, of Shared Medical Systems and Co-Chair of HL7
Chapter 7, Debbie Murray, Chair of the HL7 Implementation Committee, Stephen Moser, PhD, of the
University of Alabama at Birmingham, Susan Abernathy of the National Immunization Program, CDC,
Steven Steindel, PhD of the Public Health Practice Office, CDC, and David Eide of Group Health
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Cooperative of Puget Sound, Seattle, WA.  Final review, revision, and addition of cancer registry
reporting comments were provided by Warren Williams, National Center for Chronic Disease Prevention
and Health Promotion, CDC.
1.2 Scope
The specifications in this guide are not intended as a tutorial for either HL7 or interfacing in general.  The
reader is expected to have a basic understanding of interface concepts, HL7, and electronic laboratory-
based reporting of public health information.  This guide describes a data exchange protocol applicable
for reporting most laboratory findings of public health importance.  This guide is an implementation guide
based on the final release of HL7, version 2.3.  No violations of the standard have been made.  Any
user-defined variations are clearly described.   Reporting requirements vary by state.  For reportable
elements and reporting locations, laboratories are referred to state health departments in their states.
1.3 Contact
Dan Jernigan, MD, MPH
National Center for Infectious Diseases
Centers for Disease Control and Prevention, at





An electronic copy of this document can be can be requested by E-mail.
2.0 Definitions
The specifications presented in this guide were developed using HL7 version 2.3.  Many tables
referenced in the discussion of the message segments below can be found in Appendix B at the end of
the guide; tables not in the appendix can be found in the HL7 2.3 document.  Information about the HL7
Standard for electronic data exchange can be found at the Duke HL7 Health Informatics Internet site on
the world wide web (http://www.mcis.duke.edu/standards/HL7/hl7.htm).  Readers are referred to the
standard document and related documents on the web site for a more detailed explanation of each of the
data types below.  
2.1 Table Abbreviations 
The abbreviated terms and their definitions used in the segment table headings are as follows:
SEQ - The sequence of the elements as they are numbered in the segment.
LEN - The length of the element.
DT - The data type of the element.  The data types are described in 2.2 below.
OPT - Whether the field is required, optional, or conditional in a segment.  Required fields are
defined by HL7 2.3 and do not refer to requirements for reporting laboratory findings to
public health agencies.  The designations are:
R - Required.
O - Optional.
C - Conditional on the trigger event or on some other field(s).  The field definitions
following the segment attribute table should specify the algorithm that defines
the conditionality for the field.
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X - Not used with this trigger event.
B - Left in for backward compatibility with previous versions of HL7.  The field
definitions following the segment attribute table should denote the optionality of
the field for prior versions.
RP/# - Indicates if element repeats and number of times.
TBL# - Specific table reference.  Tables are listed in Appendix B.
ITEM# - HL7 unique item number for each element.
Element Name - Descriptive name of element in the segment.
2.2 Data Types
The abbreviated data type names used in the implementation guide are as follows:
CE = coded element SN = structured numeric
CK = composite ID w/check digit ST = string
CQ = composite quantity w/units TQ = timing quantity
CX = extended composite ID w/check digit TS = time stamp
DLN = driver’s licence number TX= text data
DT = date XAD = extended address
EI = entity identifier XCN = extended composite ID number and  
HD = hierarchic designator name for persons
ID = coded value XON = extended composite name and ID
IS = sequence ID number for organizations
NM = numeric XPN = extended person name
PT = processing type XTN = extended telecommunications number
SI = sequence ID 
3.0 Communications
The specifications presented in this guide allow for acknowledgment messages to be sent from the
receiver of the laboratory-based reporting message as a receipt to the sender.  These acknowledgment
messages may be useful in verifying that complete messages were received.  The use of
acknowledgment messages are not described in this guide; a full description can be found in HL7 2.3. 
Encryption and mechanisms for transmitting messages are not described in this guide.
4.0 Unsolicited Observation Message
Laboratories may report to public health agencies using the unsolicited observation message (i.e., ORU). 
The ORU is a collection of segments which are described below.  The segments are not unique to the
ORU but can be found in combination with other segments in other HL7 messages.  The ORU does not
contain certain elements that are important for public health reporting.  For this reason, a segment for
laboratory-based reporting of additional information to public health agencies (i.e., ZLR) has been
defined.  The addition of the ZLR follows HL7 convention for user-defined segments as described further
below.  The ZLR is not defined in the HL7 2.3 standard and therefore no discussion of the segment will
be found in the standard document.  
4.1 ORU Message Structure
The message for reporting public health information follows the HL7 2.3 ORU structure.   Braces "{ }"
denote repeatable segments; brackets "[ ]" denote optional segments.  Using the basic “building blocks”
of PID, OBR, and OBX segments (in bold type below), a clinical report can be constructed as a three-
level hierarchy with the patient information (PID) segment at the upper level, an order record (OBR) at
the next level, and one or more observation records (OBX) at the bottom.  The ZLR segment, defined for
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laboratory-based reporting, can be considered an extension of the OBR segment.
MSH Message Header                              
{
  [
    PID Patient Identification     
     [PD1] Additional Demographics
[{NTE}] Notes and Comments
[PV1 Patient Visit





ZLR Additional Information for Laboratory-Based Reporting
{[NTE]} Notes and Comments
{
[OBX] Observation/Result                             
{[NTE]} Notes and Comments
}
{[CTI]} Clinical Trial Identifier
}
   }             
[DSC] Continuation Pointer
While certain elements of the message are required for laboratory-based reporting, messages with data
populating non-required fields will not be rejected.  While the ORU allows for the use of PD1, NTE, PV1,
PV2, ORC, CTI, and DSC, these segments will not be used in the laboratory-based reporting message. 
For this reason, there is no discussion of these segments in this implementation guide.  Messages
containing these segments will not be rejected.
4.2 Segment Mapping
Each segment of the ORU used in the laboratory-based reporting message is discussed below.  A table
of the attributes for each segment leads a detailed description of each element. 
4.2.1 MSH Segment - Message Header
The message header segment (MSH) defines the intent, source, destination, and some specifics of the
syntax of a message.  The attributes of the message header segment are listed in the table below.
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MSH Attributes
SEQ LEN DT TBL# RP/# ITEM# OPT ELEMENT NAME
1 1 ST 00001 R Field separator
2 4 ST 00002 R Encoding characters
3 180 HD 00003 O Sending application
4 180 HD 00004 O Sending facility
5 180 HD 00005 O Receiving application
6 180 HD 00006 O Receiving facility
7 26 TS 00007 O Date/time of message
8 40 ST 00008 O Security
9 7 CM 00009 R Message type
10 20 ST 00010 R Message control ID
11 3 PT 00011 R Processing ID
12 8 ID 00012 R Version ID
13 15 NM 00013 O Sequence number
14 180 ST 00014 O Continuation pointer
15 2 ID 0155 00015 O Accept acknowledgment type
16 2 ID 0155 00016 O Application acknowledgment type
17 2 ID 00017 O Country code
18 6 ID 0211 Y/3 00692 O Character Set
19 60 CE 00693 O Principal Language of Message
Example Segment of MSH:
MSH|^~\&||MediLabCo-Seattle^45D0470381^CLIA|NPHSS|WA-DOH
|199602171830||ORU^R01||P|2.3
If elements that contain no data (e.g., “||”) appear at the end of a segment, HL7 allows the
elements to not appear.  For example, the message above has no data populating elements 13-
19, thus, the segment ends at element 12 (i.e., ...|2.3 ).
MSH-1 Field Separator (ST)
This field contains the separator between the segment ID, (i.e., “MSH”) and the first real field,
MSH-2-encoding characters.  As such it serves as the separator and defines the character to be
used as a separator for the rest of the message.  Recommended value is ‘|’, ASCII (124).
MSH-2 Encoding Characters (ST)
Recommended values for laboratory-based reporting are:
Component - ‘^’ ASCII(94)
Repetition - ‘~’ ASCII(126)
Escape - ‘\’ ASCII(92)
Subcomponent - ‘&’ ASCII(38)
Note that the characters in MSH-2 appear as:
|^~\&|
The order of the characters does not denote a hierarchy of separators; only ‘^’ and ‘&’ are to be
used as separators in an element.  Thus, an example of a compound element using components
and subcomponents from PID-2 described later would appear as:
|10543^^^^^Columbia Valley Memorial Hospital&01D0355944&CLIA|
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and not as:
|10543^^^^^Columbia Valley Memorial Hospital~01D0355944~CLIA|
The tilde, ‘~’, should not be used as a separator but rather should be used to identify when a
repeating field or component occurs.
MSH-3 Sending Application (HD)
Field is optional and may be left blank.  The identification of the sending laboratory appears in
MSH-4.
MSH-4 Sending Facility (HD)
The originator of the HL7 message will place the text name of the sending laboratory or reporting
site, followed by the unique Clinical Laboratory Improvement Act (CLIA) identifier of the
originating institution.  Information about CLIA can be found at
http://www.cdc.gov/phppo/dls/dlshome.htm on the world wide web.  For example:
|MediLabCo-Seattle^45D0470381^CLIA|
The data type is a hierarchic designator (HD) which has the components:
<namespace ID (IS)> ^ <universal ID  (ST)> ^ <universal ID type (ID)>
HL7 allows MSH-4 to be entirely defined by the user.  For laboratory-based reporting, MSH-4 is
defined as the following:
namespace ID - text name of the sending laboratory
universal ID - CLIA number for the sending laboratory
universal ID type - “CLIA” , indicating that the universal ID is a nationally-assigned
unique identifier
MSH-5 Receiving Application (HD)
The field should contain either the abbreviation for the National Public Health Surveillance
System (NPHSS) to denote an electronic laboratory-based report for communicable diseases or
the abbreviation for the North American Association of Central Cancer Registries (NAACCR) for
an electronic laboratory-based report for cancer pathology.  For example:
|NPHSS|
Since only the first component of the HD (“namespace ID”) is used, it is not necessary to use “^”
for the second and third components since they are blank.
MSH-6 Receiving Facility (HD)
Field is optional and may be left blank.  Certain public health agencies may request that a unique
identifier for the state health department or specific program appear here.  For example:
|WA-DOH|
MSH-7 Date/Time of Message (TS)
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Field will contain the date and time that the message was generated using the HL7-defined
timestamp (TS) which has the following components:
YYYY[LL[DD[HHMM[SS[.S[S[S[S]]]]]]]] [+/-ZZZZ] ^ <degree of precision>
where Y=year, L=month, D=day, H=hour, M=minute, S=second, and Z=the time zone relative to
Greenwich standard time.  For example, 6:30 pm, February 17, 1996 in the Pacific time zone
would appear as:
|199602171830-0900|
The time zone is optional.  Times reported will be assumed relative to the sending facility.
MSH-8 Security (ST)
Field is optional and may be left blank.
MSH-9 Message Type (CM)
The message is an unsolicited transmission of an observation message and appears as:
|ORU^R01|
MSH-10 Message Control ID (ST)
Field is required by HL7 2.3, however, the field will not be used for laboratory-based reporting.
MSH-11 Processing ID (PT)
Field appears as T for training, P for production, or D for debugging.  Data sent for reporting
should appear as a P; D can be used in early phases of implementation.  For example:  |P|
MSH-12 Version ID (ID)
Version 2.3 is strongly recommended: |2.3|
MSH-13 Sequence Number (NM)
Field is optional and may be left blank.
MSH-14 Continuation Pointer (ST)
Field is optional and may be left blank.
MSH-15 Accept Acknowledgment Type (ID)
Field is optional and may be left blank.
MSH-16 Application Acknowledgment Type (ID)
Field is optional and may be left blank.
MSH-17 Country Code (ID)
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Field is optional and may be left blank.
MSH-18 Character Set (ID)
This field contains the character set for the entire message.  Only printable 7-bit ASCII
characters should be used for laboratory-based reporting.  The field should be left blank; HL7
assumes that 7-bit ASCII characters are used when MSH-18 is left blank.
MSH-19 Principal Language of Message (CE)
Field is optional and may be left blank.
4.2.2 PID Segment - Patient Identification  
The PID segment is used as the primary means of communicating patient identification information. 
This segment contains permanent patient identifying and demographic information that is not likely to
change frequently.
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   PID Attributes
SEQ LEN DT TBL# RP/# ITEM# OPT ELEMENT NAME
1 4 SI 00104 O Set ID - Patient ID
2 20 CX 00105 O Patient ID (External ID)
3 20 CX Y 00106 R Patient ID (Internal ID)
4 20 CX Y 00107 O Alternate Patient ID - PID
5 48 XPN Y 00108 R Patient Name
6 48 XPN 00109 O Mother's Maiden Name
7 26 TS 00110 O Date/Time of Birth
8 1 IS 0001 00111 O Sex
9 48 XPN Y 00112 O Patient Alias
10 1 IS 0005 00113 O Race
11 106 XAD Y 00114 O Patient Address
12 4 IS 00115 B County Code
13 40 XTN Y 00116 O Phone Number - Home
14 40 XTN Y 00117 O Phone Number - Business
15 60 CE 0296 00118 O Primary Language
16 1 IS 0002 00119 O Marital Status
17 3 IS 0006 00120 O Religion
18 20 CX 00121 O Patient Account Number
19 16 ST 00122 O SSN Number - Patient
20 25 DLN 00123 O Driver's Lic Num - Patient
21 20 CX Y 00124 O Mother's Identifier
22 3 IS 0189 00125 O Ethnic Group
23 60 ST 00126 O Birth Place
24 2 ID 0136 00127 O Multiple Birth Indicator
25 2 NM 00128 O Birth Order
26 4 IS 0171 Y 00129 O Citizenship
27 60 CE 0172 00130 O Veterans Military Status
28 80 CE 00739 O Nationality
29 26 TS 00740 O Patient Death Date and Time
30 1 ID 0136 00741 O Patient Death Indicator
Example Segment of PID





PID-1 Set ID-patient ID (SI)
This field allows for multiple PID segments (i.e. multiple patient reports) with a single MSH.  The
Set ID field is used to identify repetitions.  For laboratory-based reporting, it is strongly
recommended that information for only one patient be sent per message, in other words, one
PID per MSH.  Thus, PID-1 may be left blank or should appear as:   |1|
PID-2 Patient ID (external ID) (CX)
HL7 2.3 has defined two places for a patient identifier (i.e., medical record number).  PID-2
allows a reporting laboratory to provide the medical record number assigned at an original
institution which submitted a specimen for testing.  PID-3 allows a reporting laboratory to provide
the medical record number assigned at their own institution.  The field has the following
components: 
<ID (ST)> ^ <check digit (ST)> ^ <code identifying the check digit scheme employed
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(ID)> ^ <assigning authority (HD)> ^ <identifier type code (IS)> ^ <assigning facility
(HD)>
The <assigning facility> is a HD data type as described in MSH-4 and has the following
subcomponents:
<namespace ID (IS)> ^ <universal ID  (ST)> ^ <universal ID type (ID)>
This field will be used for the patient’s unique identifier that was assigned at an originating
laboratory before the specimen was sent to a reference laboratory.  The field will also contain the
unique CLIA identifier for the originating laboratory.  The institution that eventually performed the
test and thus will report the result, for instance a commercial reference laboratory, will provide a
unique patient identifier as well in PID-3 below.  
For instance, an isolate from the Columbia Valley Memorial Hospital laboratory is sent to a
reference laboratory named MediLabCo; the result is reported by MediLabCo.  PID-2, the
external ID, would contain the unique patient identifier (usually a medical record number)
assigned at the originating institution (i.e., Columbia Valley Memorial Hospital) in the <ID (ST)>
component.  The unique CLIA identifier for Columbia Valley Memorial Hospital would appear in
the <assigning facility (HD)> component.  Since HL7 allows users to define the subcomponents
of the HD data type, the assigning facility in PID-2 has the following definition for the laboratory-
based reporting message:
namespace ID - Name of originating laboratory
universal ID - Unique CLIA number of originating laboratory
universal ID type - “CLIA”
This is analogous to the description of the sending facility in MSH-4.  The above described
example would appear as:   
|10543^^^^^Columbia Valley Memorial Hospital&01D0355944&CLIA|
In this example, <10543> is the patient’s medical record number, the <^^^^^> shows that the four
HL7 components “check digit”,  “code identifying the check digit scheme employed”, “assigning
authority”, and “identifier type code” are not required and thus are empty.  The next component,
<Columbia Valley Memorial Hospital &01D0355944&CLIA>, follows the user-defined HD data
type described above and contains 1) the name of the originating laboratory, 2) the CLIA
identifier for the originating laboratory, and 3) the coding system “CLIA” to denote that the
preceding identifier is a nationally-unique identifier.
Some reporting laboratories may not have the unique patient identifiers that were assigned at the
originating institution.  If this is the case, PID-2 may be left blank.
PID-3 Patient ID (internal ID) (CX) 
PID-3 is essentially the patient identifier (i.e., medical record number) from the laboratory which
is submitting the report to public health officials.  The field has the same components as PID-2: 
<ID (ST)> ^ <check digit (ST)> ^ <code identifying the check digit scheme employed
(ID)> ^ <assigning authority (HD)> ^ <identifier type code (IS)> ^ <assigning facility
(HD)>
The <assigning facility> is a HD data type as described above and has the following
user-defined subcomponents:
HL7 Specifications - Page 13
<namespace ID (IS)> ^ <universal ID  (ST)> ^ <universal ID type (ID)>
Since HL7 allows users to define the subcomponents of the HD data type, the <assigning
facility> has the following definition for the laboratory-based reporting message:
namespace ID - Name of originating laboratory
universal ID - Unique CLIA number of originating laboratory
universal ID type - “CLIA”
This is analogous to the description of the assigning facility in PID-2.  PID-3 (Patient ID -
internal ID) will be the primary patient identifier for the laboratory-based reporting
message.  In the laboratory reporting scenario described in PID-2, the unique patient identifier
from MediLabCo would appear in this field along with the name and CLIA number for
MediLabCo.  The above described example would appear as:
|95101100001^^^^^MediLabCo-Seattle&45D0470381&CLIA|
If a hospital laboratory will be reporting the result (and thus there will be only one hospital
involved in collection and processing of the specimen) then the hospital laboratory’s patient
identifier and the hospital CLIA ID will appear in the “internal ID”; no information will appear in
the “external ID”.  Equally, if a reference laboratory receives a specimen from a doctor’s office
and no preceding originating laboratory is used, then the reference laboratory’s patient identifier
and reference laboratory CLIA ID will appear in the “internal ID”; no information will appear in the
“external ID”.  
If a hospital laboratory is reporting the results of a test performed at a reference laboratory, the
“Alternate Patient ID” below should have the unique patient identifier assigned by the reference
laboratory.  The hospital laboratory that is reporting the finding would give their unique patient
identifier here in PID-3.
This field, along with  “Patient Name” (PID-5), are listed as required fields by HL7 2.3.  Although
uncommon, some laboratories may not currently collect information which may be used for either
PID-3 or PID-5.  It is strongly recommended that either a personal identifier unique to the testing
laboratory (PID-3) or the patient name (PID-5) be provided; however, if neither are available
the message for reporting should still be sent with the following populating the field: 
|nodata|
This is an exception to the standard HL7 2.3 optionality for the PID segment.
PID-4 Alternate Patient ID (CX)
For laboratory-based  reporting, PID-4 should be used for the unique patient identifier assigned
by an outside laboratory that performed the test.  For instance, Columbia Valley Memorial
Hospital has sent a specimen to MediLabCo for testing.  The test is performed and the results
are sent back to Columbia Valley Memorial Hospital which then electronically transmits the
results to a public health agency.  The unique patient identifier from Columbia Valley Memorial
Hospital would appear in PID-3, and the unique patient identifier from MediLabCo would appear
in PID-4.  Identification of the outside laboratory performing the test will appear in OBX-15 (i.e.,
Producer’s ID).  The CX data type and HD have been described above in PID-2 and PID-3.  For
example:
|95101100001^^^^^MediLabCo-Seattle&45D0470381&CLIA|
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The patient’s age should not be reported here, but should appear in ZLR-5 if no date of birth is
known.
PID-5 Patient Name (XPN)
Field has the following components:
<family name (ST)> ^ <given name (ST)> ^ <middle initial or name (ST)> ^ <suffix (e.g.,




This field, along with  “Patient ID (Internal ID)” (PID-3), are listed as required fields for HL7 2.3.
Although uncommon, some laboratories may not currently collect information which may be used
for either PID-3 or PID-5.  It is strongly recommended that either a personal identifier unique to
the testing laboratory (PID-3) or the patient name (PID-5) be provided; however, if neither are
available the message for reporting should still be sent with the following populating the
field: 
|nodata|
This is an exception to the HL7 2.3 optionality for the PID segment.
Cancer Reporting Comment: PID-5 corresponds to NAACCR version 5.0 item numbers
2230,2240,2250
PID-6 Mother’s Maiden Name (XPN) 
The field is optional but is recommended if available.  The components are the same as
described in PID-5.  For example:
|Clemmons|
PID-7 Date/Time of Birth (TS) 
The field has the same structure as defined for MSH-7.  The field should contain at least the
year, month, and date.  For example:
|19641004|
If the patient’s age only is available, HL7 2.3 allows the degree of precision to be changed so
that only the year is provided:
|1964|  
This is strongly discouraged for laboratory-based reporting.  An alternative method for sending
patient age is provided in “Patient’s Age” in the ZLR segment described below.
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 240
PID-8 Sex (IS)
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HL7 allows users to define the values for Table 0001.  The CDC-recommended values for the
laboratory-based reporting message are:






U Unknown / not stated
 
For example: |M|
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 220 
PID-9 Patient Alias (XPN)
This field contains the names by which the patient has been known at some time.  Although the
field is optional, it is recommended that the data be sent if available.  The field may repeat
multiple times for multiple different patient aliases.
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 2280
PID-10 Race (IS)
HL7 allows users to define the values for Table 0005.  The values below are recommended for
the laboratory-based reporting message:




A Asian or Pacific Islander





Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 160.  Note
NAACCR codes for race are different.
 
PID-11 Patient Address (XAD)
This field contains the mailing address of the patient.  This information is of great importance to
agencies receiving laboratory-based reports.  The information allows health officials to notify
local agencies of potential public health problems in their jurisdictions. 
Multiple addresses for the same person may be sent (using the repetition character “~”) in the
following sequence: the primary mailing address must be sent first in the sequence; if the
primary mailing address is not sent then a repeat delimiter must be sent in the first sequence.  
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The field has the following components:
<street address (ST)> ^ < other designation (ST)> ^ <city (ST)> ^ <state or province
(ST)> ^ <zip or postal code (ST)> ^ <country (ID)> ^ <address type (ID)> ^ <other
geographic designation (ST)> ^ <county/parish code (IS)> ^ <census tract (IS)>
For example:
|2166 Wells Dr^Apt B^Seattle^WA^98109^USA^^^King|
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item numbers
70,80,100,2330
PID-12 County Code (IS)
According to HL7 v. 2.3, county code should appear in the component <county/parish code> in
the “Patient Address” field above.  The element PID-12 was left in by HL7 for backward
compatibility.
PID-13 Phone Number - Home (XTN)
Field will follow the HL7-defined structure for extended telecommunications number, data type
XTN, which has the following components:
[NNN] [(999)]999-9999 [X99999] [B99999] [C any text] ^  <telecommunication use code
(ID)> ^ <telecommunication equipment type (ID)> ^ <E-mail address (ST)> ^ <country
code (NM)> ^ <area/city code (NM)> ^ <phone number (NM)> ^ <extension (NM)> ^
<any text (ST)>
Components five through nine reiterate the basic function of the first component in a delimited
form that allows the expression of both local and international telephone numbers.  In HL7
Version 2.3, the recommended form for the telephone number is to use the delimited form rather
than the unstructured form supported by the first component (which is left in for backward
compatibility only).  Alternative home phone numbers can be provided with the repeating
character “~”.  For laboratory-based  reporting, phone numbers provided in the first component
of PID-13 will be accepted as well.
For example: |^^^^^206^6793240^^call after 5:00 pm only ~ ^^^^^206^6795772|
or  |(206) 679-3240|
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 2360.
PID-14 Phone Number - Business (XTN)
Field will follow the HL7-defined structure for extended telecommunications number (XTN) as
described in PID-13.
PID-15 Primary Language - Patient (CE)
This field contains the patient’s primary language.  HL7 recommends using ISO table 639 as the
suggested values in user-defined table 0296 - Language.   The field is optional and may be left
blank.
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PID-16 Marital Status (IS)
Field uses the values listed in HL7 Table 0002.  Field is optional and may be left blank.








Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 150.
PID-17 Religion (IS)
Field is optional and may be left blank.
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 260.
PID-18 Patient Account Number (CX)
Field is optional and may be left blank.  The field may be used as an alternative patient identifier
from the laboratory.
PID-19 Social Security Number (SSN) (ST)
This field contains the patient’s social security number.  The field is optional, however, it is
recommended that the field be sent if available for laboratory-based reporting.  The field should
contain the 9 digit SSN without hyphens or spaces.
For example: |423523049|
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 2320.
PID-20 Driver’s License Number (DLN)
Field is optional and may be left blank.  The data type “Driver’s License Number” (DLN) has the
following structure:
<license number (ST)> ^ <issuing state, province, country (IS)> ^ <expiration date (DT)
For example: |DOEJ34556057^WA^19970801|
PID-21 Mother’s Identifier (CX)
Field has the following components:
<ID (ST)> ^ <check digit (ST)> ^ <code identifying the check digit scheme employed
(ID)> ^ <assigning authority (HD)>^<identifier type code (IS)>^<assigning facility (HD)>
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This field is optional; however, it is recommended that it be sent if available.  The field may be
used to further identify a neonatal patient during an admission for delivery.  The fourth
component, <assigning facility (HD)>, has the same subcomponents as described in PID-2 and
PID-3.  For example:
|10096^^^^^Columbia Valley Hospital&01D0355944&CLIA|
PID-22 Ethnic Group (IS)
HL7 allows users to define the values for Table 0189.  The following table should be used for
laboratory-based reporting if the ethnic group of the patient is known:







Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 190.  Note
that NAACCR codes for ethnic group are different
PID-23 Birth Place (ST)
Field is optional and may be left blank.
PID-24 Multiple Birth Indicator (ID)
Field is optional and may be left blank.  HL7 requires the use of HL7 table 0136 - Yes/No
Indicator  for PID-24 where Y=yes and N=no.
PID-25 Birth Order (NM)
Field is optional and may be left blank.
PID-26 Citizenship (IS)
Field is optional and may be left blank.
PID-27 Veteran’s Military Status (CE)
Field is optional and may be left blank.
PID-28 Nationality (CE) 
Field is optional and may be left blank.
PID-29 Patient death date and time (TS)
Field is optional for HL7 2.3 but is recommended for laboratory-based reporting if available.
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PID-30 Patient death indicator (ID) 
Field is optional for HL7 2.3 but is recommended for laboratory-based reporting if available.  HL7
requires the use of HL7 table 0136 - Yes/No Indicator  for PID-30 where Y=yes and N=no.   An
example for a patient that died is:   |Y|. 
4.2.3 OBR Segment - Observation Request
The Observation Request (OBR) segment is used to transmit information specific to an order for a
diagnostic study or observation, physical exam, or assessment.  The OBR defines the attributes of a
particular request for diagnostic services or clinical observations.  For laboratory-based reporting, the
OBR defines the attributes of the original request for laboratory testing.  Essentially, the OBR describes a
battery or panel of tests that are being requested or are being reported.  The OBR is somewhat
analogous to a generic lab slip which gets filled when a lab test is requested by a physician.  The
individual test names and results for the panel of tests that was performed are reported in OBX segments
which are described below.  There can be many OBX’s per OBR, and there can be many OBR’s per PID. 
There is only one ZLR per OBR and for laboratory-based reporting there should be only one PID per
MSH.
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OBR Attributes
SEQ LEN DT OPT RP/# TBL# ITEM # ELEMENT NAME
1 4 SI C 00237 Set ID -  OBR
2 22 EI C 00216 Placer Order Number
3 22 EI C 00217 Filler Order Number 
4 200 CE R 00238 Universal Service ID
5 2 ID X 00239 Priority
6 26 TS X 00240 Requested Date/Time
7 26 TS C 00241 Observation Date/Time 
8 26 TS O 00242 Observation End Date/Time 
9 20 CQ O 00243 Collection Volume 
10 60 XCN O Y 00244 Collector Identifier 
11 1 ID O 0065 00245 Specimen Action Code 
12 60 CE O 00246 Danger Code
13 300 ST O 00247 Relevant Clinical Info.
14 26 TS C 00248 Specimen Received Date/Time 
15 300 CM O 0070 00249 Specimen Source 
16 80 XCN O Y 00226 Ordering Provider
17 40 XTN O Y/2 00250 Order Callback Phone Number
18 60 ST O 00251 Placer field 1
19 60 ST O 00252 Placer field 2
20 60 ST O 00253 Filler Field 1 
21 60 ST O 00254 Filler Field 2 
22 26 TS C 00255 Results Rpt/Status Chng - Date/Time 
23 40 CM O 00256 Charge to Practice 
24 10 ID O 0074 00257 Diagnostic Serv Sect ID
25 1 ID C 0123 00258 Result Status 
26 400 CM O 00259 Parent Result 
27 200 TQ O Y 00221 Quantity/Timing
28 150 XCN O Y/5 00260 Result Copies To
29 150 CM O 00261 Parent Number
30 20 ID O 0124 00262 Transportation Mode
31 300 CE O Y 00263 Reason for Study
32 200 CM O 00264 Principal Result Interpreter 
33 200 CM O Y 00265 Assistant Result Interpreter  
34 200 CM O Y 00266 Technician 
35 200 CM O Y 00267 Transcriptionist 
36 26 TS O 00268 Scheduled Date/Time 
37 4 NM O 01028 Number of Sample Containers 
38 60 CE O Y 01029 Transport Logistics of Collected Sample 
39 200 CE O Y 01030 Collector's Comment 
40 60 CE O 01031 Transport Arrangement Responsibility
41 30 ID O 0224 01032 Transport Arranged
42 1 ID O 0225 01033 Escort Required
43 200 CE O Y 01034 Planned Patient Transport Comment
Examples of OBR segments:
For antimicrobial susceptibility testing:
OBR|2||MB99012|06730^MIC susceptibility test^L|||199601301530||||||||BLDV^Blood venous 
|^Jones^Marcus^F^Jr^Dr^MD|^^^^^206^3231921||||||||F|600-7&Microorganism identified, Blood
Culture&LN^^L-25116&Streptococcus pneumoniae&SNM
For Hepatitis A Virus testing:
OBR|1||SER122145|78334^Hepatitis Panel,
Measurement^L|||199603210830||||||||BLDV|^Welby^M^J^Jr^Dr^MD|^^^^^206^4884144||||||||F
For blood lead testing:
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OBR|5||CH96779||||199601210730||||||||BLDC^Blood capillary|^Everett^C^Sr^Dr^MD
|^^^^^206^488-0911||||||||F
OBR-1 Set ID - OBR (SI)
Field should identify the sequence number of one of multiple OBR’s under one PID.  For the first
order transmitted, the sequence number is 1, for the second order, it is 2, and so on.  If more
than one OBR per PID is transmitted, this field should be used.
For example, the second OBR under a single PID would appear as: |2|
OBR-2 Placer Order Number (EI)
The placer order number identifies an order uniquely among all orders from a particular ordering
application.  This field should be sent if available.  The data type “EI” is described below.  This
field should not contain the accession number for a specimen.
OBR-3 Filler Order Number (EI)
The field has the following components:
<unique filler ID (ST)> ^ <filler application ID>
The field will be used to report the laboratory specimen accession number.  This is the unique
identifier that the laboratory uses to track specimens.  The second component is not used.  For
example:
|MB99012|
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 2780.  The
combination of laboratory ID and filler order number will
uniquely identify a case.  If a filler order number may recycle
with a single year period, a month identifier (01 through 12)
should be prepended to it.
OBR-4 Universal Service ID (CE)
This field is the identifier code for the requested observation/test/battery.  The field is a
compound element (CE) and has the following components:
<identifier (ID)> ^ <text (ST)> ^ <name of coding system (ST)>^<alternate identifier
(ID)> ^ <alternate text (ST)> ^ <name of alternate coding system (ST)>
An example for a report of antimicrobial susceptibility would appear as:
|P3-55230^MIC susceptibility test, NOS^SNM|
The first component of the field, <P3-55230> is the Systematized Nomenclature of Human and
Veterinary Medicine (SNOMED) code for a general MIC test which has been performed and
which will have its individual antimicrobial susceptibility results reported in the OBX segment
described later.  The second component is the name of the test, <MIC susceptibility test, NOS>
as it appears in the SNOMED coding system.  SNOMED is described further in OBX-5 below. 
The third component is the name of the coding system, <SNM> which has the table where the
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codes and names of the tests can be found. Coding systems other than SNOMED, such as
LOINC (Logical Observation Identifier Names and Codes) or local codes can be used for OBR-4. 
No coding recommendation for  laboratory-based reporting has been made for OBR-4 since the
field describes the originally-requested order (e.g., a hepatitis panel or antimicrobial susceptibility
testing battery).  The “informative field” for laboratory-based reporting is OBX-3 described
below.  OBX-3 should be used to provide an unambiguous, specific test name and OBX-5
should provide the result to the test.   No specific coding system is described for OBR-4 and
information in OBR-4 will not be used routinely.  Examples of  messages for different laboratory-
reportable findings are given in Appendix A.
An example for a report of a hepatitis panel would appear as:
|78334^Hepatitis Panel, Measurement^L|
Here the code is a user-defined “local” code as indicated by the <L> in the third subcomponent. 
Note that the “Universal Service ID” is a code which often describes the battery or collection of
tests that make up a routine laboratory panel.  The individual results of the different components
of the hepatitis panel are reported in the OBX segment described below.  For most laboratory
tests that are reportable to public health officials, the description of the test and result is
sufficiently given in OBX alone.  Information in OBR-4 will not be used routinely.  An example of
this is given in Appendix A for Blood Lead reporting.
OBR-5 Priority (ID)
Field is optional and may be left blank.
OBR-6 Requested Date/Time (TS)
Field is optional and may be left blank.
OBR-7 Observation Date/Time (TS)
Field follows the HL7 timestamp (TS) structure described previously.  This field is the clinically
relevant date/time of the observation.  Field should reflect the specimen collection date/time. 
For example:
|199601301530|
OBR-8 Observation End Date/Time (TS)
Field is optional and may be left blank.
OBR-9 Collection Volume (CQ)
Field is optional and may be left blank.
OBR-10 Collector Identifier (XCN)
Field is optional and may be left blank.
OBR-11 Specimen Action Code (ID)
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Field is optional and may be left blank.
OBR-12 Danger Code (CE)
Field is optional and may be left blank.
OBR-13 Relevant Clinical Information (ST)
Field is optional and may be left blank.  This field contains any additional clinical information
about the patient or specimen.  This field is used to report the suspected diagnosis and clinical
findings on requests for interpreted diagnostic studies.  Examples include reporting the amount
of inspired carbon dioxide for blood gases, the point in the menstrual cycle for cervical pap tests,
and other conditions that influence test interpretations.  Relevant epidemiologically important
information (e.g., day-care center attendee, or nursing home patient) can be placed here;
however, there are no recommendations for specific use of this field for laboratory-based
reporting.
OBR-14 Specimen Received Date/Time (TS)
Field is optional and may be left blank.
OBR-15 Specimen Source (CM)
Field will use HL7 Table 0070 for specimen sources found in Appendix B.  The field has the data
type “composite” (i.e., CM) and has the following components:
<specimen source name or code (CE)> ^ <additives (TX)> ^ <freetext (TX)> ^ <body site
(CE)> ^ <site modifier (CE)>
The component <specimen source name or code (CE)>, <body site (CE)>, and <site
modifier (CE)> are coded elements and have the subcomponents <code&text&name of
coding system> as described previously.
An example for an isolate from a blood culture is:
|BLDV&Blood venous^^^T-D8400&Antecubital Region&SNM^LACF&Left Antecubital
Fossa|
where <BLDV> is the code, <Blood venous> is the text of the code.  Since there is no description
for the third subcomponent “coding system”, it is assumed that HL7 table 0070 is used since it is
the default coding system.  Additional description can be given in the “body site” and “site
modifier” fields using SNOMED or HL7 codes.  Here, <T-D8400&Antecubital Region&SNM> is
the SNOMED code for the body site, and <LACF&Left Antecubital Fossa> is the site modifier. 
Since there is no third subcomponent in the final component, it is assumed that the coding
system is HL7 table 0163, “Administrative Site”.  
An example for a specimen from a finger stick collection for blood lead testing where only the
specimen source is provided:
|BLDC&Blood Capillary|
An example for a stool specimen which yielded a reportable enteric organism is:
|STL&Stool=Fecal|
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It is strongly recommended that actual specimen sources be provided in OBR-15 and not
surrogate descriptions such as “lavender-top” or “serum-separator tube”.
OBR-16 Ordering Provider (XCN)
The field has the data type “extended composite ID number and name for persons” (XCN) which
differs from XPN previously described.  The components are:
<ID number (ST)> ^ <family name (ST)> ^ <given name (ST)> ^ <middle initial or name
(ST)> ^ <suffix (e.g., JR or III) (ST)> ^ <prefix (e.g., DR) (ST)> ^ <degree (e.g., MD)
(ST)> ^ <source table (IS)> ^ <assigning authority (HD)>
For example:
|^Jones^Marcus^F^Jr^Dr^MD|
Public health agencies may request that the ordering provider’s address also be provided so that
health officials can contact providers to obtain additional information during public health
investigations.  However, HL7 has not provided for the ordering provider’s address in the ORU. 
For this reason, the ordering provider’s address should be given in the ZLR segment described
below.
OBR-17 Order Callback Phone Number (XTN)
The phone number for the ordering provider listed in OBR-16 should appear here.  The
components have been previously described in PID-13.
For example: |^^^^^206^277-0908^^call before 5:00 pm only~ ^^^^^206^5620767|
or  |(206) 277-0908|
OBR-18 Placer Field #1 (ST)
Field is optional and may be left blank.
OBR-19 Placer Field #2 (ST)
Field is optional and may be left blank.
OBR-20 Filler Field #1 (ST)
Field is optional and may be left blank.
OBR-21 Filler Field #2 (ST)
Field is optional and may be left blank.
OBR-22 Results Report/Status Change - Date/Time (TS)
This field specifies the date/time results reported or status changed.  This field is used to indicate
the date and time that the results are composed into a report and released, or that a status, as
defined in Order Status, is entered or changed.  It is recommended that this be sent if available.
OBR-23 Charge to Practice (CM)
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Field is optional and may be left blank.
OBR-24 Diagnostic Service Section ID (ID)
Field is optional and may be left blank.
OBR-25 Result Status (ID)
This field is required and may have the following values found in HL7-defined Table 0123:
Result Status Table 0123
Value Description Value Description
O -Order received; specimen not yet received R -Results stored; not yet verified
I -No results available; specimen received, procedure F -Final results; results stored and verified.  Can
S -No results available; procedure scheduled, but not done X -No results available; Order canceled.
A -Preliminary: A verified early result is available, final  queries)
P results not yet obtained Z -No record of this patient. (Used only on queries)
C
incomplete only be changed with a corrected result.
-Some, but not all, results available Y -No order on record for this test.  (Used only on
-Correction to results   
Some public health agencies may want to have preliminary results for certain tests.  The
decision to transmit final versus preliminary results may vary from state to state.  
OBR-26 Parent Result (CM)
Field has the following components:
<OBX-3-observation identifier of parent result (CE)> ^ <OBX-4-sub-ID of parent result
(ST)> ^ <part of OBX-5-observation results from parent (TX) [see discussion]>
The first component is a coded element and has the following structure:
<identifier (ST)> ^ <text (ST)> ^ <name of coding system (ST)> ^ <alternate
identifier (ST)> ^ <alternate text (ST)> ^ <name of alternate coding system
(ST)>
This field is defined so that links to messages describing previously-performed tests can be
made.  This important information, together with the information in OBR-29 parent number,
uniquely identifies the parent result's OBX segment related to this order (a full description of the
OBX segment is listed below).  For instance, if the current battery (as designated in the present
OBR-4) is an antimicrobial susceptibility test, the present parent result (OBR-26) contains the
result from a previously-performed test which identified the organism on which the sensitivities
are presently run.  Thus, the OBX-3, OBX-4, and OBX-5 from a previous message appear in this
field of the present OBR.
It is important to note that this field does not take the entire result field from the parent.  It is
meant only for the text name of the organism or chemical subspecies identified.  This field is
included only to provide a method for linking back to the parent result for those systems which
could not generate unambiguous Observation ID’s and sub-ID’s.
An example is:
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|600-7&Microorganism identified&LN^^L-25116&Streptococcus pneumoniae&SNM|
In this example, <600-7> is the code for a microbial culture which appeared in a previous OBX-3,
<Microorganism identified> is the text describing the code, and <LN> is the name of the coding
system, LOINC. The second component is not used in this message and remains blank.  The
third component has the SNOMED code for Streptococcus pneumoniae, the text name of the
organism, and the name of the coding system.  The third component was the OBX-5 that
appeared in the parent result.  The report of the antimicrobial susceptibility testing performed on
the previously identified Streptococcus pneumoniae will be given in the OBX segment described
below.  Most laboratory findings that will be reported will not require the “parent result” field to be
populated.  A notable exception is the reporting of antimicrobial susceptibility testing results. 
For laboratories that develop an HL7 message for laboratory-based reporting only and do not use
HL7 within their institution, the parent result field should be used to report the name of the
organism on which sensitivities were performed.  OBR-26 would therefore appear as:
|^^L-25116&Streptococcus pneumoniae&SNM|
HL7 2.3 states that OBR-26 should only be present when the parent result is identified by OBR-
29-parent number; however, as discussed, the parent result may not always be present when a
laboratory uses HL7 for transmission of public health information only.  For this reason, OBR-26
should be populated with information in the absence of a parent number.  This is a deviation
from the HL7 2.3 specifications but is necessary to interpret data required for laboratory-based
reporting.  As described below for OBX-3 and OBX-5, LOINC is recommended for the first
component of the field and SNOMED for the third component.  This is discussed at length below
in the description of the OBX segment.
OBR-27 Quantity/Timing (TQ)
Field is optional and may be left blank.
OBR-28 Result Copies (XCN)
Send if available using the extended composite identification number and name for persons
(XCN) as described in OBR-16.  The field would appear as:
|^Parsons^Melvin^C^^Dr^MD|
OBR-29 Parent Number (CM)
The field is optional, however, it is recommended that the field be sent if available for laboratory-
based reporting. This field may be sent when a parent result is provided.  Reporting of
antimicrobial susceptibility data requires that the parent result be populated with the name of the
organism for which testing was performed (OBR-26).  The parent number, essentially the
accession number of the parent result, is a composite (CM) field which has the following
components for OBR-29:
<parent’s placer order number> ^ <parent’s filler order number>
For a parent result with no placer order number, the field would appear as:
|^MB980167|
See also OBR-26 for further description.
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OBR-30 Transportation Mode (ID)
Field is optional and may be left blank.
OBR-31 Reason for Study (CE)
Field is optional and may be left blank.
OBR-32 Principal Result Interpreter (CM)
Field has the following components:
<name (CN)> ^ <start date/time (TS)> ^ <end date/time (TS)> ^ <point of care (IS)> ^
<room (IS)> ^ <bed (IS)> ^ <facility (HD)> ^ <location status (IS)> ^ <patient location
type (IS)> ^ <building (IS)> ^ <floor (IS)>
Subcomponents of name are:
<ID number (ST)> & <family name (ST)> & <given name (ST)> & <middle initial or
name (ST)> & <suffix (e.g., Jr., III) (ST)> & <prefix (e.g., Dr.)> & <degree (e.g., MD)
(ST)> & <source table (IS)> & <assigning authority (HD)>
Subcomponents of facility are:
<namespace ID (IS)> & <universal ID (ST)> & <universal ID type (ID)>
This field identifies the physician or other clinician who interpreted the observation and is
responsible for the report content.  Field is optional for laboratory-based reporting of
communicable disease results and may be left blank.
Cancer Reporting Comment: This field is listed as optional by HL7.  For anatomic pathology
reporting, the name of the pathologist responsible for the
interpretation of the pathologic examination should appear here. 
The ID number is the reporting pathologist’s license number with
the state of licensure appended (e.g., 99999999WA)
OBR-33 Assistant Result Interpreter (CM)
Field is optional and may be left blank.
OBR-34 Technician (CM)
Field is optional and may be left blank.
OBR-35 Transcriptionist (CM)
Field is optional and may be left blank.
OBR-36 Scheduled - Date/Time (TS)
Field is optional and may be left blank.
OBR-37 Number of sample containers (NM)
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Field is optional and may be left blank.
OBR-38 Transport logistics of collected sample (CE)
Field is optional and may be left blank.
OBR-39 Collector’s comment (CE)
Field is optional and may be left blank.
OBR-40 Transport arrangement responsibility (CE)
Field is optional and may be left blank.
OBR-41 Transport arranged (ID)
Field is optional and may be left blank.
OBR-42 Escort required (ID)
Field is optional and may be left blank.
OBR-43 Planned patient transport comment (CE)
Field is optional and may be left blank.
4.2.4 ZLR Segment - Additional Information for Laboratory-Based Reporting
The Observation Results Unsolicited (ORU) message defined in HL7 2.3 does not contain certain data
elements which are of importance to public health officials.  To allow laboratories to send this
information, a “Z segment” has been constructed and is described below.  HL7 allows users to define
unique segments which can be used in trading-partner relationships such as reporting of public health
information to public health agencies.  By convention, HL7 has defined any segment beginning with the
letter “Z” to be a user-defined segment and thus, there is no description of the ZLR segment in the HL7
2.3 standard document.  The ZLR segment is defined below and is unique to the laboratory-based
reporting message for public health information.  The ZLR segment must  follow each OBR segment and
there can be only one ZLR per OBR.  Since ZLR is user-defined, additions to the segment can be made
to accommodate changing needs for reporting.  Public health agencies should notify reporting
laboratories when changes are made.  For some laboratories, the construction of user-defined segments
may not be possible.  In these situations, reporting may be possible without the use of the ZLR after
consultation with health agencies which will be receiving the data electronically.  
ZLR Attributes
SEQ LEN DT RP/# OPT TBL# ITEM# ELEMENT NAME
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1 106 XAD * * Ordering Provider’s Address
2 90 XON * * Ordering Facility Name
3 106 XAD * * Ordering Facility Address
4 40 XPN * * Ordering Facility Phone
5 20 SN * Z-0001 * Patient’s Age
6 40 XPN * * Next of Kin/Assoc. Party Name
7 40 CE * 0063 * Next of Kin/Assoc. Party Relationship 
8 106 XAD * * Next of Kin/Assoc. Party Address
9 40 XPN * * Next of Kin/Assoc. Party Phone 
* ZLR is a user-defined segment for laboratory-based reporting, thus there are no requirements or item numbers for reporting which have
been defined in HL7 version 2.3.
Examples of ZLR segments:
ZLR|115 Pike Plaza^Suite 2100^Seattle^WA^98122|Northwest Surgical Associates,
Ltd.^^57Y0470381^^^CLIA|2217 Rainier Way^^Renton^WA^98002|^^^helpline@surgassoc.com
^^206^5549097^^press “1" to speak with front desk, press “2" for scheduling|^63^Y|
Doe^Jane|spouse|2166 Wells Dr^Apt B^Seattle^WA^98109^^^^King|^^^^^206^6793240
ZLR-1 Ordering Provider’s Address (XAD)
This field contains the relevant address information for the ordering provider described in OBR-
16.  The field has the HL7-defined data type Extended Address (XAD) which has the following
components:
<street address (ST)> ^ < other designation (ST)> ^ <city (ST)> ^ <state or province
(ST)> ^ <zip or postal code (ST)> ^ <country (ST)> ^ <type (ID)> ^ <other geographic
designation (ST)> ^ <county/parish (ID)> ^ <census tract (ID)>
For example:
|115 Pike Plaza^Suite 2100^Seattle^WA^98122|
ZLR-2 Ordering Facility Name (XON)
Periodically, tests are ordered from facilities without specifying an ordering provider.  For
instance, an outpatient surgical facility may send biopsy tissue for pathologic examination
without specifying the surgeon that actually performed the biopsy.  In the case where no ordering
provider is identified, knowledge of the ordering facility allows public health officials to follow-up
on positive tests to obtain further clinical and epidemiologic information.  Information on the
ordering facility is most relevant to cancer registries.  ZLR-2 has the HL7-defined data type
Extended Organization Name (XON) which has the following components:
<organization name (ST)> ^ <organization name type code (ID)> ^ <ID number (ID)> ^
<check digit (NM)> ^ < check digit scheme (ID)> ^ <assigning authority (HD)> ^
<identifier type code (ID)> ^ <assigning facility (HD)>
The facility’s CLIA identifier should be placed in the third component <ID number (ID)> if there is
one available, and “CLIA” should appear in <assigning authority (HD)> indicating that the ID
number used here to identify the laboratory has been assigned by CLIA.  For example:
|Northwest Surgical Associates, Ltd.^^57Y0470381^^^CLIA|
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ZLR-3 Ordering Facility Address (XAD)
This field further describes the laboratory identified in ZLR-2 above. The field is the HL7-defined
data type XAD as described in ZLR-1.  For example:
|2217 Rainier Way^^Renton^WA^98002|
ZLR-4 Ordering Facility Phone Number (XTN)
This field further describes the laboratory identified in ZLR-1 above. The field is the HL7-defined
data type Extended Telephone Number (XTN) which has the following components:
[NNN] [(999)]999-9999 [X99999] [B99999] [C any text] ^  <telecommunication use code
(ID)> ^ <telecommunication equipment type (ID)> ^ <E-mail address (ST)> ^ <country
code (NM)> ^ <area/city code (NM)> ^ <phone number (NM)> ^ <extension (NM)> ^
<any text (ST)>
For example:
|^^^helpline@surgassoc.com^^206^5549097^^press “1" to speak with front desk,
press “2" for scheduling|
ZLR-5 Patient’s Age (SN)
This field contains the patient’s age when no date of birth is known.  It is not necessary to
provide this information when PID-7 (Date of Birth) is populated.  The field has the HL7-defined
data type of the structured numeric (SN):
<comparator (ST)> ^ <num1(NM)> ^ <separator or suffix (ST)> ^ <num2 (NM)>
For example, a report for a 63 year-old patient would have:
|^63^Y|
Acceptable suffixes are the following:







If no suffix is provided, then the age is presumed to be years.
ZLR-6 Next of Kin or Associated Party Name (XPN)
This field is analogous to NK1-2 (Name) which is described in the HL7 2.3 standard document. 
The field contains the name of the next of kin or associated party.  This field may be used to
describe the Guardian or Employer of the patient for blood lead reporting messages.  Multiple
names for the same person are allowed, but the legal name must be sent in the first sequence. 
If the legal name is not sent, then the repeat delimiter must be sent in the first sequence.  The
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field has the HL7-defined data type of the extended person name (XPN):
<family name (ST)> ^ <given name (ST)> ^ <middle initial or name (ST)> ^ <suffix (e.g.,




ZLR-7 Next of Kin or Associated Party Relationship (CE)
This field is analogous to NK1-3 (Relationship) which is described in the HL7 2.3 standard
document.  The field contains the actual personal relationship that the next of kin/associated
parties has to the patient.  The user-defined table 0063 - Relationship is used for appropriate
values.  The field has the HL7-defined data type of the coded element (CE):
<identifier (ST)> ^ <text (ST)> ^ <name of coding system (ST)> ^ <alternate identifier
(ST)> ^ <alternate text (ST)> ^ <name of alternate coding system (ST)>



















Emergency Contact Emergency Contact 
For example:
|spouse|
ZLR-8 Next of Kin or Associated Party Address (XAD)
This field is analogous to NK1-4 (Address) which is described in the HL7 2.3 standard document. 
The field contains the address of the next of kin/associated party identified in ZLR-3 above.  This
field may be used to provide the address of the Guardian or Employer of the patient for lead
reporting messages.   Multiple addresses are allowed for the same person.  The primary mailing
address must be sent in the first sequence.  If the mailing address is not sent, then the repeat
delimiter must be sent in the first sequence.  The field has the HL7-defined data type of XAD as
described in ZLR-3 above.  For example:
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|2166 Wells Dr^Apt B^Seattle^WA^98109^^^^King|
ZLR-9 Next of Kin or Associated Party Phone Number (XTN)
This field provides the phone number for the Next of Kin or Associated Party described in ZLR-6. 
It is analogous to NK1-5.  The field has the HL7-defined data type of the XTN as described in
ZLR-4.  For example:
|^^^^^206^6793240|
4.2.5 OBX Segment - Observation/Result
The OBX segment is used to transmit a single observation or observation fragment.  It represents the
smallest indivisible unit of a report.  The principal mission of the segment is to carry information about
observations in report messages.  Whereas OBR gives general information about the order of the test,
the OBX segment gives the specific, individual tests performed (OBX-3) and the specific results for each
test (OBX-5).  Laboratory-based reporting to public health agencies focuses on OBX-3 and OBX-5
as the most informative elements of the message and thus, full effort should be made to make
OBX-3 and OBX-5 as informative and unambiguous as possible.
OBX Attributes
SEQ LEN DT OPT RP/# TBL# ITEM# ELEMENT NAME
1 10 SI O 00569 Set ID - OBX
2 2 ID C 0125 00570 Value Type 
3 590 CE R LOINC* 00571 Observation Identifier 
4 20 ST C 00572 Observation Sub-ID
5 65536 C Y SNOMED* 00573 Observation Value
6 60 O 00574 Units
7 10 O Y/5 00575 References Range
8 5 O 0078 00576 Abnormal Flags
9 5 O Y 00577 Probability
10 2 O 0080 00578 Nature of Abnormal Test
11 1 R 0085 00579 Observ Result Status
12 26 O 00580 Date Last Obs Normal Values
13 20 O 00581 User Defined Access Checks
14 26 O 00582 Date/Time of the Observation
15 60 O 00583 Producer's ID
16 80 O 00584 Responsible Observer














*  For laboratory-based reporting, LOINC is strongly recommended for OBX-3, and SNOMED is strongly recommended for OBX-5 when
CE data types are used.  **The data type for OBX-5 can vary and is determined by OBX-2.
Example Segments for OBX:
For Hepatitis A Virus reporting:
OBX|3|CE|5182-1^Hepatitis A Virus IgM Serum Antibody EIA^LN||G-
A200^Positive^SNM||||||F|||199603241500|45D0480381
For antimicrobial susceptibility testing:
OBX|1|SN|524-9^Vancomycin Susceptibility MIC^LN|
|<^1|^µg/mL^ISO+||S|||F|||199602161300|01D0301145
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For Blood Lead reporting:
OBX|2|SN|10368-9^Quantitative Blood Lead ^LN||^45|µg/dL|||||F|||199601210800|45D0480381
OBX-1 Set ID - Observation Simple (SI)
This field contains the sequence number as described for OBR-1.  There may be many OBX’s
per OBR.  The set ID allows the receiver to maintain the relational aspects of the message.  For
example: |1|
OBX-2 Value Type (ID)
This field contains the data type of the observation value reported in OBX-5.  For instance, if the
value in OBX-2 is “CE”, then the result reported in OBX-5 must be a coded element.  When the
value type is TX or FT then the results are bulk text.  The choices allowed for the value type of
an observation are listed below in HL7 Table 0125 - Value type.




CF Coded Element With Formatted Values
CK Composite ID With Check Digit
CN Composite ID And Name
CP Composite Price
CX Extended Composite ID With Check Digit
DT Date
ED Encapsulated Data









TS Time Stamp (Date & Time)
TX Text Data (Display)
XAD Extended Address
XCN Extended Composite Name And Number For Persons
XON Extended Composite Name And Number For Organizations
XPN Extended Person Number
XTN Extended Telecommunications Number
Although NM is a valid type, observations which are usually reported as numbers will sometimes
have the string (ST) data type because non-numeric characters are often reported as part of the
result, e.g., “<0.06" to indicate the result was lower than detected by the present mechanism.  In
the example, "<0.06", "<" is a text symbol and the digit, “0.06" is considered a numeric value. 
However, this usage of the ST type should be discouraged since the SN (structured numeric)
data type now accommodates such reporting.  The SN data type is described under OBX-5
below.  For example, the value type for structured numeric would be:
|SN|
All valid HL7 data types for use in OBX-2 are listed in the table above. TX should not be used
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except to send large amounts of text.  ST should be used to send short, and possibly encodable,
text strings.  For laboratory-based reporting, the CE and SN data types should be used whenever
possible so that results can be interpreted easily.  
Cancer Reporting Comment: Pathology reporting will require use of the TX, ST, and FT if the
OBX segment contains all lab report text of a particular
category.
OBX-3 Observation Identifier (CE)
This field contains a unique identifier for the observation.  For reporting of laboratory results,
OBX-3 is the specific test that has been performed.  The format is that of the coded element
(CE) which has the following structure:
<identifier (ST)> ^ <text (ST)> ^ <name of coding system (ST)> ^ <alternate identifier
(ST)> ^ <alternate text (ST)> ^ <name of alternate coding system (ST)>
Because OBX-3 is designated as a coded element, different coding schemes can be used to
describe the test or observation in OBX-3.  The description in OBX-3 essentially “points” to a
master observation table that may provide other attributes of the observation to be used by the
receiving system to process the message.  
For laboratory-based reporting, it is necessary that OBX-3 have a code for the observation which
can be easily interpreted by the public health application receiving the message.  For this
reason, the laboratory-based reporting message strongly recommends that LOINC be
used as the coding system in OBX-3 for reporting tests that identify cases of illness
which are reportable to public health agencies.   This decision was made to minimize any
ambiguity in reporting test results.  Thus, whenever possible, OBX-3 should be used as the
informative element of the ORU; the focal point of the report.  In other words, it is strongly
recommended that OBX-3 be populated with as specific a LOINC code as possible to prevent
any misinterpretation of reported results.  LOINC codes are not recommended for pathology
reports for cancer registries.
LOINC (Logical Observation Identifier Names and Codes) is a collection of tables which provide
sets of universal names and ID codes for identifying laboratory and clinical test results.  The
LOINC codes are not intended to transmit all possible information about a test.  They are only
intended to identify the test result.  The level of detail in the LOINC definitions was intended to
distinguish tests that are usually distinguished as separate test results within the master file of
existing laboratory systems.  For laboratory-based reporting of public health information, a
subset of LOINC codes have been selected and will be made available at the CDC web site. 
General information about LOINC codes can be found at: http://www.mcis.duke.edu/standards/
termcode/loinc.htm.
Some reports currently can not be described with OBX-3 alone, for instance, the initial
identification of an organism may have an OBX-3 which is general, such as “Microbial Culture”. 
In this setting, OBX-5 would identify the specific organism which has triggered a report to be sent
to a public health agency such as “Neisseria meningitidis”.  Another example would be reporting
of antimicrobial sensitivity results where it is necessary to use OBR-26 (Parent Result) which
identifies the organism on which testing was performed.  However, it is still strongly
recommended to use LOINC codes for OBX-3 even if the chosen term is not organism-specific.
An example for a Hepatitis  A Virus result is:
|5182-1^Hepatitis A Virus IgM Serum Antibody EIA^LN|
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where <5182-1> is the identifier from the LOINC table for the Enzyme Immunoassay for
Hepatitis A Virus IgM antibody, <Hepatitis A Virus IgM Serum Antibody EIA> is the text name as
it appears in the table, and <LN> is the name of the coding system.  Any further description of
the testing may appear in OBX-17 Observation method but is not required.
For antimicrobial susceptibility testing, the antimicrobial test for which MIC’s have been
performed may appear as:
|524-9^Vancomycin Susceptibility MIC^LN|
where <524-9> is the identifier from the LOINC table for the vancomycin MIC test, <Vancomycin
Susceptibility MIC> is the text name as it appears in the table, and <LN> IS the name of the
coding system.  Identification of the method as broth dilution may appear in OBX-17 Observation
method using CDC method codes described below but is not required.
An example for reporting a lead level from a capillary blood specimen:
|10368-9^Quantitative Blood Lead^LN|
For reporting an isolate of Neisseria meningitidis, OBX-3 would have the test which yielded the
isolate.  The result of the culture (i.e., the growth of Neisseria meningitidis) would be reported in
OBX-5 below.  OBX-3 would appear as:
|600-7^Microorganism identified, Blood Culture^LN|
Cancer Reporting Comments: A locally defined coding scheme representing the pathology
report.  Described in below table to represent classification of a
local text coding scheme.  
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Table C0001 - NAACCR Text Classification Grouping
Value Description
CH Clinical History
NS Nature of Specimen
GP Gross Pathology





GN General lab report, used if report text is stored in such a way that
it may not be broken down into above categories.
 
For example: |CH^Clinical History^L|
OBX-4 Observation Sub ID (ST)
This field is used to distinguish between multiple OBX segments with the same observation ID
organized under one OBR.  Thus, the Sub-ID allows related OBX segments to be linked.   For
example a blood culture may have three different organisms growing.  By putting a “1" in the
Sub-ID of the first of these OBX segments, “2" in the second, and “3" in the third, each OBX
segment can be uniquely identified for editing or replacement.  It is strongly recommended that
numeric values be used for laboratory-based reporting so that receiving applications can
maintain easily the relational quality of the data.  For example:  |1|
OBX-5 Observation Value (*Data type varies)
The results of the test appear here.  For laboratory-based reporting, SNOMED is strongly
recommended for OBX-5 whenever the CE data type is indicated in OBX-2.   Thus, if CE
appears in OBX-2, it is assumed that the result in OBX-5 is a SNOMED code.  For numeric
results,  the SN data type is preferred for OBX-2, and thus, SNOMED is not required.  For
instance, OBX-5 may have the SNOMED code for “positive” or the SNOMED-specific names of
organisms identified in the tests described in OBX-3.  It is strongly recommended that SNOMED
be used for the modifiers “positive”, “negative”, and  “indeterminate”.  Other modifiers should be
avoided such as “limited findings”, “insufficient specimen”, “patient not at bedside”, or “see
technician”.  Pathology reports for cancer registries will be TX or ST.  Further information on
SNOMED can be found at the HL7 Health Informatics Internet site on the World Wide Web
(http://www.mcis.duke.edu/standards/termcode/snomed.htm).
For example, when a Hepatitis A Virus IgM antibody has been identified in a reference
laboratory, a report for a public health agency is triggered.  The OBX-3 would contain the code
for the Hepatitis A IgM test and OBX-5 would indicate that the test was positive.  The OBX
segment would appear as:
OBX|1|CE|5182-1^Hepatitis A Virus IgM Serum Antibody EIA^LN
||G-A200^Positive^SNM|...
where OBX-3 uses a LOINC code and OBX-5 uses a SNOMED code.  For antimicrobial
susceptibility testing, the OBX segment would appear as:
OBX|1|SN|7059-9^Vancomycin Susceptibility, Gradient Strip^LN||<^1|...
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where OBX-3 uses a LOINC code and OBX-5 has a numeric value.  The value type listed in
OBX-2 determines the structure of the reported result here (i.e., SN) and thus, SNOMED is not
recommended in this second example.  The SN data type has the following structure:
<comparator> ^ <num1(NM)> ^ <separator or suffix> ^ <num2 (NM)>
Some examples of the SN representation are:
|>^100| greater than 100
|^100^-^200| equal to range of 100 through 200
|^1^:^228| ratio of 1 to 128 (e.g., the results of a serological test)
|^2^+| categorical response (e.g., an interpretation of occult blood positivity)
For results of a culture which yielded Neisseria meningitidis, OBX-2 would be listed as a coded
element (CE) and OBX-5 would appear as:
|L-22202^Neisseria meningitidis^SNM|
It is strongly recommended that the data types CE and SN be used whenever possible to
minimize ambiguity in reporting.
Cancer Reporting Comments: This is the field which will contain the text or SNOMED codes for
the following NAACCR version 5.0 item numbers,
2860,2520,2580,2570,2680,2600.
OBX-6 Units (CE)
The units describing the results of the test appear here.  For instance, <mm> or <µg/mL> would
be placed here.  A table of the appropriate units is provided in the appendix.  The HL7-defined,
default coding system for units is based on an enhanced international standard (ISO+) which is
described at length in the HL7 2.3 standard document.  For example:
|µg/mL^microgram/milliliter^ISO+|
OBX-7 Reference Range (ST)
This field is designated as ST for string, and thus, there is no current standardized scheme for
describing a reference range.  HL7 recommends that reference ranges for numeric values be
reported in the format:
lower limit-upper limit when both lower and upper limits are defined, e.g., for
potassium "3.5 - 4.5"
> lower limit if no upper limit, e.g., ">10"
< upper limit if no lower limit, e.g., "<15"
For alphabetical values, the normal value may be reported in OBX-7 as well.  For instance, the
normal result for an assay may be “pink”.
OBX-8 Abnormal Flags (A)
Microbiology sensitivity interpretations should appear as listed in HL7 table 0078.  Abnormal
flags should be used for reporting microbiology sensitivity data.
HL7 Specifications - Page 38
Table 0078  Abnormal flags
Value Description
L Below low normal
H Above high normal
LL Below lower panic limits
HH Above upper panic limits
< Below absolute low-off instrument scale
> Above absolute high-off instrument scale
N Normal (applies to non-numeric results)
A Abnormal (applies to non-numeric results)
AA Very abnormal (applies to non-numeric units, analogous to panic
null No range defined, or normal ranges don't apply
U Significant change up
D Significant change down
B Better--use when direction not relevant
W Worse--use when direction not relevant
limits for numeric units)







Abnormal flags for antimicrobial sensitivity reporting should conform to the recommendations of
the National Committee for Clinical Laboratory Standards (NCCLS , http://www.nccls.org).  For
most reported findings, the allowable values are S, I, or R, and should be provided in addition to
the numeric value in OBX-5.
OBX-9 Probability (NM)
Field is optional and may be left blank.
OBX-10 Nature of Abnormal Test (ID)
Field is optional and may be left blank.
OBX-11 Observation Result Status (ID)
This field is required field.  
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Table 0085 - Observation Result Status Codes Interpretation
Value Description
C Record coming over is a correction and thus replaces a final result
D Deletes the OBX record
F Final results;  Can only be changed with a corrected result.
I Specimen in lab; results pending
P Preliminary results
R Results entered -- not verified
S Partial results
X Results cannot be obtained for this observation
U Results status change to Final.  without retransmitting results already
sent as ‘preliminary.   E.g., radiology changes status from
preliminary to final
W Post original as wrong, e.g., transmitted for wrong patient
For example: |F|
Cancer Reporting Comment: Corresponds to NAACCR version 5.0 item number 2830
OBX-12 Date Last Observation Normal Values (TS)
Field is optional and may be left blank.
OBX-13 User Defined Access Checks (ST)
Field is optional and may be left blank.
OBX-14 Date/Time of the Observation (TS)
This field is required in two circumstances.  The first is when the observations (OBX’s) reported
beneath one report header (OBR) have different dates, for instance when one measurement
within a battery may have a different time/date than another measurement.  The field follows the
HL7-defined timestamp (TS).  
|199602161300|
OBX-15 Producer’s ID (CE)
This field contains a unique identifier of the responsible producing service.  It should be reported
for all messages that are reported to public health agencies.  For most reports, the CLIA
identifier here will be identical to the CLIA identifier listed as the assigning facility in PID-3
(Patient ID, Internal).  When the test results are produced at outside laboratories, the CLIA
identifier for the laboratory that performed the test should appear here and will be different from
the CLIA identifier listed as the assigning facility in PID-3. The CE data type has been described




OBX-16 Responsible Observer (XCN)
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Field is optional and may be left blank.
OBX-17 Observation Method (CE)
This field is used to transmit the method or procedure by which an observation was obtained
when the sending system wishes to distinguish among one measurement obtained by different
methods and the distinction is not implicit in the test ID.  The Centers for Disease Control and
Prevention (CDC) Method Code (CDCM) can be used in OBX-17 to further describe tests
identified in OBX-3.  These codes can be obtained from Public Health Practice Office, Centers
for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA, 30421, or via FTP at:
 ftp.cdc.gov/pub/laboratory_info/CLIA 
or via Gopher at:
gopher.cdc.gov:70/11/laboratory_info/CLIA
Cancer Reporting Comment: NAACCR currently specifies the use of a locally-defined
classification for additional information to indicate how a
particular observation has been confirmed.
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Table C0002 - NAACCR Additional information on Observation method
Value Description




5 Positive laboratory test/marker study
6 Direct visualization without microscopic confirmation
7 Radiology and other imaging techniques without microscopic confirmation
8
section, surgery, autopsy, dilation and curettage, or bone marrow biopsy/aspiration.  Also
includes hematologic confirmation of leukemia (that is, a peripheral blood smear).
Positive exfoliative cytology, no  positive histology:  indicated by: microscopic
examination of cells removed from a neoplasm.  Fine-needle aspiration is frequently used
to obtain a cytologic specimen.  Cells may be recovered from exudate, secretions, or
washings from tissue, and includes cervical and vaginal smears.  Also includes
paraffin-block specimens from concentrated spinal, pleural, or peritoneal fluid.
Bone Marrow
Positive microscopic confirmation, method not specified : Indicated when: the case is
reported as microscopically confirmed, but the specific method (histology, cytology) is
unknown.
Indicated by: diagnosis of cancer based on certain laboratory tests or marker studies that
are clinically diagnostic (for instance, an abnormal electrophoretic spike for multiple
myeloma or Waldenstrom’s macroglobulinemia.)
Indicated when: diagnosis made at surgical exploration or by endoscopy (colposcope,
mediastinoscope, laparoscope).  Also includes autopsies where the only information is
from a gross autopsy report.
Indicated when: diagnosis is by radiology, ultrasound, computerized tomography, or
MRI.
Clinical diagnosis only (other than items 5, 6, and 7)
Indicated when: case has been diagnosed by clinical methods not mentioned previously.
For example: |2^Fine Needle Aspiration^L|
5.0 HL7 Batch Protocol
There are instances when it is convenient to transfer a batch of HL7 messages for reporting to
public health agencies.  Such a batch could be sent online using a common file transfer protocol,
or offline via tape or diskette.
5.1 HL7 Batch File Structure
The structure of an HL7 batch file is given by the following (using the HL7 abstract message
syntax defined in 4.1 above):
             
[FHS] File Header Segment
{
[BHS] Batch Header Segment
{
[MSH, PID, OBR,etc. Zero or more HL7 messages
  ]
  }
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[BTS]    Batch Trailer Segment
  }
[FTS] File Trailer Segment
The sequence numbering protocol has a natural application in batch transfers.  See the
discussion of batch acknowledgments that follows.  A batch for reporting to public health
agencies will consist of a single type of message (i.e., ORU).  Batches should usually contain at
least one HL7 message.  There are only two cases in which an HL7 batch file may contain zero
HL7 messages:
a) a batch containing zero HL7 messages may be sent to meet a requirement for
periodic submission of batches when there are no messages to send,
b) a batch containing zero negative acknowledgment messages may be sent to indicate
that all the HL7 messages contained in the batch being acknowledged are implicitly
acknowledged.  See “Related Segments and Data Usage” below.
5.1.1 Related Segments and Data Usage
The following segments relate to the HL7 Batch Protocol: 1) BHS - Batch Header, 2) BTS - Batch
Trailer, 3) FHS - File Header, and 4) FTS - File Trailer.  The BTS segment contains a field,
BTS-3-batch totals, which may have one or more totals drawn from fields within the individual
messages.  The method for computing such totals resides with the sending facility.
5.1.2 Acknowledging Batches
In general, the utility of sending batches of data is that the data is accepted all at once, with
errors processed on an exception basis.  However, it is a permissible application of HL7 to
acknowledge all messages.  Several options for acknowledgment are given in the HL7 2.3
standard document and are not addressed here.
5.2 Batch Segments
5.2.1 BHS Segment  -  Batch Header
The BHS segment is defined by HL7 2.3 and identifies the start of a batch.  The fields in BHS
are in the following table:
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BHS Attributes
SEQ LEN DT OPT RP/# TBL# ITEM  # ELEMENT NAME
1 1 ST R 00081 Batch Field Separator
2 3 ST R 00082 Batch Encoding Characters
3 15 ST O 00083 Batch Sending Application
4 20 ST O 00084 Batch Sending Facility
5 15 ST O 00085 Batch Receiving Application
6 20 ST O 00086 Batch Receiving Facility
7 26 TS O 00087 Batch Creation Date/Time
8 40 ST O 00088 Batch Security
9 20 ST O 00089 Batch Name/ID/Type
10 80 ST O 00090 Batch Comment
11 20 ST O 00091 Batch Control ID
12 20 ST O 00092 Reference Batch Control ID
Example Segment of BHS:
BHS|^~\&||45D0470381|NPHSS|WA-DOH|19961104
BHS-1 Batch Field Separator (ST)
This field contains the separator between the segment ID and the first real field, BHS-2-batch
encoding characters.  The field is analogous to MSH-1 described previously.  Required value for
laboratory-based reporting is  “|”, (ASCII 124).
BHS-2  Batch Encoding Characters (ST)
This field is analogous to MSH-2 and should contain the same characters:    |^~\&|
BHS-3 Batch Sending Application (ST)
Field is optional and may be left blank.
BHS-4 Batch Sending Facility (ST)
Field is analogous to MSH-4 and should contain the same CLIA identification number.  For
example:   |45D0470381|
BHS-5 Batch Receiving Application  (ST)
Field is analogous to MSH-5: |NPHSS|
BHS-6 Batch Receiving Facility  (ST)
Field is optional but may contain the public health agency receiving the batch.  For example: 
|WADOH|
BHS-7 Batch Creation Date/Time  (TS)
This  field contains the date/time that the sending system created the message.  Field is optional
and may be left blank.
BHS-8 Batch Security  (ST)
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Field is optional and may be left blank.
BHS-9 Batch Comment (ST)
Field is optional and may be left blank.
BHS-10 Batch Control ID (ST)
Field is optional and may be left blank.
BHS-11 Reference Batch Control ID (ST)
Field is optional and may be left blank.
5.2.2 BTS Segment  - Batch Trailer
The BTS Segment defines the end of a batch.
BTS Attributes
SEQ LEN DT OPT RP/# TBL ITEM # ELEMENT NAME
#
1 10 ST O 00093 Batch Message Count
2 80 ST O 00090 Batch Comment
3 100 NM O Y 00095 Batch Totals
Example Segment of BTS:
BTS|62
BTS-1 Batch Message Count (ST)
This field contains the count of the individual messages contained within the batch.  The count
should reflect then number of MSH segments within the batch.
BTS-2 Batch Comment  (ST)
Field is optional and may be left blank.
BTS-3 Batch Totals (NM)
Field is optional and may be left blank.
5.3 File Segments for Batch Reporting
5.3.1 FHS Segment - File Header
The FHS segment is used to head a file (group of batches).  Ideally, a single sending facility, for
instance a regional laboratory for a hospital consortium, could send a group of batches of
reportable findings from separate laboratories within the consortium.  In this setting, each
separate BHS would have a different CLIA identifier.  The FHS would have a different CLIA
number as well, or would have the same CLIA number as the one batch that was performed at
the sending facility.  This complexity of message processing is not common yet, either at
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laboratories or public health agencies.  The description of batch reporting in this guide
demonstrates reporting from a single facility and thus the CLIA number is the same for MSH,
BHS, and FHS.
FHS Attributes
SEQ LEN DT OPT RP/# TBL# ITEM # ELEMENT NAME
1 1 ST R 00067 File Field Separator
2 4 ST R 00068 File Encoding Characters
3 15 ST O 00069 File Sending Application
4 20 ST O 00070 File Sending Facility
5 15 ST O 00071 File Receiving Application
6 20 ST O 00072 File Receiving Facility
7 26 TS O 00073 File Creation Date/Time
8 40 ST O 00074 File Security
9 20 ST O 00075 File Name/ID
10 80 ST O 00076 File Header Comment
11 20 ST O 00077 File Control ID
12 20 ST O 00078 Reference File Control ID
Example Segment of FHS:
FHS|^~\&||45D0470381|NPHSS|WA-DOH|19961104
FHS-1 File Field Separator  (ST)
This field has the same definition as the corresponding field in MSH-1 segment: ‘|’
FHS-2 File Encoding Characters  (ST)
This field has the same definition as the corresponding field in the MSH-2:  |^~\&|
FHS-3 File Sending Application  (ST)
Field is optional and may be left blank.
FHS-4 File Sending Facility  (ST)
This field should contain the CLIA identifier for the sending facility, analogous to BHS-4 and
MSH-4
FHS-5 File Receiving Application  (ST)
This field has the same definition as the corresponding field in MSH-5:   |NPHSS|
FHS-6 File Receiving Facility (ST)
This field may contain an identifier for the public health agency.  For example:    |WADOH|
FHS-7 File Creation Date/Time (TS)
Field is optional and may be left blank.
FHS-8 File Security (ST)
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Field is optional and may be left blank.
FHS-9 File Name ID (ST)
Field is optional and may be left blank.
FHS-10 File Header Comment  (ST)
Field is optional and may be left blank.
FHS-11 File Control ID (ST)
Field is optional and may be left blank.
FHS-12 Reference File Control (ST)
Field is optional and may be left blank.
5.3.2 FTS Segment - File Trailer
The FTS segment defines the end of a file (i.e., a group of batches).
FTS Attributes
SEQ LEN DT OPT RP/# TBL# ITEM # ELEMENT NAME
1 10 NM O 00079 File Batch Count
2 80 ST O 00080 File Trailer Comment
Example Segment of FTS:
FTS|1
FTS-1 File Batch Count (NM)
This field contains the number of batches contained in this file.  For laboratory-based reporting, it
is expected that only one batch per file will be sent usually.
FTS-2 File Trailer Comment (ST)
Field is optional and may be left blank.
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Appendix A   
Example messages for laboratory-based reporting of findings of public health importance.
Example 1: Hepatitis A Virus
MSH|^~\&||MediLabCo-Seattle^45D0470381^CLIA|NPHSS|WA-DOH |199602171830||ORU^R01||P|2.3










OBX||CE|5182-1^Hepatitis A Virus, Serum Antibody EIA^LN||G-A200^Positive^SNM| 
|||||F|||199603241500|45D0480381
Example 2: Bordetella pertussis
MSH|^~\&||MediLabCo-Seattle^45D0470381^CLIA|NPHSS|WA-DOH |199602171830||ORU^R01||P|2.3










OBX||CE|626-2^Microorganism identified, Throat Culture^LN||L-12801^Bordetella pertussis^SNM| 
|||||F|||199602161330|45D0470381
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Example 3: Lead
MSH|^~\&||MediLabCo-Seattle^45D0470381^CLIA|NPHSS|WA-DOH |199602171830||ORU^R01||P|2.3











Example 4: Drug-Resistant Streptococcus pneumoniae
MSH|^~\&||MediLabCo-Seattle^45D0470381^CLIA|NPHSS|WA-DOH |199602171830||ORU^R01||P|2.3




OBR|||MB99012|06730^MIC susceptibility test^L|||199601301530||||||||BLDV^Blood venous
|^Jones^Marcus^F^Jr^Dr^MD|^^^^^206^3231921||||||||F|600-7&Microorganism
identified, Blood Culture&LN^^L-25116&Streptococcus pneumoniae&SNM










Appendix C - Table II
HL7- and User-Defined Tables















0005 A Asian or Pacific Islander
























0063 Emergency Emergency Contact
Contact
HL7 0065 Specimen Action Code
0065 A Add ordered tests to the existing specimen
0065 G Generated order; reflex order
0065 L Lab to obtain specimen from patient
0065 O Specimen obtained by service other than Lab
0065 P Pending specimen; Order sent prior to delivery
0065 R Revised order
0065 S Schedule the tests specified below
HL7 0070 Specimen Source Codes
0070 ABS Abcess
0070 AMN Amniotic fluid
0070 ASP Aspirate
0070 BPH Basophils
0070 BIFL Bile fluid
0070 BLDA Blood  arterial
0070 BBL Blood bag
0070 BLDC Blood  capillary
0070 BPU Blood product unit
0070 BLDV Blood  venous
0070 BON Bone
0070 BRTH Breath (use EXHLD)
0070 BRO Bronchial
0070 BRN Burn
0070 CALC Calculus (=Stone)
0070 CDM Cardiac muscle
0070 CNL Cannula
0070 CTP Catheter tip
0070 CSF Cerebral spinal fluid
0070 CVM Cervical mucus
0070 CVX Cervix
0070 COL Colostrum




0070 DIAF Dialysis fluid
0070 DOSE Dose med or substance 
0070 DRN Drain
0070 DUFL Duodenal fluid
0070 EAR Ear











0070 FLU Body fluid, unsp
0070 GAS Gas
0070 GAST Gastric fluid/contents
0070 GEN Genital
0070 GENC Genital cervix
0070 GENL Genital lochia
0070 GENV Genital vaginal
0070 HAR Hair
0070 IHG Inhaled Gas





0070 LNA Line arterial
0070 LNV Line venous





0070 MBLD Menstrual blood
0070 MLK Milk
0070 MILK Breast milk
0070 NAIL Nail
0070 NOS Nose (nasal passage)
0070 ORH Other
0070 PAFL Pancreatic fluid
0070 PAT Patient
0070 PRT Peritoneal fluid /ascites
0070 PLC Placenta
0070 PLAS Plasma
0070 PLB Plasma bag
0070 PLR Pleural fluid (thoracentesis fld)
0070 PMN Polymorphonuclear neutrophils
0070 PPP Patelet poor plasma
0070 PRP Platelet rich plasma
0070 PUS Pus
0070 RT Route of medicine
0070 SAL Saliva
0070 SEM Seminal fluid
0070 SER Serum
0070 SKN Skin
0070 SKM Skeletal muscle
0070 SPRM Spermatozoa
0070 SPT Sputum
0070 SPTC Sputum - coughed
0070 SPTT Sputum - tracheal aspirate
0070 STON Stone (use CALC)
0070 STL Stool = Fecal
0070 SWT Sweat
0070 SNV Synovial fluid (Joint fluid)
0070 TEAR Tears
0070 THRT Throat
0070 THRB Thrombocyte (platelet)
0070 TISS Tissue
0070 TISG Tissue gall bladder
0070 TLGI Tissue large intestine
0070 TLNG Tissue lung
0070 TISPL Tissue placenta
0070 TSMI Tissue small intestine
0070 TISU Tissue ulcer
0070 TUB Tube NOS
0070 ULC Ulcer
0070 UMB Umbilical blood
0070 UMED Unknown medicine
0070 URTH Urethra
0070 UR Urine
0070 URC Urine clean catch
0070 URT Urine catheter
0070 URNS Urine sediment
0070 USUB Unknown substance
0070 VOM Vomitus
0070 BLD Whole blood 




0070 WNDA Wound abscess
0070 WNDE Wound exudate
0070 WNDD Wound drainage
0070 XXX To be specified in another part of the message
HL7 0078 Abnormal Flags
0078 L Below low normal
0078 H Above high normal
0078 LL Below lower panic limits
0078 HH Above upper panic limits
0078 < Below absolute low-off instrument scale
0078 > Above absolute high-off instrument scale
0078 N Normal (applies to non-numeric results)
0078 A Abnormal (applies to non-numeric results)
0078 AA Very abnormal (applies to non-numeric units, analogous to
panic limits for numeric units)
0078 null No range defined, or normal ranges don't apply
0078 U Significant change up
0078 D Significant change down
0078 B Better--use when direction not relevant
0078 W Worse--use when direction not relevant
0078 S Sensitive (microbiology sensitivities only)
0078 R Resistant (microbiology sensitivities only)
0078 I Intermediate (microbiology sensitivities only)
0078 MS Moderately sensitive (microbiology sensitivities only)
0078 VS Very sensitive (microbiology sensitivities only)
HL7 0080 Nature of Abnormal Testing
0080 A An age-based population
0080 N None - generic normal range
0080 R A race-based population
0080 S A sex-based population
HL7 0085 Observation Result Status Codes Interpretation
0085 C Record coming over is a correction and thus replaces a final
result
0085 D Deletes the OBX record
0085 F Final results;  Can only be changed with a corrected result.
0085 I Specimen in lab; results pending
0085 P Preliminary results
0085 R Results entered -- not verified
0085 S Partial results
0085 X Results cannot be obtained for this observation
0085 U Results status change to Final.  Results did not change
(don't transmit test).  E.g., radiology changes status from
preliminary to final
0085 W Post original as wrong, e.g., transmitted for wrong patient
HL7 0123 Result Status
0123 O Order received; specimen not yet received
0123 I No results available; specimen received, procedure
incomplete
0123 S No results available; procedure scheduled, but not done
0123 A Some, but not all, results available
0123 P Preliminary: A verified early result is available, final results
not yet obtained
0123 C Correction to results
0123 R Results stored; not yet verified
0123 F Final results; results stored and verified.  Can only be
changed with a corrected result.
0123 X No results available; Order canceled.
0123 Y No order on record for this test.  (Used only on queries)
0123 Z No record of this patient. (Used only on queries)
HL7 0125 Value Type
0125 AD Address
0125 CE Coded Entry
0125 CF Coded Element With Formatted Values
0125 CK Composite ID With Check Digit
0125 CN Composite ID And Name
0125 CP Composite Price
0125 CX Extended Composite ID With Check Digit
0125 DT Date
0125 ED Encapsulated Data
0125 FT Formatted Text (Display)
0125 ID Coded Value
0125 MO Money
0125 NM Numeric
0125 PN Person Name
0125 RP Reference Pointer
0125 SN Structured Numeric
0125 ST String Data
0125 TM Time
0125 TN Telephone Number
0125 TS Time Stamp (Date & Time)
0125 TX Text Data (Display)
0125 XAD Extended Address
0125 XCN Extended Composite Name And Number For Persons
0125 XON Extended Composite Name And Number For Organizations
0125 XPN Extended Person Number
0125 XTN Extended Telecommunications Number
HL7 0136 Yes/No Indicator
0136 Y Yes
0136 N No
HL7 0163 Administrative Site
0163 BE Bilateral Ears
0163 OU Bilateral Eyes
0163 BN Bilateral Nares
0163 BU Buttock
0163 CT Chest Tube
0163 LA Left Arm
0163 LAC Left Anterior Chest
0163 LACF Left Antecubital Fossa
0163 LD Left Deltoid
0163 LE Left Ear
0163 LEJ Left External Jugular 
0163 OS Left Eye
0163 LF Left Foot
0163 LG Left Gluteus Medius
0163 LH Left Hand
0163 LIJ Left Internal Jugular
0163 LLAQ Left Lower Abd Quadrant
0163 LLFA Left Lower Forearm
0163 LMFA Left Mid Forearm
0163 LN Left Naris
0163 LPC Left Posterior Chest
0163 LSC Left Subclavian
0163 LT Left Thigh
0163 LUA Left Upper Arm
0163 LUAQ Left Upper Abd Quadrant
0163 LUFA Left Upper Forearm
0163 LVG Left Ventragluteal




0163 RA Right Arm
0163 RAC Right Anterior Chest
0163 RACF Right Antecubital Fossa
0163 RD Right Deltoid
0163 RE Right Ear
0163 REJ Right External Jugular
0163 OD Right Eye
0163 RF Right Foot
0163 RG Right Gluteus Medius
0163 RH Right Hand
0163 RIJ Right Internal Jugular
0163 RLAQ Rt Lower Abd Quadrant
0163 RLFA Right Lower Forearm
0163 RMFA Right Mid Forearm
0163 RN Right Naris
0163 RPC Right Posterior Chest
0163 RSC Right Subclavian
0163 RT Right Thigh
0163 RUA Right Upper Arm
0163 RUAQ Right Upper Abd Quadrant
0163 RUFA Right Upper Forearm
0163 RVL Right Vastus Lateralis
0163 RVG Right Ventragluteal
User 0171 Citizenship
0171 No suggested values or use ISO 3166





0296 No suggested values or ISO 639





User C0001 NAACCR Text Classification Grouping
C0001 CH Clinical History
C0001 NS Nature of Specimen
C0001 GP Gross Pathology
C0001 MP Microscopic Pathology
C0001 FD Final Diagnosis
C0001 CM Comment Section
C0001 SR Supplemental Reports / Addendum
C0001 PR Staging Parameters
C0001 GN General Laboratory Report (used if report of text is stored in
such a way that it may not be broken down into above
categories)
User C0002 NAACCR Additional Information on
Observation Method
C0002 1 Positive Histology:  Indicated when sample is: tissue
specimen from biopsy, frozen section, surgery, autopsy,
dilation and curettage, or bone marrow biopsy/aspiration. 
Also includes hematologic confirmation of leukemia (that is,
a peripheral blood smear).
C0002 2 Positive exfoliative cytology, no  positive histology:  indicated
by: microscopic examination of cells removed from a
neoplasm.  Fine-needle aspiration is frequently used to
obtain a cytologic specimen.  Cells may be recovered from
exudate, secretions, or washings from tissue, and includes
cervical and vaginal smears.  Also includes paraffin-block
specimens from concentrated spinal, pleural, or peritoneal
fluid.
C0002 3 Bone Marrow
C0002 4 Positive microscopic confirmation, method not specified:
Indicated when: the case is reported as microscopically
confirmed, but the specific method (histology, cytology) is
unknown.
C0002 5 Positive laboratory test/marker study. Indicated by: diagnosis
of cancer based on certain laboratory tests or marker studies
that are clinically diagnostic (for instance, an abnormal
electrophoretic spike for multiple myeloma or
Waldenstrom’s macroglobulinemia.)
C0002 6 Direct visualization without microscopic confirmation
Indicated when: diagnosis made at surgical exploration or by
endoscopy (colposcope, mediastinoscope, laparoscope). 
Also includes autopsies where the only information is from a
gross autopsy report.
C0002 7 Radiology and other imaging techniques without
microscopic confirmation.  Indicated when: diagnosis is by
radiology, ultrasound, computerized tomography, or MRI.
C0002 8 Clinical diagnosis only (other than items 5, 6, and 7)
Indicated when: case has been diagnosed by clinical
methods not mentioned previously.
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Table 1.  Reporting Requirements for Nationally Notifiable Diseases and Conditions
Survey of State\Territorial Epidemiologists, May  1997
Draft Report,  10/97
AK AL AZ AR CA CO CT DC DE FL GA Guam HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NYC NYS NC ND OH OK OR
APP  N  N  P  B  P  N  N  B  N  N  N  N  N  B  N  N  P  B  N  N  P  B  B  N  N  P  B  B  N  N  P  N  P
AIDS  P  B  P  B  P  P  B  B  B  P  B  P  B  P  P  B  B  B  B  B  P  P  P  B  B  B  B  B  B  B  B  B  B  B  P  B  P  B  B
Anthrax  B  B  P  B  P  B  B  B  B  B  N  B  B  B  B  B  P  B  P  B  P  P  B  B  B  B  B  B  B  B  P  B  B  B  P  B  B  B  P
Botulism  B  B  P  B  P  B  B  B  B  B  B  B  B  P  P  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P
Brucellosis  B  B  B  B  P  B  B  B  B  B  N  B  B  B  B  B  P  B  P  N  P  P  B  B  B  B  B  B  B  B  L  B  B  B  P  N  B  B  P
Chancroid  N  B  P  B  P  B  B  B  B  B  B  B  B  N  P  N  P  B  B  B  P  B  B  B  B  B  B  N  B  N  L  B  B  B  P  N  B  N  P
Chlamydia  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B  B  B  B  B  L  B  B  B  B  B  B  B  B  B  L  B  B  N  P  B  B  B  B
Cholera  B  B  P  B  P  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  L  B  B  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  B
Coccidioidomycosis N  N  B  N  P  N  N  N  N  N  B  N  N  N  N  N  N  N  P  N  N  N  B  N  B  B  N  B  N  N  N  N  N  N  N
Cryptosporidiosis B  N  B  B  B  B  B  B  B  B  N  N  N  B  B  B  L  L  B  B  L  B  B  B  L  B  B  B  B  B  L  B  B  B  N  B  B  B  B
Diphtheria  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B
En-CA sero  P  B  P  B  B  L  B  B  B  N  N  B  B  L  B  P  B  B  B  P  B  P  B  N  B  B  N  P  B  B  P  N  B  N  N
En-EE  P  B  P  B  B  L  B  B  B  N  N  B  B  L  B  P  B  B  B  P  B  P  B  B  N  B  B  N  P  B  B  P  B  B  N  N
En-SL  P  B  P  B  B  B  N  B  B  B  N  N  B  B  L  B  P  B  B  B  P  B  P  B  B  N  B  B  N  P  B  B  P  B  B  N  N
En-WE  P  B  P  B  B  B  N  B  B  B  N  N  B  B  L  B  P  B  B  B  P  B  P  B  B  N  B  B  N  P  B  B  P  B  B  N  N
Ecoli 0 P57:H7  L  B  B  B  B  B  B  B  B  B  N  N  B  B  N  B  L  B  B  B  L  B  B  B  B  B  B  B  B  B  L  B  B  B  B  B  B  B  B
Gonorrhea  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  L  B  B  B  B  B  B  B  B
Hi invasive  N  B  B  B  P  B  B  B  B  N  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  L  B  B  B  P  N  B  B  B
Leprosy  B  B  P  B  P  B  B  B  B  N  B  B  B  P  L  B  P  B  B  N  P  B  P  B  L  N  B  B  B  B  L  B  B  B  P  N  B  N  P
HPS  N  N  P  B  P  B  N  B  B  N  N  B  N  N  N  B  B  N  B  B  N  B  B  N  P  B  N  B  B  B  N  B  B  N  N
HUS  N  B  N  B  P  B  P  B  B  N  N  N  P  N  B  N  B  P  P  P  B  P  B  B  N  P  B  P  B  B  B  N  B  B  B  P
A  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B  B  P  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  B
B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  B
C  B  N  B  B  P  B  P  B  B  B  B  N  B  N  N  B  P  B  B  B  B  P  B  B  B  B  B  B  B  N  B  B  B  P  B  B  B  P
NANB  N  B  P  B  P  P  P  B  B  N  B  P  N  P  B  B  P  N  B  B  P  B  P  B  B  B  B  B  B  B  N  B  B  B  P  B  B  B  P
HIV-name,  Ped  N  B  B  B  N  B  N  B  N  B  N  B  N  N  N  N  N  N  N  P  B  B  B  N  B  B  N  B  N  N  N  P  B  L  B  P
HIV-name, Peri  N  B  B  B  N  B  B  B  N  B  N  B  N  B  N  N  N  N  N  P  B  B  B  N  B  B  N  B  N  N  N  P  B  L  B  P
HIV-ID,  Ped  N  N  N  N  N  N  N  N  N  N  N  B  N  B  B  B  B  N  L  N  N  N  N  B  B  N  N  B  N  N  N  N  N  N  N  N  N
HIV-ID,  Peri  N  N  N  N  N  N  N  N  N  N  N  B  B  B  B  B  B  N  L  N  N  N  N  B  N  N  N  B  N  N  N  N  N  N  N  N  N
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Survey of State\Territorial Epidemiologists, May  1997
Draft Report,  10/97
AK AL AZ AR CA CO CT DC DE FL GA Guam HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NYC NYS NC ND OH OK OR
Legionellosis  B  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  N
Lyme  P  B  P  B  P  B  P  B  B  B  N  P  B  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P  B  B  B  P
Malaria  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  B
Measles  B  B  P  B  B  B  B  B  B  B  B  P  B  P  B  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B
Meningococ  L  B  P  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  P  N  B  B  B
Mumps  B  B  P  B  P  B  B  B  B  B  B  P  B  P  B  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  N  B  B  P  B  B  B  N
Pertussis  B  B  B  B  P  B  B  B  B  B  B  B  B  P  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P
Plague  B  N  P  B  B  B  B  B  B  N  B  B  B  B  B  N  P  B  B  B  P  L  B  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  P
Polio  B  B  P  B  P  B  B  B  B  B  B  B  B  P  B  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P
Psittacosis  B  B  P  B  P  B  N  B  B  B  N  P  B  B  B  B  P  B  N  B  P  P  P  B  B  B  B  B  B  B  L  B  B  B  P  N  B  N  P
Animal Rab  L  B  N  B  B  B  B  B  B  B  B  L  N  L  N  B  P  N  B  L  P  L  N  B  B  B  B  B  B  B  N  B  B  B  N  B  B  B  P
Human Rab  B  B  P  B  B  B  B  B  B  B  B  B  B  P  B  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P
RMSF  N  B  P  B  P  B  B  B  B  B  N  P  B  B  B  B  P  B  B  N  B  B  P  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  P
Rubella  B  B  P  B  P  B  B  B  B  B  B  P  B  P  P  B  P  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B
CRS  P  B  P  B  P  B  B  B  B  B  N  P  B  P  P  B  P  B  B  B  P  P  B  B  B  N  B  B  B  B  P  B  B  B  P  B  B  B  P
Salmonella  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  L  B  B  B  B  B  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  B
Shigella  B  B  P  B  P  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  B
Silicosis  N  N  N  B  P  N  P  N  N  N  N  B  B  P  N  P  P  N  N  B  N  N  P  P  B  B  P  N  P  B  N
Strep A invas  N  N  P  B  P  N  B  B  B  B  P  B  P  N  N  B  N  B  B  L  P  B  N  B  N  B  N  B  L  B  B  B  N  B  B  N  N
S Pneu-I  N  N  L  N  N  B  B  N  N  N  P  N  N  N  N  N  N  B  B  B  P  B  N  N  B  N  N  N  N  B  N  N  N  N  B  N  N
S Pneu-R  N  N  L  B  N  B  B  B  B  N  N  N  N  N  N  L  B  B  N  N  B  N  N  B  N  N  B  L  N  B  B  N  B  B  N  N
Strep TSS  N  N  P  B  P  B  P  B  B  N  P  B  P  N  B  N  N  B  P  P  B  N  N  N  N  N  B  P  B  B  B  P  B  B  B  N
Syphillis  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B
Con Syph  P  B  P  B  P  B  B  B  B  B  N  B  B  B  N  B  P  B  B  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  P
Tetanus  B  B  P  B  P  B  B  B  B  B  B  P  B  P  P  B  P  B  B  B  P  B  P  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  P
TSS  N  B  P  B  P  B  N  B  B  B  N  P  B  P  P  B  P  B  N  P  P  P  B  N  B  N  B  B  B  P  B  B  B  P  B  B  B  N
Trichinosis  B  B  P  N  P  B  B  B  B  N  B  B  N  B  B  B  N  B  B  P  P  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  N  P
TB  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B  B
Typh fev  P  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  P  B  B  B  B  B  B  B  B  B  B  B  B  B  L  B  B  B  P  B  B  B  B
Yel fev  B  B  P  B  P  B  P  B  B  N  B  B  N  N  B  B  P  B  B  N  B  B  B  B  N  B  B  N  N  P  B  B  B  P  N  B  B  P
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 P=Provider reportable only
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Table  1.  Reporting Requirements for Nationally Notifiable Diseases and Conditions
Survey of State\Territorial Epidemiologists, May  1997
Draft Report,  10/97
 PA PR RI SC SD TN TX UT VT VA WA WV WI WY Amer SamoaCNMI Marshall IslandsMicronesia Palau USVI
APP  N  N  N  N  N  B  B  P  P  N  B  N
AIDS  P  P  B  P  B  B  B  B  P  P  B  B  B  B
Anthrax  P  P  B  B  B  B  B  B  B  B  B  B  B  B
Botulism  B  P  B  P  B  B  B  B  B  P  B  B  B  P
Brucellosis  B  P  B  N  B  B  B  B  B  P  B  B  B  B
Chancroid  N  P  B  B  B  B  B  B  N  P  P  P  B  B
Chlamydia  B  B  L  B  B  B  B  B  B  B  B  B  B
Cholera  B  P  B  B  B  B  B  B  B  B  B  B  B  B
Coccidioidomycosis N  N  N  N  N  N  B  N  N  N  N  N  P
Cryptosporidiosis N  B  B  B  B  B  N  B  N  N  B  N  B
Diphtheria  B  P  B  B  B  B  B  B  B  B  B  B  B  B
En-CA sero  P  P  B  B  B  B  B  B  P  N  B
En-EE  P  P  B  B  B  B  B  B  P  N  B
En-SL  P  P  B  B  B  B  B  B  P  B  N  B
En-WE  P  P  B  B  B  B  B  B  P  B  N  B  L
Ecoli 0 P57:H7  N  P  B  B  B  B  B  B  B  N  B  B  N  B
Gonorrhea  B  P  B  B  B  B  B  B  B  B  B  B  B  B
Hi invasive  B  P  B  B  B  B  B  B  B  B  B  B  N  B
Leprosy  N  B  P  B  B  B  B  N  P  B  N  B  B
HPS  N  B  P  B  B  B  B  P  N  N  N  N  B
HUS  N  B  P  B  B  B  N  P  N  N  B  N  B
A  B  P  B  P  B  B  B  B  B  B  B  B  B  B
B  B  P  B  P  B  B  B  B  B  P  B  B  B  B
C  L  P  B  P  B  B  B  B  B  N  B  B  N  B
NANB  P  P  B  P  B  N  B  B  B  P  B  P  B
HIV-name,  Ped  N  N  B  B  B  B  N  B  N  B  B  B
HIV-name, Peri  N  N  B  B  B  B  B  N  B  N  B  B  B
HIV-ID,  Ped  N  B  N  N  N  N  N  N  N
HIV-ID,  Peri  N  B  N  N  N  N  N  N  N
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 PA PR RI SC SD TN TX UT VT VA WA WV WI WY Amer SamoaCNMI Marshall IslandsMicronesia Palau USVI
Legionellosis  B  B  P  B  B  B  B  B  B  B  N  B  B
Lyme  B  B  P  B  B  B  B  B  P  P  B  B  B
Malaria  B  P  B  B  B  B  B  B  B  B  B  B  B  B
Measles  P  P  B  B  B  B  B  B  B  P  B  B  B  B
Meningococ  B  P  B  B  B  B  B  B  B  B  B  N  B  B
Mumps  P  P  B  P  B  B  N  B  B  P  B  B  B  B
Pertussis  P  P  B  B  B  B  B  B  B  B  B  B  B  B
Plague  B  P  B  B  B  B  B  B  B  B  B  B  B  B
Polio  P  P  B  B  B  B  B  B  B  B  P  B  B  B
Psittacosis  B  P  B  P  B  B  N  B  B  P  P  B  B  P
Animal Rab  B  P  B  L  B  B  B  B  B  B  B  B  N  P
Human Rab  B  P  B  P  B  B  B  B  B  P  B  B  B  B
RMSF  B  B  B  B  B  B  B  B  P  P  B  B  B
Rubella  P  P  B  B  B  B  B  B  B  P  P  B  B  B
CRS  P  P  P  P  B  B  B  B  B  P  P  P  B  P
Salmonella  B  P  B  B  B  B  B  B  B  B  B  B  B  B
Shigella  B  P  B  B  B  B  B  B  B  B  B  B  B  B
Silicosis  N  B  N  N  N  N  N  N  P  N  P
Strep A invas  N  P  B  P  B  B  B  N  B  N  N  B  N  B
S Pneu-I  N  P  B  N  N  N  N  N  B  N  N  B  N
S Pneu-R  N  P  B  L  B  B  N  N  B  N  N  B  N  B
Strep TSS  N  B  P  N  B  N  N  P  N  B  N  N  B
Syphillis  B  P  B  B  B  B  B  B  B  B  B  B  B  B
Con Syph  B  P  B  P  B  B  B  B  B  P  P  B  B  B
Tetanus  P  P  B  P  B  B  B  B  P  P  P  B  B
TSS  P  B  B  B  B  N  B  P  P  N  B  B
Trichinosis  B  P  B  B  B  B  B  B  B  P  B  B  B
TB  B  P  B  B  B  B  B  B  B  B  B  B  B
Typh fev  B  P  B  B  B  B  B  B  B  P  B  B  P
Yel fev  P  P  B  P  B  B  B  B  B  P  P  B  B  P
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A B C D E F G H I
Condition Name Fully specified LOINC entry Reportable Result
LOINC# COMPONENT PROP TM SYS PR METHOD
Amebiasis 10641-9 AMOEBA IDENTIFIED PRID PT ASP QL IMMUNE STAIN Amebiasis organism list
Amebiasis 10642-7 AMOEBA IDENTIFIED PRID PT ASP QL WET PREPARATION Amebiasis organism list
Amebiasis 10643-5 AMOEBA IDENTIFIED PRID PT STL QL ORGANISM SPECIFIC CULTURE Amebiasis organism list
Amebiasis 6594-6 AMOEBA IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Amebiasis organism list
Amebiasis 5150-8 ENTAMOEBA HISTOLYTICA AB ACNC PT SER QN EIA Not reportable
Amebiasis 5151-6 ENTAMOEBA HISTOLYTICA AB ACNC PT SER QN HAI Not reportable
Amebiasis 7880-8 ENTAMOEBA HISTOLYTICA AB ACNC PT SER QN Not reportable
Amebiasis 9420-1 ENTAMOEBA HISTOLYTICA AB TITR PT SER QN CF Not reportable
Amebiasis 9421-9 ENTAMOEBA HISTOLYTICA AB ACNC PT SER QN ID Not reportable
Amebiasis 9521-6 ENTAMOEBA HISTOLYTICA AB.IGA ACNC PT SER QN EIA
Amebiasis 9522-4 ENTAMOEBA HISTOLYTICA AB.IGG ACNC PT SER QN EIA
Amebiasis 9523-2 ENTAMOEBA HISTOLYTICA AB.IGM ACNC PT SER QN EIA
Amebiasis 6397-4 ENTAMOEBA HISTOLYTICA AG ACNC PT SER QN EIA Positive
Amebiasis 6398-2 ENTAMOEBA HISTOLYTICA AG ACNC PT STL QN EIA Positive
Amebiasis 6399-0 ENTAMOEBA HISTOLYTICA AG ACNC PT XXX QN EIA Positive
Amebiasis 6396-6 ENTAMOEBA HISTOLYTICA DNA ACNC PT XXX SQ PCR/PROBE Positive
Amebiasis 6470-9 MICROSCOPIC OBSERVATION PRID PT STL QL WET PREPARATION Amebiasis organism list
Amebiasis 9785-7 MICROSCOPIC OBSERVATION PRID PT STL QL OVA AND PARASITE PREPARATION Amebiasis organism list
Amebiasis 10356-4 MICROSCOPIC OBSERVATION PRID PT STL QL TRICHROME STAIN Amebiasis organism list
Amebiasis 6665-4 MICROSCOPIC OBSERVATION PRID PT TISS QL HEMATOXYLIN AND EOSIN STAIN Amebiasis organism list
Amebiasis 6674-6 MICROSCOPIC OBSERVATION PRID PT TISS QL OVA AND PARASITE PREPARATION Amebiasis organism list
Amebiasis 6473-3 MICROSCOPIC OBSERVATION PRID PT TISS QL TRICHROME STAIN Amebiasis organism list
Amebiasis 6680-3 MICROSCOPIC OBSERVATION PRID PT TISS QL WET PREPARATION Amebiasis organism list
Amebiasis 665-0 MICROSCOPIC OBSERVATION PRID PT XXX QL HEMATOXYLIN AND EOSIN STAIN Amebiasis organism list
Amebiasis 673-4 MICROSCOPIC OBSERVATION PRID PT XXX QL OVA AND PARASITE PREPARATION Amebiasis organism list
Amebiasis 678-3 MICROSCOPIC OBSERVATION PRID PT XXX QL TRICHROME STAIN Amebiasis organism list
Amebiasis 680-9 MICROSCOPIC OBSERVATION PRID PT XXX QL WET PREPARATION Amebiasis organism list
Amebiasis 10701-1 OVA + PARASITES IDENTIFIED PRID PT STL QL CONCENTRATION Amebiasis organism list
Amebiasis 10702-9 OVA + PARASITES IDENTIFIED PRID PT STL QL IMMUNE STAIN Amebiasis organism list
Amebiasis 10703-7 OVA + PARASITES IDENTIFIED PRID PT STL QL KH STAIN Amebiasis organism list
Amebiasis 10704-5 OVA + PARASITES IDENTIFIED PRID PT STL QL MICROSCOPY.LIGHT Amebiasis organism list
Anthrax 5055-9 BACILLUS ANTHRACIS AB ACNC PT SER QN HAI Not reportable
Anthrax 11467-8 BACILLUS ANTHRACIS AB ACNC PT SER QN IB Positive
Anthrax 11468-6 BACILLUS ANTHRACIS AB ACNC PT XXX QN IF Positive
Anthrax 11469-4 BACILLUS ANTHRACIS IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Positive
Arbovirus 6309-9 ARBOVIRUS IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Arbovirus organism list
Arbovirus 6310-7 ARBOVIRUS IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Arbovirus organism list
Arbovirus 5134-2 EASTERN EQUINE ENCEPHALITIS VIRUS AB ACNC PT SER QN
Arbovirus 13228-2 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGG ACNC PT CSF QN
Arbovirus 10897-7 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGG TITR PT CSF QN IF Positive
Arbovirus 7860-0 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGG ACNC PT SER QN Positive
Arbovirus 10896-9 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGG TITR PT SER QN IF Positive
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Arbovirus 13229-0 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGM ACNC PT CSF QN
Arbovirus 10899-3 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGM TITR PT CSF QN IF Positive
Arbovirus 7861-8 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGM ACNC PT SER QN Positive
Arbovirus 10898-5 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGM TITR PT SER QN IF Positive
Arbovirus 6388-3 EASTERN EQUINE ENCEPHALITIS VIRUS AG ACNC PT SER SQ EIA Positive
Arbovirus 6389-1 EASTERN EQUINE ENCEPHALITIS VIRUS AG ACNC PT SER SQ IF Positive
Arbovirus 7933-5 JAPANESE ENCEPHALITIS VIRUS AB ACNC PT CSF SQ EIA
Arbovirus 7934-3 JAPANESE ENCEPHALITIS VIRUS AB ACNC PT SER SQ EIA
Arbovirus 7935-0 JAPANESE ENCEPHALITIS VIRUS AB ACNC PT SER QN HAI
Arbovirus 11608-7 JAPANESE ENCEPHALITIS VIRUS AB ACNC PT SER QN
Arbovirus 7936-8 JAPANESE ENCEPHALITIS VIRUS RNA ACNC PT SER SQ PCR/PROBE Positive
Arbovirus 9538-0 LA CROSSE VIRUS AB TITR PT CSF QN IF
Arbovirus 5073-2 LA CROSSE VIRUS AB ACNC PT SER QN
Arbovirus 7938-4 LA CROSSE VIRUS AB ACNC PT SER SQN EIA
Arbovirus 7939-2 LA CROSSE VIRUS AB ACNC PT SER SQN IF
Arbovirus 9539-8 LA CROSSE VIRUS AB.IGG TITR PT CSF QN IF
Arbovirus 7940-0 LA CROSSE VIRUS AB.IGG ACNC PT SER QN
Arbovirus 10904-1 LA CROSSE VIRUS AB.IGG TITR PT SER QN IF
Arbovirus 9540-6 LA CROSSE VIRUS AB.IGM TITR PT CSF QN IF Positive
Arbovirus 7941-8 LA CROSSE VIRUS AB.IGM ACNC PT SER QN Positive
Arbovirus 10905-8 LA CROSSE VIRUS AB.IGM TITR PT SER QN IF Positive
Arbovirus 7942-6 LASSA VIRUS AB.IGG ACNC PT SER SQ EIA
Arbovirus 7943-4 LASSA VIRUS AB.IGG TITR PT SER QN IF
Arbovirus 7944-2 LASSA VIRUS AB.IGM ACNC PT SER SQ EIA Positive
Arbovirus 7945-9 LASSA VIRUS AB.IGM TITR PT SER QN IF Positive
Arbovirus 7946-7 LASSA VIRUS AG ACNC PT SER SQ EIA Positive
Arbovirus 8021-8 SAINT LOUIS ENCEPHALITIS VIRUS AB ACNC PT CSF SQ EIA
Arbovirus 9577-8 SAINT LOUIS ENCEPHALITIS VIRUS AB TITR PT CSF QN IF
Arbovirus 5365-2 SAINT LOUIS ENCEPHALITIS VIRUS AB ACNC PT SER QN
Arbovirus 8022-6 SAINT LOUIS ENCEPHALITIS VIRUS AB ACNC PT SER QN CF
Arbovirus 8023-4 SAINT LOUIS ENCEPHALITIS VIRUS AB ACNC PT SER SQ EIA
Arbovirus 8024-2 SAINT LOUIS ENCEPHALITIS VIRUS AB ACNC PT SER SQ IF
Arbovirus 9578-6 SAINT LOUIS ENCEPHALITIS VIRUS AB TITR PT SER QN IF
Arbovirus 13230-8 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGG ACNC PT CSF QN
Arbovirus 8016-8 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGG ACNC PT SER QN
Arbovirus 10906-6 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGG TITR PT SER QN IF
Arbovirus 9634-7 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGG TITR PT XXX QN
Arbovirus 13231-6 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGM ACNC PT CSF QN
Arbovirus 8017-6 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGM ACNC PT SER QN Positive
Arbovirus 10907-4 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGM TITR PT SER QN IF Positive
Arbovirus 9635-4 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGM TITR PT XXX QN Positive
Arbovirus 6549-0 SAINT LOUIS ENCEPHALITIS VIRUS AG ACNC PT SER QN Positive
Arbovirus 8025-9 SAINT LOUIS ENCEPHALITIS VIRUS RNA ACNC PT SER SQ PCR/PROBE Positive
Arbovirus 6571-4 VENEZUELAN EQUINE ENCEPHALITIS VIRUS AB ACNC PT SER QN
Arbovirus 8050-7 VENEZUELAN EQUINE ENCEPHALITIS VIRUS AB.IGG ACNC PT SER QN
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Arbovirus 8051-5 VENEZUELAN EQUINE ENCEPHALITIS VIRUS AB.IGM ACNC PT SER QN Positive
Arbovirus 6572-2 VENEZUELAN EQUINE ENCEPHALITIS VIRUS AG ACNC PT SER SQ EIA Positive
Arbovirus 6573-0 VENEZUELAN EQUINE ENCEPHALITIS VIRUS AG ACNC PT SER SQ IF Positive
Arbovirus 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Arbovirus organism list
Arbovirus 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Arbovirus organism list
Arbovirus 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Arbovirus organism list
Arbovirus 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Arbovirus organism list
Arbovirus 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Arbovirus organism list
Arbovirus 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Arbovirus organism list
Arbovirus 9314-6 WESTERN EQUINE ENCEPHALITIS VIRUS AB TITR PT CSF QN IF
Arbovirus 5406-4 WESTERN EQUINE ENCEPHALITIS VIRUS AB ACNC PT SER QN
Arbovirus 9581-0 WESTERN EQUINE ENCEPHALITIS VIRUS AB TITR PT SER QN IF
Arbovirus 9315-3 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGG TITR PT CSF QN IF
Arbovirus 8052-3 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGG ACNC PT SER QN
Arbovirus 6957-5 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGG TITR PT SER QN IF
Arbovirus 9316-1 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGM TITR PT CSF QN IF Positive
Arbovirus 8053-1 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGM ACNC PT SER QN Positive
Arbovirus 6958-3 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGM TITR PT SER QN IF Positive
Arbovirus 6585-4 WESTERN EQUINE ENCEPHALITIS VIRUS AG ACNC PT SER SQ EIA Positive
Arbovirus 6586-2 WESTERN EQUINE ENCEPHALITIS VIRUS AG ACNC PT SER SQ IF Positive
Babesiosis 9584-4 BABESIA SP AB.IGG TITR PT SER QN IF >1:256
Babesiosis 9585-1 BABESIA SP AB.IGM TITR PT SER QN IF >1:256
Babesiosis 6311-5 BABESIA MICROTI AB ACNC PT SER QN EIA
Babesiosis 7812-1 BABESIA MICROTI AB ACNC PT SER QN
Babesiosis 10347-3 BABESIA MICROTI IDENTIFIED PRID PT BLD QL MICROSCOPY.LIGHT Babesiosis organism list
Babesiosis 5054-2 BABESIA SP AB TITR PT SER QN IF >1:256
Babesiosis 7813-9 BABESIA SP AB ACNC PT SER QN
Babesiosis 10647-6 BABESIA SP IDENTIFIED PRID PT BLD QL THICK FILM Babesiosis organism list
Babesiosis 10648-4 BABESIA SP IDENTIFIED PRID PT BLD QL THIN FILM Babesiosis organism list
Babesiosis 637-9 MICROSCOPIC OBSERVATION PRID PT BLD QL MALARIA THICK SMEAR Babesiosis organism list
Bartonellosis 5326-4 BARTONELLA HENSELAE AB.IGG ACNC PT SER QN
Bartonellosis 7815-4 BARTONELLA HENSELAE AB.IGG ACNC PT SER QN EIA
Bartonellosis 6954-2 BARTONELLA HENSELAE AB.IGG TITR PT SER QN IF
Bartonellosis 5327-2 BARTONELLA HENSELAE AB.IGM ACNC PT SER QN
Bartonellosis 6312-3 BARTONELLA HENSELAE AB.IGM ACNC PT SER QN EIA Positive
Bartonellosis 6955-9 BARTONELLA HENSELAE AB.IGM TITR PT SER QN IF Positive
Bartonellosis 8009-3 BARTONELLA QUINTANA AB.IGG ACNC PT SER QN
Bartonellosis 9360-9 BARTONELLA QUINTANA AB.IGG TITR PT SER QN
Bartonellosis 8010-1 BARTONELLA QUINTANA AB.IGM ACNC PT SER QN Positive
Bartonellosis 9361-7 BARTONELLA QUINTANA AB.IGM TITR PT SER QN Positive
Bartonellosis 13325-6 BARTONELLA SP IDENTIFIED PRID PT BLD SQ MICROSCOPY.LIGHT
Bartonellosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Bartonellosis organism list
Bartonellosis 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Bartonellosis organism list
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Bartonellosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Bartonellosis organism list
Bartonellosis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Bartonellosis organism list
Bartonellosis 11546-9 MICROSCOPIC OBSERVATION PRID PT XXX QL Bartonellosis organism list
Blastomycosis 5057-5 BLASTOMYCES DERMATITIDIS AB TITR PT SER QN CF
Blastomycosis 5058-3 BLASTOMYCES DERMATITIDIS AB ACNC PT SER SQ ID
Blastomycosis 7816-2 BLASTOMYCES DERMATITIDIS AB ACNC PT SER SQ
Blastomycosis 9494-6 BLASTOMYCES DERMATITIDIS AB.IGG ACNC PT SER QN
Blastomycosis 6313-1 BLASTOMYCES DERMATITIDIS AG ACNC PT SER SQ EIA Positive
Blastomycosis 4990-8 BLASTOMYCES DERMATITIDIS RRNA ACNC PT XXX SQ DNA PROBE Positive
Blastomycosis 568-6 FUNGUS IDENTIFIED PRID PT ASP QL ROUTINE FUNGAL CULTURE Blastomycosis organism list
Blastomycosis 577-7 FUNGUS IDENTIFIED PRID PT SPT QL ROUTINE FUNGAL CULTURE Blastomycosis organism list
Blastomycosis 6409-7 FUNGUS IDENTIFIED PRID PT SPTT QL ROUTINE FUNGAL CULTURE Blastomycosis organism list
Blastomycosis 10666-6 FUNGUS IDENTIFIED PRID PT TISS QL FONTANA-MASSON STAIN Blastomycosis organism list
Blastomycosis 578-5 FUNGUS IDENTIFIED PRID PT TISS QL ROUTINE FUNGAL CULTURE Blastomycosis organism list
Blastomycosis 580-1 FUNGUS IDENTIFIED PRID PT XXX QL ROUTINE FUNGAL CULTURE Blastomycosis organism list
Blastomycosis 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Blastomycosis organism list
Blastomycosis 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Blastomycosis organism list
Blastomycosis 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Blastomycosis organism list
Blastomycosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Blastomycosis organism list
Blastomycosis 11475-1 MICROORGANISM IDENTIFIED PRID PT XXX QL CULTURE Blastomycosis organism list
Blastomycosis 648-6 MICROSCOPIC OBSERVATION PRID PT SPT QL GRAM STAIN Blastomycosis organism list
Blastomycosis 6468-3 MICROSCOPIC OBSERVATION PRID PT SPT QL CALCOFLUOR WHITE PREPARATION Blastomycosis organism list
Blastomycosis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Blastomycosis organism list
Blastomycosis 6472-5 MICROSCOPIC OBSERVATION PRID PT TISS QL CALCOFLUOR WHITE PREPARATION Blastomycosis organism list
Blastomycosis 6664-7 MICROSCOPIC OBSERVATION PRID PT TISS QL GRAM STAIN Blastomycosis organism list
Blastomycosis 6667-0 MICROSCOPIC OBSERVATION PRID PT TISS QL KOH PREPARATION Blastomycosis organism list
Blastomycosis 6675-3 MICROSCOPIC OBSERVATION PRID PT TISS QL PERIODIC ACID-SCHIFF STAIN Blastomycosis organism list
Blastomycosis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Blastomycosis organism list
Botulism 11470-2 CLOSTRIDIUM BOTULINUM TOXIN ACNC PT STL QN Positive
Botulism 6459-2 MICROORGANISM IDENTIFIED PRID PT FOOD QL FOOD CULTURE Botulism organism list
Brucellosis 5066-6 BRUCELLA ABORTUS AB ACNC PT SER SQ LA >1:160
Brucellosis 5067-4 BRUCELLA ABORTUS AB TITR PT SER QN LA >1:160
Brucellosis 6324-8 BRUCELLA ABORTUS AB TITR PT SER QN AGGL >1:160
Brucellosis 6325-5 BRUCELLA ABORTUS AB TITR PT SER QN CF
Brucellosis 6910-4 BRUCELLA ABORTUS AB.IGA ACNC PT SER QN
Brucellosis 6911-2 BRUCELLA ABORTUS AB.IGG ACNC PT SER QN
Brucellosis 6326-3 BRUCELLA ABORTUS AB.IGM ACNC PT SER QN EIA Positive
Brucellosis 6327-1 BRUCELLA CANIS AB ACNC PT SER QN EIA Positive
Brucellosis 11587-3 BRUCELLA CANIS AB ACNC PT SER QN
Brucellosis 5068-2 BRUCELLA CANIS AB TITR PT SER QN LA >1:160
Brucellosis 13214-2 BRUCELLA CANIS AB.IGG ACNC PT CSF QN
Brucellosis 9495-3 BRUCELLA CANIS AB.IGG ACNC PT SER QN EIA Positive
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Brucellosis 13215-9 BRUCELLA CANIS AB.IGM ACNC PT CSF QN
Brucellosis 9496-1 BRUCELLA CANIS AB.IGM ACNC PT SER QN EIA Positive
Brucellosis 11588-1 BRUCELLA MELITENSIS AB ACNC PT SER QN
Brucellosis 5069-0 BRUCELLA MELITENSIS AB TITR PT SER QN LA >1:160
Brucellosis 10349-9 BRUCELLA SP AB ACNC PT SER QN
Brucellosis 6328-9 BRUCELLA SP AB TITR PT SER QN IF >1:64
Brucellosis 13211-8 BRUCELLA SP AB.IGA ACNC PT SER/PLA
S
QN
Brucellosis 13210-0 BRUCELLA SP AB.IGG ACNC PT SER/PLA
S
QN
Brucellosis 5070-8 BRUCELLA SP AB.IGM ACNC PT SER QN Positive
Brucellosis 551-2 BRUCELLA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Brucellosis organism list
Brucellosis 552-0 BRUCELLA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Brucellosis organism list
Brucellosis 11589-9 BRUCELLA SUIS AB ACNC PT SER QN
Brucellosis 5071-6 BRUCELLA SUIS AB TITR PT SER QN LA >1:160
Brucellosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Brucellosis organism list
Brucellosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Brucellosis organism list
Brucellosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Brucellosis organism list
Brucellosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Brucellosis organism list
Campylobacteriosis 6329-7 CAMPYLOBACTER COLI RRNA ACNC PT XXX SQ DNA PROBE Positive
Campylobacteriosis 6330-5 CAMPYLOBACTER IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Campylobacter organism list
Campylobacteriosis 6331-3 CAMPYLOBACTER IDENTIFIED PRID PT STL QL ORGANISM SPECIFIC CULTURE Campylobacter organism list
Campylobacteriosis 6332-1 CAMPYLOBACTER IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Campylobacter organism list
Campylobacteriosis 9655-2 CAMPYLOBACTER JEJUNI AB TITR PT SER QN
Campylobacteriosis 6333-9 CAMPYLOBACTER JEJUNI RRNA ACNC PT XXX SQ DNA PROBE Positive
Campylobacteriosis 6334-7 CAMPYLOBACTER LARI RRNA ACNC PT XXX SQ DNA PROBE Positive
Campylobacteriosis 6335-4 CAMPYLOBACTER SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Campylobacter organism list
Campylobacteriosis 4992-4 CAMPYLOBACTER SP RRNA ACNC PT XXX SQ DNA PROBE Positive
Chanchroid 6600-1 HAEMOPHILUS SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Chanchroid organism list
Chanchroid 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Chanchroid organism list
Chanchroid 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Chanchroid organism list
Chanchroid 10352-3 MICROORGANISM IDENTIFIED PRID PT GEN QL AEROBIC CULTURE Chanchroid organism list
Chanchroid 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Chanchroid organism list
Chanchroid 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Chanchroid organism list
Chickenpox 10734-2 VARICELLA-ZOSTER VIRUS IDENTIFIED PRID PT SKN QL MICROSCOPY.ELECTRON Chickpox organism list
Chickenpox 9636-2 VARICELLA VIRUS AB ACNC PT CSF SQ
Chickenpox 8046-5 VARICELLA VIRUS AB ACNC PT SER QN
Chickenpox 12271-3 VARICELLA VIRUS AB ACNC PT SER SQ LA
Chickenpox 5401-5 VARICELLA VIRUS AB TITR PT SER QN CF
Chickenpox 5402-3 VARICELLA VIRUS AB TITR PT SER QN LA
Chickenpox 5403-1 VARICELLA VIRUS AB.IGG ACNC PT SER QN EIA
Chickenpox 8047-3 VARICELLA VIRUS AB.IGG ACNC PT SER QN
Chickenpox 6569-8 VARICELLA VIRUS AB.IGG TITR PT SER QN IF
Chickenpox 5404-9 VARICELLA VIRUS AB.IGM ACNC PT SER QN EIA
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Chickenpox 8048-1 VARICELLA VIRUS AB.IGM ACNC PT SER QN
Chickenpox 6570-6 VARICELLA VIRUS AB.IGM TITR PT SER QN IF
Chickenpox 5881-8 VARICELLA VIRUS AG ACNC PT SKN SQ IF Positive
Chickenpox 5882-6 VARICELLA VIRUS AG ACNC PT XXX SQ IF Positive
Chickenpox 10860-5 VARICELLA ZOSTER ACNC PT XXX SQ ORGANISM SPECIFIC CULTURE Chickpox organism list
Chickenpox 8049-9 VARICELLA ZOSTER VIRUS DNA ACNC PT SER SQ PCR/PROBE Chickpox organism list
Chickenpox 11483-5 VARICELLA ZOSTER VIRUS DNA ACNC PT XXX SQ PCR/PROBE Chickpox organism list
Chickenpox 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Chickpox organism list
Chickenpox 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Chickpox organism list
Chickenpox 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Chickpox organism list
Chickenpox 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Chickpox organism list
Chickenpox 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Chickpox organism list
Chickenpox 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Chickpox organism list
Chickenpox 10739-1 VIRUS IDENTIFIED PRID PT XXX QL MICROSCOPY.ELECTRON Chickpox organism list
Chickenpox 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Chickpox organism list
Chlamydia infection 5078-1 CHLAMYDIA PNEUMONIAE AB ACNC PT SER QN
Chlamydia infection 6912-0 CHLAMYDIA PNEUMONIAE AB.IGA TITR PT SER SQN IF
Chlamydia infection 6913-8 CHLAMYDIA PNEUMONIAE AB.IGG TITR PT SER SQN IF
Chlamydia infection 6914-6 CHLAMYDIA PNEUMONIAE AB.IGM TITR PT SER QN IF
Chlamydia infection 10651-8 CHLAMYDIA PNEUMONIAE AG ACNC PT SPT/BRO SQ Positive
Chlamydia infection 10652-6 CHLAMYDIA PNEUMONIAE DNA ACNC PT SPT/BRO SQ AMP/PROBE Positive
Chlamydia infection 7821-2 CHLAMYDIA PNEUMONIAE RNA ACNC PT SER SQ PCR/PROBE Positive
Chlamydia infection 7822-0 CHLAMYDIA PSITTACI AB ACNC PT SER QN
Chlamydia infection 5079-9 CHLAMYDIA PSITTACI AB TITR PT SER QN CF
Chlamydia infection 6915-3 CHLAMYDIA PSITTACI AB.IGA TITR PT SER QN IF
Chlamydia infection 5080-7 CHLAMYDIA PSITTACI AB.IGG ACNC PT SER QN
Chlamydia infection 6916-1 CHLAMYDIA PSITTACI AB.IGG TITR PT SER QN IF
Chlamydia infection 5081-5 CHLAMYDIA PSITTACI AB.IGM ACNC PT SER QN Positive
Chlamydia infection 6917-9 CHLAMYDIA PSITTACI AB.IGM TITR PT SER QN IF
Chlamydia infection 6338-8 CHLAMYDIA PSITTACI AG ACNC PT GEN SQ EIA Positive
Chlamydia infection 6339-6 CHLAMYDIA PSITTACI AG ACNC PT GEN SQ IF Positive
Chlamydia infection 6340-4 CHLAMYDIA PSITTACI AG ACNC PT XXX SQ EIA Positive
Chlamydia infection 6341-2 CHLAMYDIA PSITTACI AG ACNC PT XXX SQ IF Positive
Chlamydia infection 5082-3 CHLAMYDIA SP AB ACNC PT SER QN EIA
Chlamydia infection 7823-8 CHLAMYDIA SP AB ACNC PT SER QN
Chlamydia infection 5083-1 CHLAMYDIA SP AB TITR PT SER QN CF
Chlamydia infection 5084-9 CHLAMYDIA SP AB TITR PT SER QN IF
Chlamydia infection 5085-6 CHLAMYDIA SP AB.IGG ACNC PT SER QN
Chlamydia infection 10848-0 CHLAMYDIA SP AB.IGG TITR PT SER QN IF
Chlamydia infection 5086-4 CHLAMYDIA SP AB.IGM ACNC PT SER QN
Chlamydia infection 10849-8 CHLAMYDIA SP AB.IGM TITR PT SER QN IF
Chlamydia infection 6343-8 CHLAMYDIA SP AG ACNC PT CNJT SQ EIA Positive
Chlamydia infection 6344-6 CHLAMYDIA SP AG ACNC PT CNJT SQ IF Positive
Chlamydia infection 6345-3 CHLAMYDIA SP AG ACNC PT GEN SQ EIA Positive
Diane Dwyer, M.D., Rashid Chotani, M.D. M.P.H., Blaine Y. Takesue, M.D., Clement J. McDonald, M.D.
LOINC Names and Codes (c) 1995-1997
Maryland Dept of Health and Mental Hygiene, Regenstrief Inst for Health Care and LOINC Committee 6 of 49 2/10/98
DRAFT Appendix C
Table IV: LOINC List
1
A B C D E F G H I














































Chlamydia infection 6346-1 CHLAMYDIA SP AG ACNC PT GEN SQ IF Positive
Chlamydia infection 561-1 CHLAMYDIA SP AG ACNC PT XXX SQ IF Positive
Chlamydia infection 6347-9 CHLAMYDIA SP AG ACNC PT XXX SQ EIA Positive
Chlamydia infection 556-1 CHLAMYDIA SP IDENTIFIED PRID PT CNJT QL ORGANISM SPECIFIC CULTURE Chlamydia organism list
Chlamydia infection 557-9 CHLAMYDIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Chlamydia organism list
Chlamydia infection 6348-7 CHLAMYDIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Chlamydia organism list
Chlamydia infection 558-7 CHLAMYDIA SP IDENTIFIED PRID PT THRT QL ORGANISM SPECIFIC CULTURE
Chlamydia infection 559-5 CHLAMYDIA SP IDENTIFIED PRID PT URTH QL ORGANISM SPECIFIC CULTURE Chlamydia organism list
Chlamydia infection 560-3 CHLAMYDIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Chlamydia organism list
Chlamydia infection 7824-6 CHLAMYDIA TRACHOMATIS AB ACNC PT SER QN Not reportable
Chlamydia infection 5087-2 CHLAMYDIA TRACHOMATIS AB TITR PT SER QN CF Not reportable
Chlamydia infection 5088-0 CHLAMYDIA TRACHOMATIS AB TITR PT SER QN IF Not reportable
Chlamydia infection 6918-7 CHLAMYDIA TRACHOMATIS AB.IGA TITR PT SER QN IF Not reportable
Chlamydia infection 5089-8 CHLAMYDIA TRACHOMATIS AB.IGG ACNC PT SER QN Not reportable
Chlamydia infection 6919-5 CHLAMYDIA TRACHOMATIS AB.IGG TITR PT SER QN IF Not reportable
Chlamydia infection 5090-6 CHLAMYDIA TRACHOMATIS AB.IGM ACNC PT SER QN
Chlamydia infection 6920-3 CHLAMYDIA TRACHOMATIS AB.IGM TITR PT SER QN IF
Chlamydia infection 6350-3 CHLAMYDIA TRACHOMATIS AG ACNC PT CNJT SQ EIA Positive
Chlamydia infection 6351-1 CHLAMYDIA TRACHOMATIS AG ACNC PT CNJT SQ IF Positive
Chlamydia infection 6352-9 CHLAMYDIA TRACHOMATIS AG ACNC PT STL SQ IF
Chlamydia infection 6353-7 CHLAMYDIA TRACHOMATIS AG ACNC PT TISS SQ IF
Chlamydia infection 6354-5 CHLAMYDIA TRACHOMATIS AG ACNC PT XXX SQ EIA Positive
Chlamydia infection 6355-2 CHLAMYDIA TRACHOMATIS AG ACNC PT XXX SQ IF Positive
Chlamydia infection 6356-0 CHLAMYDIA TRACHOMATIS DNA ACNC PT GEN SQ PCR/PROBE Positive
Chlamydia infection 6357-8 CHLAMYDIA TRACHOMATIS DNA ACNC PT UR SQ PCR/PROBE Positive
Chlamydia infection 6349-5 CHLAMYDIA TRACHOMATIS IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Chlamydia organism list
Chlamydia infection 4993-2 CHLAMYDIA TRACHOMATIS RRNA ACNC PT XXX SQ DNA PROBE Positive
Chlamydia infection 13217-5 CHLAMYDIA TRACHOMATIS TYPE B AB ACNC PT SER/PLA
S
QN
Chlamydia infection 13223-3 CHLAMYDIA TRACHOMATIS TYPE B AB.TOTAL ACNC PT SER/PLA
S
QN
Chlamydia infection 13218-3 CHLAMYDIA TRACHOMATIS TYPE C AB ACNC PT SER/PLA
S
QN
Chlamydia infection 13220-9 CHLAMYDIA TRACHOMATIS TYPE C AB.IGM ACNC PT SER/PLA
S
QN
Chlamydia infection 13222-5 CHLAMYDIA TRACHOMATIS TYPE C AB.TOTAL ACNC PT SER/PLA
S
QN
Chlamydia infection 13219-1 CHLAMYDIA TRACHOMATIS TYPE G+F+K AB ACNC PT SER/PLA
S
QN
Chlamydia infection 13221-7 CHLAMYDIA TRACHOMATIS TYPE G+F+K AB.IGM ACNC PT SER/PLA
S
QN
Chlamydia infection 13224-1 CHLAMYDIA TRACHOMATIS TYPE G+F+K AB.TOTAL ACNC PT SER/PLA
S
QN
Cholera 5405-6 VIBRIO CHOLERA AB MCNC PT SER QN
Cholera 6578-9 VIBRIO SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Cholerae organism list
Cholera 6579-7 VIBRIO SP IDENTIFIED PRID PT STL QL ORGANISM SPECIFIC CULTURE Cholerae organism list
Cholera 6580-5 VIBRIO SP IDENTIFIED PRID PT WAT QL ORGANISM SPECIFIC CULTURE Cholerae organism list
Cholera 6581-3 VIBRIO SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Cholerae organism list
Coccidioidomycosis 10655-9 COCCIDIA IDENTIFIED PRID PT DUFL QL ACID FAST STAIN Coccidiodomycosis organism list
Coccidioidomycosis 10656-7 COCCIDIA IDENTIFIED PRID PT STL QL ACID FAST STAIN Coccidiodomycosis organism list
Coccidioidomycosis 5094-8 COCCIDIOIDES IMMITIS AB ACNC PT SER QN EIA
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Coccidioidomycosis 5095-5 COCCIDIOIDES IMMITIS AB ACNC PT SER SQ ID
Coccidioidomycosis 5096-3 COCCIDIOIDES IMMITIS AB TITR PT SER QN CF
Coccidioidomycosis 6368-5 COCCIDIOIDES IMMITIS AB TITR PT SER QN LA
Coccidioidomycosis 7825-3 COCCIDIOIDES IMMITIS AB ACNC PT SER SQN
Coccidioidomycosis 9705-5 COCCIDIOIDES IMMITIS AB.IGA ACNC PT SER QN
Coccidioidomycosis 7826-1 COCCIDIOIDES IMMITIS AB.IGG ACNC PT SER QN
Coccidioidomycosis 7827-9 COCCIDIOIDES IMMITIS AB.IGM ACNC PT SER QN Postive
Coccidioidomycosis 4994-0 COCCIDIOIDES IMMITIS RRNA ACNC PT XXX SQ DNA PROBE Positive
Coccidioidomycosis 568-6 FUNGUS IDENTIFIED PRID PT ASP QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 569-4 FUNGUS IDENTIFIED PRID PT CSF QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 570-2 FUNGUS IDENTIFIED PRID PT FLU QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 577-7 FUNGUS IDENTIFIED PRID PT SPT QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 6409-7 FUNGUS IDENTIFIED PRID PT SPTT QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 10666-6 FUNGUS IDENTIFIED PRID PT TISS QL FONTANA-MASSON STAIN Coccidiodomycosis organism list
Coccidioidomycosis 578-5 FUNGUS IDENTIFIED PRID PT TISS QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 579-3 FUNGUS IDENTIFIED PRID PT WND QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 580-1 FUNGUS IDENTIFIED PRID PT XXX QL ROUTINE FUNGAL CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 606-4 MICROORGANISM IDENTIFIED PRID PT CSF QL STERILE BODY FLUID CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 632-0 MICROORGANISM IDENTIFIED PRID PT WND QL AEROBIC CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Coccidiodomycosis organism list
Coccidioidomycosis 639-5 MICROSCOPIC OBSERVATION PRID PT CSF QL KOH PREPARATION Coccidiodomycosis organism list
Coccidioidomycosis 648-6 MICROSCOPIC OBSERVATION PRID PT SPT QL GRAM STAIN Coccidiodomycosis organism list
Coccidioidomycosis 6468-3 MICROSCOPIC OBSERVATION PRID PT SPT QL CALCOFLUOR WHITE PREPARATION Coccidiodomycosis organism list
Coccidioidomycosis 6664-7 MICROSCOPIC OBSERVATION PRID PT TISS QL GRAM STAIN Coccidiodomycosis organism list
Coccidioidomycosis 6472-5 MICROSCOPIC OBSERVATION PRID PT TISS QL CALCOFLUOR WHITE PREPARATION Coccidiodomycosis organism list
Coccidioidomycosis 6667-0 MICROSCOPIC OBSERVATION PRID PT TISS QL KOH PREPARATION Coccidiodomycosis organism list
Coccidioidomycosis 6675-3 MICROSCOPIC OBSERVATION PRID PT TISS QL PERIODIC ACID-SCHIFF STAIN Coccidiodomycosis organism list
Coccidioidomycosis 10357-2 MICROSCOPIC OBSERVATION PRID PT WND QL GRAM STAIN Coccidiodomycosis organism list
Colorado tick fever 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Colorado tick fever organism list
Colorado tick fever 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Colorado tick fever organism list
Colorado tick fever 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Colorado tick fever organism list
Colorado tick fever 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Colorado tick fever organism list
Colorado tick fever 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Colorado tick fever organism list
Colorado tick fever 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Colorado tick fever organism list
Colorado tick fever 10739-1 VIRUS IDENTIFIED PRID PT XXX QL MICROSCOPY.ELECTRON Colorado tick fever organism list
Colorado tick fever 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Colorado tick fever organism list
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Cryptococcosis 6369-3 CRYPTOCOCCUS NEOFORMANS AB TITR PT SER QN AGGL Not reportable
Cryptococcosis 7842-8 CRYPTOCOCCUS NEOFORMANS AB ACNC PT SER QN Not reportable
Cryptococcosis 5118-5 CRYPTOCOCCUS NEOFORMANS AG TITR PT CSF QN LA Positive
Cryptococcosis 5119-3 CRYPTOCOCCUS NEOFORMANS AG TITR PT SER QN LA Positive
Cryptococcosis 10657-5 CRYPTOCOCCUS NEOFORMANS AG ACNC PT TISS QL IF Positive
Cryptococcosis 11471-0 CRYPTOCOCCUS NEOFORMANS AG TITR PT XXX QN Positive
Cryptococcosis 11472-8 CRYPTOCOCCUS NEOFORMANS AG ACNC PT XXX QL Positive
Cryptococcosis 4995-7 CRYPTOCOCCUS NEOFORMANS RRNA ACNC PT XXX SQ DNA PROBE Positive
Cryptococcosis 6370-1 CRYPTOCOCCUS SP AB ACNC PT SER SQ IF Not reportable
Cryptococcosis 7843-6 CRYPTOCOCCUS SP AB ACNC PT SER SQ Not reportable
Cryptococcosis 9817-8 CRYPTOCOCCUS SP AG TITR PT CSF QN EIA Postive
Cryptococcosis 9819-4 CRYPTOCOCCUS SP AG TITR PT CSF QN LA Positive
Cryptococcosis 9818-6 CRYPTOCOCCUS SP AG TITR PT SER QN EIA Positive
Cryptococcosis 9820-2 CRYPTOCOCCUS SP AG TITR PT SER QN LA Positive
Cryptococcosis 11473-6 CRYPTOCOCCUS SP AG TITR PT XXX QN
Cryptococcosis 568-6 FUNGUS IDENTIFIED PRID PT ASP QL ROUTINE FUNGAL CULTURE Cryptococcus organism list
Cryptococcosis 569-4 FUNGUS IDENTIFIED PRID PT CSF QL ROUTINE FUNGAL CULTURE Cryptococcus organism list
Cryptococcosis 575-1 FUNGUS IDENTIFIED PRID PT SKN QL ROUTINE FUNGAL CULTURE Cryptococcus organism list
Cryptococcosis 577-7 FUNGUS IDENTIFIED PRID PT SPT QL ROUTINE FUNGAL CULTURE Cryptococcus organism list
Cryptococcosis 6409-7 FUNGUS IDENTIFIED PRID PT SPTT QL ROUTINE FUNGAL CULTURE Cryptococcus organism list
Cryptococcosis 10666-6 FUNGUS IDENTIFIED PRID PT TISS QL FONTANA-MASSON STAIN Cryptococcus organism list
Cryptococcosis 578-5 FUNGUS IDENTIFIED PRID PT TISS QL ROUTINE FUNGAL CULTURE Cryptococcus organism list
Cryptococcosis 580-1 FUNGUS IDENTIFIED PRID PT XXX QL ROUTINE FUNGAL CULTURE Cryptococcus organism list
Cryptococcosis 606-4 MICROORGANISM IDENTIFIED PRID PT CSF QL STERILE BODY FLUID CULTURE Cryptococcus organism list
Cryptococcosis 620-5 MICROORGANISM IDENTIFIED PRID PT SKN QL AEROBIC CULTURE Cryptococcus organism list
Cryptococcosis 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Cryptococcus organism list
Cryptococcosis 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Cryptococcus organism list
Cryptococcosis 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Cryptococcus organism list
Cryptococcosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Cryptococcus organism list
Cryptococcosis 638-7 MICROSCOPIC OBSERVATION PRID PT CSF QL INDIA INK PREPARATION Cryptococcus organism list
Cryptococcosis 639-5 MICROSCOPIC OBSERVATION PRID PT CSF QL KOH PREPARATION Cryptococcus organism list
Cryptococcosis 648-6 MICROSCOPIC OBSERVATION PRID PT SPT QL GRAM STAIN Cryptococcus organism list
Cryptococcosis 6468-3 MICROSCOPIC OBSERVATION PRID PT SPT QL CALCOFLUOR WHITE PREPARATION Cryptococcus organism list
Cryptococcosis 6472-5 MICROSCOPIC OBSERVATION PRID PT TISS QL CALCOFLUOR WHITE PREPARATION Cryptococcus organism list
Cryptococcosis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Cryptococcus organism list
Cryptococcosis 6664-7 MICROSCOPIC OBSERVATION PRID PT TISS QL GRAM STAIN Cryptococcus organism list
Cryptococcosis 6666-2 MICROSCOPIC OBSERVATION PRID PT TISS QL INDIA INK PREPARATION Cryptococcus organism list
Cryptococcosis 6667-0 MICROSCOPIC OBSERVATION PRID PT TISS QL KOH PREPARATION Cryptococcus organism list
Cryptococcosis 6675-3 MICROSCOPIC OBSERVATION PRID PT TISS QL PERIODIC ACID-SCHIFF STAIN Cryptococcus organism list
Cryptococcosis 658-5 MICROSCOPIC OBSERVATION PRID PT XXX QL CALCOFLUOR WHITE PREPARATION Cryptococcus organism list
Cryptococcosis 664-3 MICROSCOPIC OBSERVATION PRID PT XXX QL GRAM STAIN Cryptococcus organism list
Cryptococcosis 666-8 MICROSCOPIC OBSERVATION PRID PT XXX QL INDIA INK PREPARATION Cryptococcus organism list
Cryptococcosis 667-6 MICROSCOPIC OBSERVATION PRID PT XXX QL KOH PREPARATION Cryptococcus organism list
Cryptococcosis 674-2 MICROSCOPIC OBSERVATION PRID PT XXX QL PERIODIC ACID-SCHIFF STAIN Cryptococcus organism list
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Cryptosporidiosis 6371-9 CRYPTOSPORIDIUM AG ACNC PT STL SQ EIA
Cryptosporidiosis 6372-7 CRYPTOSPORIDIUM AG TITR PT STL QN IF Positive
Cryptosporidiosis 566-0 CRYPTOSPORIDIUM SP AG ACNC PT XXX SQ IF Positive
Cryptosporidiosis 9785-7 MICROSCOPIC OBSERVATION PRID PT STL QL OVA AND PARASITE PREPARATION Cryptosporidiosis organism list
Cryptosporidiosis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Cryptosporidiosis organism list
Cryptosporidiosis 11479-3 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN Cryptosporidiosis organism list
Cryptosporidiosis 6655-5 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.KINYOUN Cryptosporidiosis organism list
Cryptosporidiosis 6656-3 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.KINYOUN MODIFIED Cryptosporidiosis organism list
Cryptosporidiosis 6657-1 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.ZIEHL-NEELSEN Cryptosporidiosis organism list
Cryptosporidiosis 6473-3 MICROSCOPIC OBSERVATION PRID PT TISS QL TRICHROME STAIN Cryptosporidiosis organism list
Cryptosporidiosis 6674-6 MICROSCOPIC OBSERVATION PRID PT TISS QL OVA AND PARASITE PREPARATION Cryptosporidiosis organism list
Cryptosporidiosis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Cryptosporidiosis organism list
Cryptosporidiosis 11545-1 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN Cryptosporidiosis organism list
Cryptosporidiosis 654-4 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN.KINYOUN Cryptosporidiosis organism list
Cryptosporidiosis 655-1 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN.KINYOUN MODIFIED Cryptosporidiosis organism list
Cryptosporidiosis 656-9 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN.ZIEHL-NEELSEN Cryptosporidiosis organism list
Cryptosporidiosis 673-4 MICROSCOPIC OBSERVATION PRID PT XXX QL OVA AND PARASITE PREPARATION Cryptosporidiosis organism list
Cryptosporidiosis 678-3 MICROSCOPIC OBSERVATION PRID PT XXX QL TRICHROME STAIN Cryptosporidiosis organism list
Cryptosporidiosis 10701-1 OVA AND PARASITES IDENTIFIED PRID PT STL QL CONCENTRATION Cryptosporidiosis organism list
Cryptosporidiosis 10702-9 OVA AND PARASITES IDENTIFIED PRID PT STL QL IMMUNE STAIN Cryptosporidiosis organism list
Cryptosporidiosis 10703-7 OVA AND PARASITES IDENTIFIED PRID PT STL QL KH STAIN Cryptosporidiosis organism list
Cryptosporidiosis 10704-5 OVA+PARASITES IDENTIFIED PRID PT STL QL MICROSCOPY.LIGHT Cryptosporidiosis organism list
Cyclospora 10850-6 CYCLOSPORA CYAETINESUS ACNC PT XXX SQ Positive
Cyclospora 10659-1 CYCLOSPORA IDENTIFIED PRID PT STL QL ACID FAST STAIN Cyclospora organism list
Cyclospora 10356-4 MICROSCOPIC OBSERVATION PRID PT STL QL TRICHROME STAIN Cyclospora organism list
Cyclospora 9785-7 MICROSCOPIC OBSERVATION PRID PT STL QL OVA AND PARASITE PREPARATION Cyclospora organism list
Cyclospora 10701-1 OVA AND PARASITES IDENTIFIED PRID PT STL QL CONCENTRATION Cyclospora organism list
Cyclospora 10702-9 OVA AND PARASITES IDENTIFIED PRID PT STL QL IMMUNE STAIN Cyclospora organism list
Cyclospora 10703-7 OVA AND PARASITES IDENTIFIED PRID PT STL QL KH STAIN Cyclospora organism list
Cyclospora 10704-5 OVA AND PARASITES IDENTIFIED PRID PT STL QL MICROSCOPY.LIGHT Cyclospora organism list
Cysticercosis 9601-6 CYSTICERCUS 13KD AB ACNC PT SER SQ IB
Cysticercosis 9602-4 CYSTICERCUS 14KD AB ACNC PT SER SQ IB
Cysticercosis 9603-2 CYSTICERCUS 18KD AB ACNC PT SER SQ IB
Cysticercosis 9604-0 CYSTICERCUS 21KD AB ACNC PT SER SQ IB
Cysticercosis 9605-7 CYSTICERCUS 24KD AB ACNC PT SER SQ IB
Cysticercosis 9606-5 CYSTICERCUS 39-42KD AB ACNC PT SER SQ IB
Cysticercosis 9607-3 CYSTICERCUS 50KD AB ACNC PT SER SQ IB
Cysticercosis 9600-8 CYSTICERCUS AB ACNC PT SER SQ IB
Cysticercosis 7844-4 CYSTICERCUS AB.IGA ACNC PT CSF SQ
Cysticercosis 7845-1 CYSTICERCUS AB.IGA ACNC PT SER SQ
Cysticercosis 7846-9 CYSTICERCUS AB.IGG ACNC PT CSF SQ
Cysticercosis 6373-5 CYSTICERCUS AB.IGG ACNC PT CSF SQ IB
Cysticercosis 6374-3 CYSTICERCUS AB.IGG ACNC PT SER SQ IB
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Cysticercosis 7847-7 CYSTICERCUS AB.IGG ACNC PT SER SQ
Cysticercosis 7848-5 CYSTICERCUS AB.IGM ACNC PT CSF SQ Positive
Cysticercosis 7849-3 CYSTICERCUS AB.IGM ACNC PT SER SQ Positive
Cysticercosis 5120-1 CYSTICERCUS SP AB ACNC PT SER QN HAI
Cysticercosis 7850-1 CYSTICERCUS SP AB ACNC PT SER QN
Cysticercosis 10671-6 HELMINTH IDENTIFIED PRID PT XXX QL Cysticercosis organism list
Cysticercosis 10672-4 HELMINTH/ARTHROPOD IDENTIFIED PRID PT XXX QL Cysticercosis organism list
Cysticercosis 5375-1 TAENIA SOLIUM AB ACNC PT SER QN EIA
Cysticercosis 8037-4 TAENIA SOLIUM AB ACNC PT SER QN
Cysticercosis 10719-3 TAENIA SOLIUM AB ACNC PT SER/PLAS QN IB
Cytomegalovirus 9514-1 CYTOMEGALOVIRUS AB TITR PT CSF QN CF
Cytomegalovirus 5121-9 CYTOMEGALOVIRUS AB TITR PT PLAS QN LA
Cytomegalovirus 5122-7 CYTOMEGALOVIRUS AB ACNC PT SER QN ACIF
Cytomegalovirus 7851-9 CYTOMEGALOVIRUS AB ACNC PT SER QN
Cytomegalovirus 5123-5 CYTOMEGALOVIRUS AB TITR PT SER QN LA
Cytomegalovirus 9513-3 CYTOMEGALOVIRUS AB TITR PT SER QN CF
Cytomegalovirus 6921-1 CYTOMEGALOVIRUS AB.IGG ACNC PT CSF QN EIA
Cytomegalovirus 11008-0 CYTOMEGALOVIRUS AB.IGG TITR PT CSF QN IF
Cytomegalovirus 5124-3 CYTOMEGALOVIRUS AB.IGG ACNC PT SER QN EIA
Cytomegalovirus 7852-7 CYTOMEGALOVIRUS AB.IGG ACNC PT SER QN
Cytomegalovirus 5125-0 CYTOMEGALOVIRUS AB.IGG TITR PT SER QN IF
Cytomegalovirus 13225-8 CYTOMEGALOVIRUS AB.IGG^BS ACNC PT SER/PLA
S
QN
Cytomegalovirus 13226-6 CYTOMEGALOVIRUS AB.IGM ACNC PT CSF QN
Cytomegalovirus 5126-8 CYTOMEGALOVIRUS AB.IGM ACNC PT SER QN EIA Positive
Cytomegalovirus 7853-5 CYTOMEGALOVIRUS AB.IGM ACNC PT SER QN Positive
Cytomegalovirus 5127-6 CYTOMEGALOVIRUS AB.IGM TITR PT SER QN IF Positive
Cytomegalovirus 6375-0 CYTOMEGALOVIRUS AG ACNC PT BLD SQN EMIA
Cytomegalovirus 6376-8 CYTOMEGALOVIRUS AG ACNC PT SER SQ EIA
Cytomegalovirus 6377-6 CYTOMEGALOVIRUS AG ACNC PT SER SQ IF
Cytomegalovirus 10660-9 CYTOMEGALOVIRUS AG ACNC PT TISS SQ IMMUNE STAIN Positive
Cytomegalovirus 6378-4 CYTOMEGALOVIRUS AG ACNC PT UR SQN EMIA
Cytomegalovirus 6379-2 CYTOMEGALOVIRUS AG ACNC PT XXX SQ EIA Positive
Cytomegalovirus 6380-0 CYTOMEGALOVIRUS AG ACNC PT XXX SQN EMIA
Cytomegalovirus 6381-8 CYTOMEGALOVIRUS AG ACNC PT XXX SQ IF
Cytomegalovirus 4996-5 CYTOMEGALOVIRUS DNA ACNC PT BLD SQ PCR/PROBE Positive
Cytomegalovirus 4997-3 CYTOMEGALOVIRUS DNA ACNC PT TISS SQ DNA PROBE Positive
Cytomegalovirus 4998-1 CYTOMEGALOVIRUS DNA ACNC PT TISS SQ PCR/PROBE Positive
Cytomegalovirus 4999-9 CYTOMEGALOVIRUS DNA ACNC PT UR SQ PCR/PROBE Positive
Cytomegalovirus 5000-5 CYTOMEGALOVIRUS DNA ACNC PT XXX SQ PCR/PROBE Positive
Cytomegalovirus 5835-4 CYTOMEGALOVIRUS IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Cytomegalovirus organism list
Cytomegalovirus 5836-2 CYTOMEGALOVIRUS IDENTIFIED PRID PT TISS QL ORGANISM SPECIFIC CULTURE Cytomegalovirus organism list
Cytomegalovirus 5837-0 CYTOMEGALOVIRUS IDENTIFIED PRID PT UR QL ORGANISM SPECIFIC CULTURE
Cytomegalovirus 5838-8 CYTOMEGALOVIRUS IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Cytomegalovirus organism list
Cytomegalovirus 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Cytomegalovirus organism list
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Cytomegalovirus 5887-5 VIRUS IDENTIFIED PRID PT THRT QL VIRUS CULTURE
Cytomegalovirus 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Cytomegalovirus organism list
Cytomegalovirus 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Cytomegalovirus organism list
Dengue fever 7855-0 DENGUE 1-4 VIRUS RNA ACNC PT SER SQ PCR/PROBE Positive 
Dengue fever 7854-3 DENGUE 1 VIRUS AB ACNC PT SER SQ EIA
Dengue fever 7856-8 DENGUE 2 VIRUS AB ACNC PT SER SQ EIA
Dengue fever 7857-6 DENGUE 3 VIRUS AB ACNC PT SER SQ EIA
Dengue fever 7858-4 DENGUE 4 VIRUS AB ACNC PT SER SQ EIA
Dengue fever 6382-6 DENGUE VIRUS AB ACNC PT SER SQN
Dengue fever 7859-2 DENGUE VIRUS AB ACNC PT SER QN
Dengue fever 6383-4 DENGUE VIRUS AB ACNC PT XXX SQN
Dengue fever 6811-4 DENGUE VIRUS AB.IGG TITR PT SER SQ
Dengue fever 6812-2 DENGUE VIRUS AB.IGM TITR PT SER SQ Positive 
Dengue fever 6384-2 DENGUE VIRUS AG ACNC PT SER SQ IF Positive 
Dengue fever 6385-9 DENGUE VIRUS AG ACNC PT XXX SQ IF Positive 
Dengue fever 6386-7 DENGUE VIRUS DNA ACNC PT SER SQ DNA/PROBE Positive 
Dengue fever 6387-5 DENGUE VIRUS DNA ACNC PT XXX SQ DNA/PROBE Positive 
Dengue fever 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Dengue fever organism list
Dengue fever 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Dengue fever organism list
Dengue fever 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Dengue fever organism list
Dengue fever 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Dengue fever organism list
Dengue fever 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Dengue fever organism list
Dengue fever 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Dengue fever organism list
Dengue fever 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Dengue fever organism list
Diphtheria 5115-1 CORYNEBACTERIUM DIPHTHERIA AB ACNC PT SER QN
Diphtheria 5116-9 CORYNEBACTERIUM DIPHTHERIA AB ACNC PT SER QN EIA
Diphtheria 6596-1 DIPHTHERIA SP IDENTIFIED PRID PT ISLT QL ORGANISM SPECIFIC CULTURE Diphtheria organism list
Diphtheria 567-8 DIPHTHERIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Diphtheria organism list
Diphtheria 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Diphtheria organism list
Diphtheria 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 10353-1 MICROORGANISM IDENTIFIED PRID PT NOS QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 620-5 MICROORGANISM IDENTIFIED PRID PT SKN QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Diphtheria organism list
Diphtheria 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Diphtheria organism list
Diphtheria 6460-0 MICROORGANISM IDENTIFIED PRID PT SPT QL ROUTINE BACTERIAL CULTURE Diphtheria organism list
Diphtheria 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Diphtheria organism list
Diphtheria 632-0 MICROORGANISM IDENTIFIED PRID PT WND QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 6462-6 MICROORGANISM IDENTIFIED PRID PT WND QL ROUTINE BACTERIAL CULTURE Diphtheria organism list
Diphtheria 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Diphtheria organism list
Diphtheria 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Diphtheria organism list
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Diphtheria 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Diphtheria organism list
Ebola 11581-6 EBOLA VIRUS AB ACNC PT SER QN
Ebola 7862-6 EBOLA VIRUS AB TITR PT SER QN IF
Ebola 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Ebola virus organism list
Ebola 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Ebola virus organism list
Ebola 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Ebola virus organism list
Echinococciasis 5135-9 ECHINOCOCCUS SP AB ACNC PT SER QN HAI
Echinococciasis 6390-9 ECHINOCOCCUS SP AB ACNC PT SER QN CF
Echinococciasis 6391-7 ECHINOCOCCUS SP AB ACNC PT SER QN EIA
Echinococciasis 7863-4 ECHINOCOCCUS SP AB ACNC PT SER QN
Echinococciasis 9656-0 ECHINOCOCCUS SP AB.IGG ACNC PT SER QN EIA
Echinococciasis 9657-8 ECHINOCOCCUS SP AB.IGM ACNC PT SER QN EIA Positive
Echinococciasis 10671-6 HELMINTH IDENTIFIED PRID PT XXX QL Echinococciasis organism list
Echinococciasis 10672-4 HELMINTH/ARTHROPOD IDENTIFIED PRID PT XXX QL Echinococciasis organism list
Echinococciasis 10683-1 HYDATID CYST IDENTIFIED PRID PT ASP QL IMMUNE STAIN Echinococciasis organism list
Echinococciasis 10684-9 HYDATID CYST IDENTIFIED PRID PT LIVER QL WET PREPARATION Echinococciasis organism list
Echinococciasis 10685-6 HYDATID CYST IDENTIFIED PRID PT TLNG QL WET PREPARATION Echinococciasis organism list
Echinococciasis 11474-4 HYDATID CYST IDENTIFIED PRID PT XXX QL WET PREPARATION Echinococciasis organism list
Ehrlichiosis 6400-6 EHRLICHIA CANIS AB ACNC PT SER SQ EIA
Ehrlichiosis 7874-1 EHRLICHIA CANIS AB ACNC PT SER SQ
Ehrlichiosis 13195-3 EHRLICHIA CHAFFEENSIS AB ACNC PT SER/PLA
S
QN
Ehrlichiosis 6401-4 EHRLICHIA CHAFFEENSIS AB.IGG ACNC PT SER SQ EIA
Ehrlichiosis 7875-8 EHRLICHIA CHAFFEENSIS AB.IGG ACNC PT SER QN EIA
Ehrlichiosis 9783-2 EHRLICHIA CHAFFEENSIS AB.IGG TITR PT SER QN
Ehrlichiosis 6402-2 EHRLICHIA CHAFFEENSIS AB.IGM ACNC PT SER SQ EIA
Ehrlichiosis 7876-6 EHRLICHIA CHAFFEENSIS AB.IGM ACNC PT SER SQ
Ehrlichiosis 9784-0 EHRLICHIA CHAFFEENSIS AB.IGM TITR PT SER QN
Ehrlichiosis 6403-0 EHRLICHIA EQUI AB ACNC PT SER SQ EIA
Ehrlichiosis 7877-4 EHRLICHIA EQUI AB ACNC PT SER SQ
Ehrlichiosis 6404-8 EHRLICHIA PHAGOCYTOPHILA AB ACNC PT SER SQ EIA
Ehrlichiosis 7878-2 EHRLICHIA PHAGOCYTOPHILA AB ACNC PT SER SQ
Ehrlichiosis 6405-5 EHRLICHIA SP AB ACNC PT SER SQ EIA
Ehrlichiosis 7879-0 EHRLICHIA SP AB ACNC PT SER SQ
Ehrlichiosis 13196-1 EHRLICHIA SP AB.IGG ACNC PT SER/PLA
S
SQ
Ehrlichiosis 13197-9 EHRLICHIA SP AB.IGM ACNC PT SER/PLA
S
SQ
Ehrlichiosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Ehrlichiosis organism list
Ehrlichiosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Ehrlichiosis organism list
Ehrlichiosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Ehrlichiosis organism list
Ehrlichiosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Ehrlichiosis organism list
Endemic typhus 5878-4 RICKETTSIA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Endemic typhus organism list
Endemic typhus 6544-1 RICKETTSIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Endemic typhus organism list
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Endemic typhus 6545-8 RICKETTSIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Endemic typhus organism list
Endemic typhus 6546-6 RICKETTSIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Endemic typhus organism list
Endemic typhus 8007-7 RICKETTSIA TYPHI AB.IGG ACNC PT SER QN
Endemic typhus 5324-9 RICKETTSIA TYPHI AB.IGG TITR PT SER QN IF
Endemic typhus 8008-5 RICKETTSIA TYPHI AB.IGM ACNC PT SER QN
Endemic typhus 5325-6 RICKETTSIA TYPHI AB.IGM TITR PT SER QN IF
Enterococcus, Vancomycin-
resistant
13316-5 ENTEROCOCCUS B1025 VANCOMYCIN RESISTANT 
IDENTIFIED
PRID PT XXX QL
Epidemic typhus 6542-5 RICKETTSIA PROWAZEKII AB ACNC PT SER QN CF
Epidemic typhus 7995-4 RICKETTSIA PROWAZEKII AB ACNC PT SER QN
Epidemic typhus 7996-2 RICKETTSIA PROWAZEKII RNA ACNC PT SER SQ PCR/PROBE Positive
Epidemic typhus 5878-4 RICKETTSIA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Epidemic typhus organism list
Epidemic typhus 6544-1 RICKETTSIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Epidemic typhus organism list
Epidemic typhus 6545-8 RICKETTSIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Epidemic typhus organism list
Epidemic typhus 6546-6 RICKETTSIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Epidemic typhus organism list
Escherichia coli O157:H7 12276-2 ESCHERICHIA COLI O157 H7 IDENTIFIED PRID PT STL QL
Escherichia coli O157:H7 infection 10851-4 ESCHERICHIA COLI O157:H7 ACNC PT STL SQ ORGANISM SPECIFIC CULTURE Positive
Escherichia coli O157:H7 infection 625-4 MICROORGANISM IDENTIFIED PRID PT STL QL STOOL CULTURE Esherichia coli O157:H7 organism list
Escherichia coli O157:H7 infection 6574-8 VEROTOXIN 1 PRID PT STL QL
Escherichia coli O157:H7 infection 6575-5 VEROTOXIN 1 AB TITR PT STL QN NEUT
Escherichia coli O157:H7 infection 6576-3 VEROTOXIN 2 PRID PT STL QL
Escherichia coli O157:H7 infection 6577-1 VEROTOXIN 2 AB TITR PT STL QN NEUT
Fifth's disease 6517-7 PARVOVIRUS AB.IGM ACNC PT SER SQ IB Positive
Fifth's disease 7981-4 PARVOVIRUS AB.IGM ACNC PT SER SQ Positive
Fifth's disease 5272-0 PARVOVIRUS B19 AB ACNC PT SER QN EIA
Fifth's disease 7982-2 PARVOVIRUS B19 AB ACNC PT SER QN
Fifth's disease 5273-8 PARVOVIRUS B19 AB.IGG ACNC PT SER QN EIA
Fifth's disease 7983-0 PARVOVIRUS B19 AB.IGG ACNC PT SER QN
Fifth's disease 5274-6 PARVOVIRUS B19 AB.IGM ACNC PT SER QN EIA Positive
Fifth's disease 7984-8 PARVOVIRUS B19 AB.IGM ACNC PT SER QN Positive
Fifth's disease 9572-9 PARVOVIRUS B19 DNA ACNC PT SER SQ PCR/PROBE Positive
Fifth's disease 9571-1 PARVOVIRUS B19 DNA ACNC PT XXX SQ PCR/PROBE Positive
Fifth's disease 5030-2 PARVOVIRUS B19 RNA ACNC PT BLD SQ PCR/PROBE Positive
Fifth's disease 5031-0 PARVOVIRUS B19 RNA ACNC PT TISS SQ PCR/PROBE Positive
Fifth's disease 5032-8 PARVOVIRUS B19 RNA ACNC PT XXX SQ PCR/PROBE Positive
Fifth's disease 11484-3 VIRUS IDENTIFIED PRID PT AMN QL VIRUS CULTURE Fifth's disease organism list
Fifth's disease 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Fifth's disease organism list
Fifth's disease 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Fifth's disease organism list
Fifth's disease 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Fifth's disease organism list
Fifth's disease 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Fifth's disease organism list
Fifth's disease 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Fifth's disease organism list
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Filariasis 6606-8 BRUGIA MALAYI AB ACNC PT SER SQ EIA
Filariasis 7819-6 BRUGIA MALAYI AB ACNC PT SER SQ
Filariasis 13244-9 FILARIA AB.IGG ACNC PT SER/PLA
S
QN
Filariasis 13245-6 FILARIA AB.IGM ACNC PT SER/PLA
S
QN
Filariasis 10671-6 HELMINTH IDENTIFIED PRID PT XXX QL Filariasis organism list
Filariasis 10672-4 HELMINTH/ARTHROPOD IDENTIFIED PRID PT XXX QL Filariasis organism list
Genital warts 12222-6 HUMAN PAPILLOMA VIRUS AG ACNC PT GEN SQ ICMA
Genital warts 12223-4 HUMAN PAPILLOMA VIRUS AG.SUBTYPE 16/18 ACNC PT GEN SQ ICMA
Genital warts 6510-2 PAPILLOMA VIRUS AB ACNC PT GEN SQ EIA
Genital warts 7975-6 PAPILLOMA VIRUS AB ACNC PT GEN SQ
Genital warts 6511-0 PAPILLOMA VIRUS AB ACNC PT GEN SQ IB
Genital warts 6513-6 PAPILLOMA VIRUS AB ACNC PT TISS SQ IB
Genital warts 6512-8 PAPILLOMA VIRUS AB ACNC PT TISS SQ EIA
Genital warts 13321-5 PAPILLOMA VIRUS AB.IGG ACNC PT SER/PLA
S
SQ
Genital warts 13322-3 PAPILLOMA VIRUS AB.IGM ACNC PT SER/PLA
S
SQ
Genital warts 10705-2 PAPILLOMA VIRUS AG ACNC PT TISS SQ IMMUNE STAIN Positive
Genital warts 11083-3 PAPILLOMA VIRUS IDENTIFIED PRID PT CVX QL Genital warts organism list
Genital warts 11481-9 PAPILLOMA VIRUS IDENTIFIED PRID PT XXX QL Genital warts organism list
Genital warts 6514-4 PAPILLOMA VIRUS RRNA ACNC PT GEN SQ PCR/PROBE Positive
Genital warts 6515-1 PAPILLOMA VIRUS RRNA ACNC PT TISS SQ PCR/PROBE Positive
Genital warts 6516-9 PAPILLOMA VIRUS RRNA ACNC PT XXX SQ PCR/PROBE Positive
Genital warts 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Genital warts organism list
Genital warts 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Genital warts organism list
Genital warts 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Genital warts organism list
Genital warts 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Genital warts organism list
Giardiasis 5169-8 GIARDIA LAMBLIA AB ACNC PT SER QN
Giardiasis 9524-0 GIARDIA LAMBLIA AB TITR PT SER QN IF Not reportable
Giardiasis 9658-6 GIARDIA LAMBLIA AB.IGA ACNC PT SER QN
Giardiasis 6411-3 GIARDIA LAMBLIA AB.IGG TITR PT SER QN IF Not reportable
Giardiasis 7891-5 GIARDIA LAMBLIA AB.IGG ACNC PT SER QN
Giardiasis 7892-3 GIARDIA LAMBLIA AB.IGM ACNC PT SER QN
Giardiasis 6412-1 GIARDIA LAMBLIA AG ACNC PT STL SQ EIA Positive
Giardiasis 6413-9 GIARDIA LAMBLIA AG ACNC PT XXX SQ EIA Positive
Giardiasis 10670-8 GIARDIA SP IDENTIFIED PRID PT STL QL ORGANISM SPECIFIC CULTURE Giardiasis organism list
Giardiasis 6470-9 MICROSCOPIC OBSERVATION PRID PT STL QL WET PREPARATION Giardiasis organism list
Giardiasis 9785-7 MICROSCOPIC OBSERVATION PRID PT STL QL OVA AND PARASITE PREPARATION Giardiasis organism list
Giardiasis 10356-4 MICROSCOPIC OBSERVATION PRID PT STL QL TRICHROME STAIN Giardiasis organism list
Giardiasis 10701-1 OVA AND PARASITES IDENTIFIED PRID PT STL QL CONCENTRATION Giardiasis organism list
Giardiasis 10702-9 OVA AND PARASITES IDENTIFIED PRID PT STL QL IMMUNE STAIN Giardiasis organism list
Giardiasis 10703-7 OVA AND PARASITES IDENTIFIED PRID PT STL QL KH STAIN Giardiasis organism list
Giardiasis 10704-5 OVA+PARASITES IDENTIFIED PRID PT STL QL MICROSCOPY.LIGHT Giardiasis organism list
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Gonorrhea 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Gonorrhoeae organism list
Gonorrhea 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Gonorrhoeae organism list
Gonorrhea 609-8 MICROORGANISM IDENTIFIED PRID PT EYE QL AEROBIC CULTURE Gonorrhoeae organism list
Gonorrhea 10352-3 MICROORGANISM IDENTIFIED PRID PT GEN QL AEROBIC CULTURE Gonorrhoeae organism list
Gonorrhea 620-5 MICROORGANISM IDENTIFIED PRID PT SKN QL AEROBIC CULTURE Gonorrhoeae organism list
Gonorrhea 621-3 MICROORGANISM IDENTIFIED PRID PT SNV QL STERILE BODY FLUID CULTURE Gonorrhoeae organism list
Gonorrhea 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Gonorrhoeae organism list
Gonorrhea 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Gonorrhoeae organism list
Gonorrhea 10354-9 MICROORGANISM IDENTIFIED PRID PT URT QL URINE CULTURE Gonorrhoeae organism list
Gonorrhea 6464-2 MICROSCOPIC OBSERVATION PRID PT CVX QL GRAM STAIN Gonorrhoeae organism list
Gonorrhea 6467-5 MICROSCOPIC OBSERVATION PRID PT GENF QL GRAM STAIN Gonorrhoeae organism list
Gonorrhea 10856-3 MICROSCOPIC OBSERVATION PRID PT GENM QL GRAM STAIN Gonorrhoeae organism list
Gonorrhea 664-3 MICROSCOPIC OBSERVATION PRID PT XXX QL GRAM STAIN Gonorrhoeae organism list
Gonorrhea 688-2 NEISSERIA GONORRHOEAE ACNC PT CVX SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 690-8 NEISSERIA GONORRHOEAE ACNC PT ENDM SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 691-6 NEISSERIA GONORRHOEAE ACNC PT GEN SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 692-4 NEISSERIA GONORRHOEAE ACNC PT GENL SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 693-2 NEISSERIA GONORRHOEAE ACNC PT GENV SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 694-0 NEISSERIA GONORRHOEAE ACNC PT SMN SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 695-7 NEISSERIA GONORRHOEAE ACNC PT SNV SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 696-5 NEISSERIA GONORRHOEAE ACNC PT THRT SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 697-3 NEISSERIA GONORRHOEAE ACNC PT URTH SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 698-1 NEISSERIA GONORRHOEAE ACNC PT XXX SQ ORGANISM SPECIFIC CULTURE Positive
Gonorrhea 5261-3 NEISSERIA GONORRHOEAE AB ACNC PT SER QN Not reportable
Gonorrhea 9568-7 NEISSERIA GONORRHOEAE AB TITR PT SER QN CF Not reportable
Gonorrhea 6487-3 NEISSERIA GONORRHOEAE AG ACNC PT GEN SQ EIA Positive
Gonorrhea 6488-1 NEISSERIA GONORRHOEAE AG ACNC PT GEN SQ IF Positive
Gonorrhea 6489-9 NEISSERIA GONORRHOEAE AG ACNC PT GEN SQ LA Positive
Gonorrhea 6490-7 NEISSERIA GONORRHOEAE AG ACNC PT URTH SQ Positive
Gonorrhea 5028-6 NEISSERIA GONORRHOEAE RRNA ACNC PT XXX SQ DNA PROBE Positive
Granuloma inguinale 6595-3 CALYMMATOBACTERIUM GRANULOMATIS IDENTIFIED PRID PT ISLT QL ORGANISM SPECIFIC CULTURE Granuloma inguinale organism list
Granuloma inguinale 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Granuloma inguinale organism list
Granuloma inguinale 6681-1 MICROSCOPIC OBSERVATION PRID PT TISS QL WRIGHT STAIN Granuloma inguinale organism list
Haemophilus influenzae 5178-9 HAEMOPHILUS INFLUENZAE AB ACNC PT SER QN EIA Not reportable
Haemophilus influenzae 7894-9 HAEMOPHILUS INFLUENZAE AB ACNC PT SER QN Not reportable
Haemophilus influenzae 5006-2 HAEMOPHILUS INFLUENZAE RRNA ACNC PT XXX SQ DNA PROBE Positive
Haemophilus influenzae 6610-0 HAEMOPHILUS INFLUENZAE TYPE A AG ACNC PT CSF SQ IF Positive
Haemophilus influenzae 6414-7 HAEMOPHILUS INFLUENZAE TYPE A AG ACNC PT XXX SQ IF Positive
Haemophilus influenzae 13246-4 HAEMOPHILUS INFLUENZAE TYPE B AB ACNC PT SER/PLA
S
QN
Haemophilus influenzae 6611-8 HAEMOPHILUS INFLUENZAE TYPE B AG ACNC PT CSF SQ IF Positive
Haemophilus influenzae 6599-5 HAEMOPHILUS INFLUENZAE TYPE B AG ACNC PT XXX SQ IF Positive
Haemophilus influenzae 6612-6 HAEMOPHILUS INFLUENZAE TYPE C AG ACNC PT CSF SQ IF Positive
Haemophilus influenzae 8271-9 HAEMOPHILUS INFLUENZAE TYPE C AG ACNC PT XXX SQ IF Positive
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Haemophilus influenzae 6613-4 HAEMOPHILUS INFLUENZAE TYPE D AG ACNC PT CSF SQ IF Positive
Haemophilus influenzae 6416-2 HAEMOPHILUS INFLUENZAE TYPE D AG ACNC PT XXX SQ IF Positive
Haemophilus influenzae 6614-2 HAEMOPHILUS INFLUENZAE TYPE E AG ACNC PT CSF SQ IF Positive
Haemophilus influenzae 6417-0 HAEMOPHILUS INFLUENZAE TYPE E AG ACNC PT XXX SQ IF Positive
Haemophilus influenzae 6615-9 HAEMOPHILUS INFLUENZAE TYPE F AG ACNC PT CSF SQ IF Positive
Haemophilus influenzae 6418-8 HAEMOPHILUS INFLUENZAE TYPE F AG ACNC PT XXX SQ IF Positive
Haemophilus influenzae 6600-1 HAEMOPHILUS SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 606-4 MICROORGANISM IDENTIFIED PRID PT CSF QL STERILE BODY FLUID CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 10353-1 MICROORGANISM IDENTIFIED PRID PT NOS QL AEROBIC CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Not reportable
Haemophilus influenzae 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Not reportable
Haemophilus influenzae 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Not reportable
Haemophilus influenzae 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Not reportable
Haemophilus influenzae 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Haemophilus influenzae organism list
Haemophilus influenzae 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Haemophilus influenzae organism list
Hantavirus 7895-6 HANTAVIRUS HANTAAN AB.IGG ACNC PT SER QN
Hantavirus 7896-4 HANTAVIRUS HANTAAN AB.IGM ACNC PT SER QN Positive
Hantavirus 13289-4 HANTAVIRUS HANTAAN AB.TOTAL ACNC PT SER/PLA
S
QN
Hantavirus 7897-2 HANTAVIRUS PUUMALA AB.IGG ACNC PT SER QN
Hantavirus 7898-0 HANTAVIRUS PUUMALA AB.IGM ACNC PT SER QN Positive
Hantavirus 7899-8 HANTAVIRUS RNA ACNC PT SER SQ PCR/PROBE Positive
Hantavirus 5046-8 HANTAVIRUS SP AB ACNC PT SER QN
Hantavirus 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Hantavirus organism list
Hantavirus 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Hantavirus organism list
Hantavirus 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Hantavirus organism list
Hantavirus 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Hantavirus organism list
Hepatitis A 5179-7 HEPATITIS A VIRUS AB.IGG ACNC PT SER QN EIA Not reportable
Hepatitis A 5180-5 HEPATITIS A VIRUS AB.IGG ACNC PT SER QN RIA Not reportable
Hepatitis A 5181-3 HEPATITIS A VIRUS AB.IGM ACNC PT SER QN EIA Positive
Hepatitis A 5182-1 HEPATITIS A VIRUS AB.IGM ACNC PT SER QN RIA Positive
Hepatitis A 5183-9 HEPATITIS A VIRUS AB.TOTAL ACNC PT SER QN EIA Not reportable
Hepatitis A 5184-7 HEPATITIS A VIRUS AB.TOTAL ACNC PT SER QN RIA Not reportable
Hepatitis A 7904-6 HEPATITIS A VIRUS RNA ACNC PT SER SQ PCR/PROBE Positive
Hepatitis A 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Hepatitis A organism list
Hepatitis A 10737-5 VIRUS IDENTIFIED PRID PT STL QL MICROSCOPY.ELECTRON
Hepatitis A 5886-7 VIRUS IDENTIFIED PRID PT STL QL VIRUS CULTURE
Hepatitis A 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Hepatitis A organism list
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Hepatitis A 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Hepatitis A organism list
Hepatitis B 10673-2 HEPATITIS B CORE AG ACNC PT TISS SQ IMMUNE STAIN Positive
Hepatitis B 10674-0 HEPATITIS B SURFACE AG ACNC PT TISS SQ IMMUNE STAIN Positive
Hepatitis B 10675-7 HEPATITIS B SURFACE AG PRID PT TISS QL ORCEIN STAIN Positive
Hepatitis B 5185-4 HEPATITIS B VIRUS CORE AB.IGM ACNC PT SER QN EIA Positive
Hepatitis B 5186-2 HEPATITIS B VIRUS CORE AB.IGM ACNC PT SER QN RIA Positive
Hepatitis B 5187-0 HEPATITIS B VIRUS CORE AB.TOTAL ACNC PT SER QN EIA Not reportable
Hepatitis B 5188-8 HEPATITIS B VIRUS CORE AB.TOTAL ACNC PT SER QN RIA Not reportable
Hepatitis B 5007-0 HEPATITIS B VIRUS DNA ACNC PT BLD SQ PCR/PROBE Positive
Hepatitis B 13126-8 HEPATITIS B VIRUS DNA ACNC PT BLD SQ IB
Hepatitis B 5008-8 HEPATITIS B VIRUS DNA ACNC PT TISS SQ PCR/PROBE Positive
Hepatitis B 5009-6 HEPATITIS B VIRUS DNA ACNC PT XXX SQ PCR/PROBE Positive
Hepatitis B 5189-6 HEPATITIS B VIRUS LITTLE E AB ACNC PT SER QN EIA Not reportable
Hepatitis B 5190-4 HEPATITIS B VIRUS LITTLE E AB ACNC PT SER QN RIA Not reportable
Hepatitis B 5191-2 HEPATITIS B VIRUS LITTLE E AG ACNC PT SER QN EIA Positive
Hepatitis B 5192-0 HEPATITIS B VIRUS LITTLE E AG ACNC PT SER SQ RIA Positive
Hepatitis B 6421-2 HEPATITIS B VIRUS RRNA ACNC PT XXX SQ DNA PROBE Positive
Hepatitis B 10900-9 HEPATITIS B VIRUS SURFACE AB ACNC PT SER SQ EIA Not reportable
Hepatitis B 5193-8 HEPATITIS B VIRUS SURFACE AB ACNC PT SER QN EIA Not reportable
Hepatitis B 5194-6 HEPATITIS B VIRUS SURFACE AB ACNC PT SER QN RIA Not reportable
Hepatitis B 5195-3 HEPATITIS B VIRUS SURFACE AG ACNC PT SER SQ Positive
Hepatitis B 5196-1 HEPATITIS B VIRUS SURFACE AG ACNC PT SER SQ EIA Positive
Hepatitis B 5197-9 HEPATITIS B VIRUS SURFACE AG ACNC PT SER SQ RIA Positive
Hepatitis B 7905-3 HEPATITIS B VIRUS SURFACE AG ACNC PT SER SQ NEUT Positive
Hepatitis B 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Hepatitis B organism list
Hepatitis B 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Hepatitis B organism list
Hepatitis B 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Hepatitis B organism list
Hepatitis C 9608-1 HEPATITIS C VIRUS 100-3 AB ACNC PT SER/PLAS SQ IB
Hepatitis C 9609-9 HEPATITIS C VIRUS 22-3 AB ACNC PT SER/PLAS SQ IB
Hepatitis C 9610-7 HEPATITIS C VIRUS 33C AB+B57+B139 ACNC PT SER/PLAS SQ IB
Hepatitis C 11076-7 HEPATITIS C VIRUS 5-1-1 AB ACNC PT SER/PLAS SQ IB
Hepatitis C 5198-7 HEPATITIS C VIRUS AB ACNC PT SER QN EIA
Hepatitis C 5199-5 HEPATITIS C VIRUS AB ACNC PT SER SQ IB
Hepatitis C 11077-5 HEPATITIS C VIRUS AB.SUPEROXIDE DISMUTASE ACNC PT SER/PLAS SQ IB
Hepatitis C 13125-0 HEPATITIS C VIRUS C33C AB ACNC PT SER/PLA
S
SQ
Hepatitis C 5010-4 HEPATITIS C VIRUS RNA ACNC PT BLD SQ PCR/PROBE
Hepatitis C 10676-5 HEPATITIS C VIRUS RNA ACNC PT SER QN AMP/PROBE
Hepatitis C 11011-4 HEPATITIS C VIRUS RNA ACNC PT SER QN PCR
Hepatitis C 5011-2 HEPATITIS C VIRUS RNA ACNC PT TISS SQ PCR/PROBE
Hepatitis C 5012-0 HEPATITIS C VIRUS RNA ACNC PT XXX SQ PCR/PROBE
Hepatitis C 6422-0 HEPATITIS C VIRUS RRNA ACNC PT XXX SQ DNA PROBE
Hepatitis C 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Hepatitis C organism list
Hepatitis C 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Hepatitis C organism list
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Hepatitis D 9526-5 HEPATITIS D AG ACNC PT SER SQN EIA Positive
Hepatitis D 5200-1 HEPATITIS D VIRUS AB ACNC PT SER QN EIA Not reportable
Hepatitis D 5201-9 HEPATITIS D VIRUS AB ACNC PT SER QN RIA Not reportable
Hepatitis D 13248-0 HEPATITIS D VIRUS AB ACNC PT SER/PLA
S
SQ
Hepatitis D 9525-7 HEPATITIS D VIRUS AB.IGM ACNC PT SER SQN Positive
Hepatitis D 7906-1 HEPATITIS D VIRUS RNA ACNC PT SER SQ PCR/PROBE Positive
Hepatitis D 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Hepatitis D organism list
Hepatitis D 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Hepatitis D organism list
Hepatitis E 13294-4 HEPATITIS E AB ACNC PT SER/PLA
S
SQ
Hepatitis E 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Hepaitis E organism list
Herpes simplex    9454-0 HERPES SIMPLEX VIRUS AB TITR PT CSF QN CF Not reportable
Herpes simplex    5202-7 HERPES SIMPLEX VIRUS AB ACNC PT SER QN EIA Not reportable
Herpes simplex    5203-5 HERPES SIMPLEX VIRUS AB ACNC PT SER QN LA Not reportable
Herpes simplex    7907-9 HERPES SIMPLEX VIRUS AB ACNC PT SER QN Not reportable
Herpes simplex    5204-3 HERPES SIMPLEX VIRUS AB TITR PT SER QN CF Not reportable
Herpes simplex    9659-4 HERPES SIMPLEX VIRUS AB.IGG ACNC PT CSF QN EIA Not reportable
Herpes simplex    9422-7 HERPES SIMPLEX VIRUS AB.IGG ACNC PT SER QN Not reportable
Herpes simplex    10350-7 HERPES SIMPLEX VIRUS AB.IGM TITR PT SER QN EIA
Herpes simplex    5850-3 HERPES SIMPLEX VIRUS AG ACNC PT GEN SQ EIA
Herpes simplex    5851-1 HERPES SIMPLEX VIRUS AG ACNC PT GEN SQ IF
Herpes simplex    5852-9 HERPES SIMPLEX VIRUS AG ACNC PT SKN SQ EIA
Herpes simplex    5853-7 HERPES SIMPLEX VIRUS AG ACNC PT SKN SQ IF
Herpes simplex    5854-5 HERPES SIMPLEX VIRUS AG ACNC PT XXX SQ EIA
Herpes simplex    5855-2 HERPES SIMPLEX VIRUS AG ACNC PT XXX SQ IF
Herpes simplex    5013-8 HERPES SIMPLEX VIRUS DNA ACNC PT CSF SQ PCR/PROBE
Herpes simplex    5014-6 HERPES SIMPLEX VIRUS DNA ACNC PT XXX SQ PCR/PROBE
Herpes simplex    10680-7 HERPES SIMPLEX VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Herpes simplex organism list
Herpes simplex    5856-0 HERPES SIMPLEX VIRUS IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Herpes simplex organism list
Herpes simplex    5857-8 HERPES SIMPLEX VIRUS IDENTIFIED PRID PT ISLT QL IF Herpes simplex organism list
Herpes simplex    5858-6 HERPES SIMPLEX VIRUS IDENTIFIED PRID PT SKN QL ORGANISM SPECIFIC CULTURE Herpes simplex organism list
Herpes simplex    10681-5 HERPES SIMPLEX VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Herpes simplex organism list
Herpes simplex    5859-4 HERPES SIMPLEX VIRUS IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Herpes simplex organism list
Herpes simplex    10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Herpes simplex organism list
Herpes simplex    5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Herpes simplex organism list
Herpes simplex    5887-5 VIRUS IDENTIFIED PRID PT THRT QL VIRUS CULTURE Herpes simplex organism list
Herpes simplex    10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Herpes simplex organism list
Herpes simplex    5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Herpes simplex organism list
Herpes simplex    6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Herpes simplex organism list
Herpes simplex    12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Herpes simplex organism list
Herpes simplex type 1 5844-6 HERPES SIMPLEX TYPE 1 VIRUS AG ACNC PT GEN SQ IF Positive
Herpes simplex type 1 5845-3 HERPES SIMPLEX TYPE 1 VIRUS AG ACNC PT SKN SQ IF Positive
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Herpes simplex type 1 10677-3 HERPES SIMPLEX TYPE 1 VIRUS AG ACNC PT TISS SQ IMMUNE STAIN Positive
Herpes simplex type 1 5846-1 HERPES SIMPLEX TYPE 1 VIRUS AG ACNC PT XXX SQ IF Positive
Herpes simplex type 1 10678-1 HERPES SIMPLEX TYPE 1+TYPE 2 VIRUS AG ACNC PT TISS SQ IMMUNE STAIN Positive
Herpes simplex type 1 5205-0 HERPES SIMPLEX VIRUS TYPE 1 AB ACNC PT SER QN EIA Not reportable
Herpes simplex type 1 7908-7 HERPES SIMPLEX VIRUS TYPE 1 AB ACNC PT SER QN Not reportable
Herpes simplex type 1 13324-9 HERPES SIMPLEX VIRUS TYPE 1 AB ACNC PT SER/PLA
S
QN ACIF
Herpes simplex type 1 5206-8 HERPES SIMPLEX VIRUS TYPE 1 AB.IGG ACNC PT SER QN EIA Not reportable
Herpes simplex type 1 7909-5 HERPES SIMPLEX VIRUS TYPE 1 AB.IGG ACNC PT SER QN Not reportable
Herpes simplex type 1 13251-4 HERPES SIMPLEX VIRUS TYPE 1 AB.IGM ACNC PT CSF QN
Herpes simplex type 1 5207-6 HERPES SIMPLEX VIRUS TYPE 1 AB.IGM ACNC PT SER QN EIA
Herpes simplex type 1 7910-3 HERPES SIMPLEX VIRUS TYPE 1 AB.IGM ACNC PT SER QN
Herpes simplex type 1 13505-3 HERPES SIMPLEX VIRUS TYPE 1+2 AB PATTERN IMP PT SER/PLA
S
QL
Herpes simplex type 1 13249-8 HERPES SIMPLEX VIRUS TYPE 1+2 AB.IGG ACNC PT CSF QN
Herpes simplex type 1 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Herpes simplex type 1 organism list
Herpes simplex type 1 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Herpes simplex type 1 organism list
Herpes simplex type 1 5887-5 VIRUS IDENTIFIED PRID PT THRT QL VIRUS CULTURE Herpes simplex type 1 organism list
Herpes simplex type 1 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Herpes simplex type 1 organism list
Herpes simplex type 1 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Herpes simplex type 1 organism list
Herpes simplex type 1 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Herpes simplex type 1 organism list
Herpes simplex type 1 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Herpes simplex type 1 organism list
Herpes simplex type 2 10678-1 HERPES SIMPLEX TYPE 1+TYPE 2 VIRUS AG ACNC PT TISS SQ IMMUNE STAIN Positive
Herpes simplex type 2 5847-9 HERPES SIMPLEX TYPE 2 VIRUS AG ACNC PT GEN SQ IF Positive
Herpes simplex type 2 5848-7 HERPES SIMPLEX TYPE 2 VIRUS AG ACNC PT SKN SQ IF Positive
Herpes simplex type 2 5849-5 HERPES SIMPLEX TYPE 2 VIRUS AG ACNC PT XXX SQ IF Positive
Herpes simplex type 2 13505-3 HERPES SIMPLEX VIRUS TYPE 1+2 AB PATTERN IMP PT SER/PLA
S
QL
Herpes simplex type 2 13249-8 HERPES SIMPLEX VIRUS TYPE 1+2 AB.IGG ACNC PT CSF QN
Herpes simplex type 2 5208-4 HERPES SIMPLEX VIRUS TYPE 2 AB ACNC PT SER QN EIA Not reportable
Herpes simplex type 2 7911-1 HERPES SIMPLEX VIRUS TYPE 2 AB ACNC PT SER QN Not reportable
Herpes simplex type 2 13323-1 HERPES SIMPLEX VIRUS TYPE 2 AB ACNC PT SER/PLA
S
QN
Herpes simplex type 2 13501-2 HERPES SIMPLEX VIRUS TYPE 2 AB PATTERN IMP PT SER/PLA
S
QL
Herpes simplex type 2 5209-2 HERPES SIMPLEX VIRUS TYPE 2 AB.IGG ACNC PT SER QN EIA Not reportable
Herpes simplex type 2 7912-9 HERPES SIMPLEX VIRUS TYPE 2 AB.IGG ACNC PT SER QN Not reportable
Herpes simplex type 2 13252-2 HERPES SIMPLEX VIRUS TYPE 2 AB.IGM ACNC PT CSF QN
Herpes simplex type 2 5210-0 HERPES SIMPLEX VIRUS TYPE 2 AB.IGM ACNC PT SER QN EIA
Herpes simplex type 2 7913-7 HERPES SIMPLEX VIRUS TYPE 2 AB.IGM ACNC PT SER QN
Herpes simplex type 2 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Herpes simplex type 2 organism list
Herpes simplex type 2 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Herpes simplex type 2 organism list
Herpes simplex type 2 5887-5 VIRUS IDENTIFIED PRID PT THRT QL VIRUS CULTURE Herpes simplex type 2 organism list
Herpes simplex type 2 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Herpes simplex type 2 organism list
Herpes simplex type 2 5888-3 VIRUS IDENTIFIED PRID PT TISS QL VIRUS CULTURE Herpes simplex type 2 organism list
Herpes simplex type 2 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Herpes simplex type 2 organism list
Herpes simplex type 2 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Herpes simplex type 2 organism list
Histoplasmosis 10852-2 FUNGUS IDENTIFIED PRID PT BLD QL ROUTINE FUNGAL CULTURE HIstoplasmosis organism list
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Histoplasmosis 572-8 FUNGUS IDENTIFIED PRID PT MAR QL ROUTINE FUNGAL CULTURE HIstoplasmosis organism list
Histoplasmosis 577-7 FUNGUS IDENTIFIED PRID PT SPT QL ROUTINE FUNGAL CULTURE HIstoplasmosis organism list
Histoplasmosis 6409-7 FUNGUS IDENTIFIED PRID PT SPTT QL ROUTINE FUNGAL CULTURE HIstoplasmosis organism list
Histoplasmosis 580-1 FUNGUS IDENTIFIED PRID PT XXX QL ROUTINE FUNGAL CULTURE
Histoplasmosis 5218-3 HISTOPLASMA CAPSULATUM AB ACNC PT SER SQ ID
Histoplasmosis 6426-1 HISTOPLASMA CAPSULATUM AB ACNC PT SER QN EIA
Histoplasmosis 6427-9 HISTOPLASMA CAPSULATUM AB ACNC PT SER SQ LA
Histoplasmosis 7916-0 HISTOPLASMA CAPSULATUM AB ACNC PT SER QN
Histoplasmosis 5219-1 HISTOPLASMA CAPSULATUM AB TITR PT SER QN CF
Histoplasmosis 9528-1 HISTOPLASMA CAPSULATUM AB.IGA ACNC PT SER QN EIA
Histoplasmosis 9529-9 HISTOPLASMA CAPSULATUM AB.IGG ACNC PT SER QN EIA
Histoplasmosis 9530-7 HISTOPLASMA CAPSULATUM AB.IGM ACNC PT SER QN EIA
Histoplasmosis 6428-7 HISTOPLASMA CAPSULATUM AG ACNC PT SER QN EIA
Histoplasmosis 5015-3 HISTOPLASMA CAPSULATUM DNA ACNC PT XXX SQ PCR/PROBE
Histoplasmosis 12456-0 HISTOPLASMA CAPSULATUM MYCELIAL AB ACNC PT CSF SQ
Histoplasmosis 6816-3 HISTOPLASMA CAPSULATUM MYCELIAL AB ACNC PT SER SQ
Histoplasmosis 5016-1 HISTOPLASMA CAPSULATUM RRNA ACNC PT XXX SQ DNA PROBE
Histoplasmosis 12455-2 HISTOPLASMA CAPSULATUM YEAST AB ACNC PT CSF SQ
Histoplasmosis 6817-1 HISTOPLASMA CAPSULATUM YEAST AB ACNC PT SER SQ Not reportable
Histoplasmosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Histoplasmosis organism list
Histoplasmosis 601-5 MICROORGANISM IDENTIFIED PRID PT BLD QL FUNGAL BLOOD CULTURE Histoplasmosis organism list
Histoplasmosis 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Histoplasmosis organism list
Histoplasmosis 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Histoplasmosis organism list
Histoplasmosis 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Histoplasmosis organism list
Histoplasmosis 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Histoplasmosis organism list
Histoplasmosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Histoplasmosis organism list
Histoplasmosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Histoplasmosis organism list
Histoplasmosis 10355-6 MICROSCOPIC OBSERVATION PRID PT MAR QL WRIGHT GIEMSA STAIN Histoplasmosis organism list
Histoplasmosis 648-6 MICROSCOPIC OBSERVATION PRID PT SPT QL GRAM STAIN Histoplasmosis organism list
Histoplasmosis 6468-3 MICROSCOPIC OBSERVATION PRID PT SPT QL CALCOFLUOR WHITE PREPARATION Histoplasmosis organism list
Histoplasmosis 6472-5 MICROSCOPIC OBSERVATION PRID PT TISS QL CALCOFLUOR WHITE PREPARATION Histoplasmosis organism list
Histoplasmosis 6667-0 MICROSCOPIC OBSERVATION PRID PT TISS QL KOH PREPARATION Histoplasmosis organism list
Histoplasmosis 6675-3 MICROSCOPIC OBSERVATION PRID PT TISS QL PERIODIC ACID-SCHIFF STAIN Histoplasmosis organism list
Histoplasmosis 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Histoplasmosis organism list
Histoplasmosis 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Histoplasmosis organism list
Histoplasmosis 658-5 MICROSCOPIC OBSERVATION PRID PT XXX QL CALCOFLUOR WHITE PREPARATION Histoplasmosis organism list
Histoplasmosis 667-6 MICROSCOPIC OBSERVATION PRID PT XXX QL KOH PREPARATION Histoplasmosis organism list
Histoplasmosis 674-2 MICROSCOPIC OBSERVATION PRID PT XXX QL PERIODIC ACID-SCHIFF STAIN Histoplasmosis organism list
Human immunodeficiency virus 5220-9 HIV 1 AB ACNC PT SER QN EIA
Human immunodeficiency virus 5221-7 HIV 1 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 7917-8 HIV 1 AB ACNC PT SER SQ Positive
Human immunodeficiency virus 13499-9 HIV 1 AB BAND PATTERN IMP PT SER/PLA
S
QL IB
Human immunodeficiency virus 5222-5 HIV 1 AG ACNC PT SER SQ EIA Positive
Human immunodeficiency virus 9837-6 HIV 1 DNA ACNC PT BLD SQ AMP Positive
Diane Dwyer, M.D., Rashid Chotani, M.D. M.P.H., Blaine Y. Takesue, M.D., Clement J. McDonald, M.D.
LOINC Names and Codes (c) 1995-1997
Maryland Dept of Health and Mental Hygiene, Regenstrief Inst for Health Care and LOINC Committee 21 of 49 2/10/98
DRAFT Appendix C
Table IV: LOINC List
1
A B C D E F G H I














































Human immunodeficiency virus 12893-4 HIV 1 GP105 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9661-0 HIV 1 GP120 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 9660-2 HIV 1 GP160 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 12870-2 HIV 1 GP34 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9662-8 HIV 1 GP41 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 12872-8 HIV 1 P15 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9663-6 HIV 1 P17 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 12859-5 HIV 1 P18 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 12855-3 HIV 1 P23 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9664-4 HIV 1 P24 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 9665-1 HIV 1 P24 AG ACNC PT SER QN Positive
Human immunodeficiency virus 9821-0 HIV 1 P24 AG ACNC PT SER SQ Positive
Human immunodeficiency virus 12871-0 HIV 1 P26 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 12857-9 HIV 1 P28 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9666-9 HIV 1 P31 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 12858-7 HIV 1 P32 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9667-7 HIV 1 P51 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 12876-9 HIV 1 P53 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9668-5 HIV 1 P55 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 12895-9 HIV 1 P58 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 12875-1 HIV 1 P64 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 12856-1 HIV 1 P65 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 9669-3 HIV 1 P66 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 12894-2 HIV 1 P68 AB ACNC PT SER/PLA
S
SQ IB
Human immunodeficiency virus 5017-9 HIV 1 RNA ACNC PT BLD SQ PCR/PROBE Positive
Human immunodeficiency virus 10351-5 HIV 1 RNA ACNC PT PLAS QN AMP/PROBE Positive
Human immunodeficiency virus 10682-3 HIV 1 RNA ACNC PT SER/PLAS QN AMP/PROBE Positive
Human immunodeficiency virus 5018-7 HIV 1 RNA ACNC PT XXX SQ PCR/PROBE Positive
Human immunodeficiency virus 5223-3 HIV 1+2 AB ACNC PT SER QN EIA Positive
Human immunodeficiency virus 7918-6 HIV 1+2 AB ACNC PT SER SQ Positive
Human immunodeficiency virus 5225-8 HIV 2 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 5224-1 HIV 2 AB ACNC PT SER QN EIA Positive
Human immunodeficiency virus 7919-4 HIV 2 AB ACNC PT SER SQ Positive
Human immunodeficiency virus 10901-7 HIV 2 GP125 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 10902-5 HIV 2 GP36 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 11078-3 HIV 2 GP80 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 11079-1 HIV 2 P26 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 11080-9 HIV 2 P53 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 11081-7 HIV 2 P56 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 11082-5 HIV 2 P68 AB ACNC PT SER SQ IB Positive
Human immunodeficiency virus 9836-8 HIV DNA ACNC PT BLD SQ AMP Positive
Human immunodeficiency virus 6429-5 HIV IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Human immunodeficiency virus organism list
Human immunodeficiency virus 6430-3 HIV IDENTIFIED PRID PT SMN QL ORGANISM SPECIFIC CULTURE Human immunodeficiency virus organism list
Human immunodeficiency virus 6431-1 HIV IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Human immunodeficiency virus organism list
Human immunodeficiency virus 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Human immunodeficiency virus organism list
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Human immunodeficiency virus 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Human immunodeficiency virus organism list
Human immunodeficiency virus 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Human immunodeficiency virus organism list
Human T-lymphotrophic virus 5226-6 HTLV-I+II AB ACNC PT SER QN EIA
Human T-lymphotrophic virus 5019-5 HTLV-I+II RNA ACNC PT XXX SQ PCR/PROBE Positive
Human T-lymphotrophic virus 6432-9 HTLV 1 AB ACNC PT SER SQ IB
Human T-lymphotrophic virus 6433-7 HTLV 1 AB.IGG ACNC PT SER SQ EIA
Human T-lymphotrophic virus 11609-5 HTLV I AB ACNC PT SER QN
Human T-lymphotrophic virus 13247-2 HTLV I+II AB ACNC PT CSF QN
Human T-lymphotrophic virus 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Human T-lymphotrophic virus organism list
Human T-lymphotrophic virus 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Human T-lymphotrophic virus organism list
Human T-lymphotrophic virus 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Human T-lymphotrophic virus organism list
Human T-lymphotrophic virus 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Human T-lymphotrophic virus organism list
Human T-lymphotrophic virus 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Human T-lymphotrophic virus organism list
Influenza 9531-5 INFLUENZA VIRUS A AB TITR PT CSF QN
Influenza 5229-0 INFLUENZA VIRUS A AB TITR PT SER QN CF
Influenza 7920-2 INFLUENZA VIRUS A AB ACNC PT SER QN
Influenza 9532-3 INFLUENZA VIRUS A AB.IGG TITR PT SER QN
Influenza 9533-1 INFLUENZA VIRUS A AB.IGM TITR PT SER QN Positive
Influenza 5860-2 INFLUENZA VIRUS A AG ACNC PT THRT SQ EIA Positive
Influenza 5861-0 INFLUENZA VIRUS A AG ACNC PT THRT SQ IF Positive
Influenza 5862-8 INFLUENZA VIRUS A AG ACNC PT XXX SQ EIA Positive
Influenza 5863-6 INFLUENZA VIRUS A AG ACNC PT XXX SQ IF Positive
Influenza 6639-9 INFLUENZA VIRUS A BANGKOK AB ACNC PT SER QN HAI Not reportable
Influenza 7921-0 INFLUENZA VIRUS A BANGKOK AB ACNC PT SER QN Not reportable
Influenza 6635-7 INFLUENZA VIRUS A ENGLAND AB ACNC PT SER QN HAI Not reportable
Influenza 7922-8 INFLUENZA VIRUS A ENGLAND AB ACNC PT SER QN Not reportable
Influenza 6634-0 INFLUENZA VIRUS A HONG KONG AB ACNC PT SER QN HAI Not reportable
Influenza 7923-6 INFLUENZA VIRUS A HONG KONG AB ACNC PT SER QN Not reportable
Influenza 6642-3 INFLUENZA VIRUS A LENINGRAD AB ACNC PT SER QN HAI Not reportable
Influenza 7924-4 INFLUENZA VIRUS A LENINGRAD AB ACNC PT SER QN Not reportable
Influenza 6641-5 INFLUENZA VIRUS A MISSISSIPPI AB ACNC PT SER QN HAI Not reportable
Influenza 7925-1 INFLUENZA VIRUS A MISSISSIPPI AB ACNC PT SER QN Not reportable
Influenza 6640-7 INFLUENZA VIRUS A PHILLIPINES AB ACNC PT SER QN HAI Not reportable
Influenza 7926-9 INFLUENZA VIRUS A PHILLIPINES AB ACNC PT SER QN Not reportable
Influenza 6636-5 INFLUENZA VIRUS A PORT CHALMERS AB ACNC PT SER QN HAI Not reportable
Influenza 7927-7 INFLUENZA VIRUS A PORT CHALMERS AB ACNC PT SER QN Not reportable
Influenza 6638-1 INFLUENZA VIRUS A TEXAS AB ACNC PT SER QN HAI Not reportable
Influenza 7928-5 INFLUENZA VIRUS A TEXAS AB ACNC PT SER QN Not reportable
Influenza 6637-3 INFLUENZA VIRUS A VICTORIA AB ACNC PT SER QN HAI Not reportable
Influenza 7929-3 INFLUENZA VIRUS A VICTORIA AB ACNC PT SER QN Not reportable
Influenza 6434-5 INFLUENZA VIRUS A+B AB TITR PT SER QN IF Not reportable
Influenza 7930-1 INFLUENZA VIRUS A+B AB ACNC PT SER QN Not reportable
Influenza 6435-2 INFLUENZA VIRUS A+B AG ACNC PT THRT SQ EIA Positive
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Influenza 6436-0 INFLUENZA VIRUS A+B AG ACNC PT THRT SQ IF Positive
Influenza 6437-8 INFLUENZA VIRUS A+B AG ACNC PT XXX SQ EIA Positive
Influenza 6438-6 INFLUENZA VIRUS A+B AG ACNC PT XXX SQ IF Positive
Influenza 6439-4 INFLUENZA VIRUS A+B+C AG ACNC PT THRT SQ EIA Positive
Influenza 6440-2 INFLUENZA VIRUS A+B+C AG ACNC PT THRT SQ IF Positive
Influenza 6441-0 INFLUENZA VIRUS A+B+C AG ACNC PT XXX SQ EIA Positive
Influenza 6442-8 INFLUENZA VIRUS A+B+C AG ACNC PT XXX SQ IF Positive
Influenza 9534-9 INFLUENZA VIRUS B AB TITR PT CSF QN Not reportable
Influenza 5230-8 INFLUENZA VIRUS B AB TITR PT SER QN CF Not reportable
Influenza 7931-9 INFLUENZA VIRUS B AB ACNC PT SER QN Not reportable
Influenza 9535-6 INFLUENZA VIRUS B AB.IGG TITR PT SER QN Not reportable
Influenza 9536-4 INFLUENZA VIRUS B AB.IGM TITR PT SER QN Positive
Influenza 5864-4 INFLUENZA VIRUS B AG ACNC PT THRT SQ EIA Positive
Influenza 5865-1 INFLUENZA VIRUS B AG ACNC PT THRT SQ IF Positive
Influenza 5866-9 INFLUENZA VIRUS B AG ACNC PT XXX SQ EIA Positive
Influenza 5867-7 INFLUENZA VIRUS B AG ACNC PT XXX SQ IF Positive
Influenza 5231-6 INFLUENZA VIRUS C AB TITR PT SER QN CF Not reportable
Influenza 7932-7 INFLUENZA VIRUS C AB ACNC PT SER QN Not reportable
Influenza 6601-9 INFLUENZA VIRUS IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Influenza virus organism list
Influenza 6602-7 INFLUENZA VIRUS IDENTIFIED PRID PT SPTT QL ORGANISM SPECIFIC CULTURE Influenza virus organism list
Influenza 6603-5 INFLUENZA VIRUS IDENTIFIED PRID PT THRT QL ORGANISM SPECIFIC CULTURE Influenza virus organism list
Influenza 6604-3 INFLUENZA VIRUS IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Influenza virus organism list
Isosporiasis 10853-0 ISOSPORA BELLI ACNC PT XXX SQ KINYOUN STAIN
Lassa fever 7942-6 LASSA VIRUS AB.IGG ACNC PT SER SQ EIA
Lassa fever 7943-4 LASSA VIRUS AB.IGG TITR PT SER QN IF
Lassa fever 7944-2 LASSA VIRUS AB.IGM ACNC PT SER SQ EIA Positive
Lassa fever 7945-9 LASSA VIRUS AB.IGM TITR PT SER QN IF Positive
Lassa fever 7946-7 LASSA VIRUS AG ACNC PT SER SQ EIA Positive
Lassa fever 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Lassa fever organism list
Lassa fever 6584-7 VIRUS IDENTIFIED PRID PT XXX QL VIRUS CULTURE Lassa fever organism list
Lassa fever 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Lassa fever organism list
Legionellosis 13255-5 LEGIONELLA LONGBEACHAE S1+S2 AB ACNC PT SER/PLA
S
SQ
Legionellosis 13253-0 LEGIONELLA NON PNEUMOPHILA SP AB ACNC PT SER/PLA
S
SQ
Legionellosis 5236-5 LEGIONELLA PNEUMOPHILA AB ACNC PT SER SQ IF >1:256
Legionellosis 7947-5 LEGIONELLA PNEUMOPHILA AB ACNC PT SER SQ
Legionellosis 5237-3 LEGIONELLA PNEUMOPHILA AB TITR PT SER QN IF >1:256
Legionellosis 13254-8 LEGIONELLA PNEUMOPHILA AB.ATYPICAL ACNC PT SER/PLA
S
SQ
Legionellosis 6445-1 LEGIONELLA PNEUMOPHILA AG ACNC PT SPT SQ IF Positive
Legionellosis 6446-9 LEGIONELLA PNEUMOPHILA AG ACNC PT SPT SQ LA Positive
Legionellosis 6447-7 LEGIONELLA PNEUMOPHILA AG ACNC PT UR SQ EIA Positive
Legionellosis 6448-5 LEGIONELLA PNEUMOPHILA AG ACNC PT UR SQ RIA Positive
Legionellosis 6449-3 LEGIONELLA PNEUMOPHILA AG ACNC PT XXX SQ LA
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Legionellosis 588-4 LEGIONELLA PNEUMOPHILA AG ACNC PT XXX SQ IF Positive
Legionellosis 7948-3 LEGIONELLA PNEUMOPHILA SEROGROUP 1 AB TITR PT SER QN IF >1:256
Legionellosis 9541-4 LEGIONELLA PNEUMOPHILA SEROGROUP 1 AB.IGG TITR PT SER QN IF >1:256
Legionellosis 9542-2 LEGIONELLA PNEUMOPHILA SEROGROUP 1 AB.IGM TITR PT SER QN IF >1:256
Legionellosis 7949-1 LEGIONELLA PNEUMOPHILA SEROGROUP 2 AB TITR PT SER QN IF >1:256
Legionellosis 9544-8 LEGIONELLA PNEUMOPHILA SEROGROUP 2 AB.IGG TITR PT SER QN IF >1:256
Legionellosis 9545-5 LEGIONELLA PNEUMOPHILA SEROGROUP 2 AB.IGM TITR PT SER QN IF >1:256
Legionellosis 7950-9 LEGIONELLA PNEUMOPHILA SEROGROUP 3 AB TITR PT SER QN IF >1:256
Legionellosis 9546-3 LEGIONELLA PNEUMOPHILA SEROGROUP 3 AB.IGG TITR PT SER QN IF >1:256
Legionellosis 9547-1 LEGIONELLA PNEUMOPHILA SEROGROUP 3 AB.IGM TITR PT SER QN IF >1:256
Legionellosis 7951-7 LEGIONELLA PNEUMOPHILA SEROGROUP 4 AB TITR PT SER QN IF
Legionellosis 9548-9 LEGIONELLA PNEUMOPHILA SEROGROUP 4 AB.IGG TITR PT SER QN IF >1:256
Legionellosis 9549-7 LEGIONELLA PNEUMOPHILA SEROGROUP 4 AB.IGM TITR PT SER QN IF >1:256
Legionellosis 7952-5 LEGIONELLA PNEUMOPHILA SEROGROUP 5 AB TITR PT SER QN IF >1:256
Legionellosis 9550-5 LEGIONELLA PNEUMOPHILA SEROGROUP 5 AB.IGG TITR PT SER QN IF >1:256
Legionellosis 9551-3 LEGIONELLA PNEUMOPHILA SEROGROUP 5 AB.IGM TITR PT SER QN IF >1:256
Legionellosis 7953-3 LEGIONELLA PNEUMOPHILA SEROGROUP 6 AB TITR PT SER QN IF >1:256
Legionellosis 9552-1 LEGIONELLA PNEUMOPHILA SEROGROUP 6 AB.IGG TITR PT SER QN IF >1:256
Legionellosis 9553-9 LEGIONELLA PNEUMOPHILA SEROGROUP 6 AB.IGM TITR PT SER QN IF >1:256
Legionellosis 7954-1 LEGIONELLA PNEUMOPHILA SEROGROUP 7 AB TITR PT SER QN IF >1:256
Legionellosis 7955-8 LEGIONELLA PNEUMOPHILA SEROGROUP 8 AB TITR PT SER QN IF >1:256
Legionellosis 7956-6 LEGIONELLA PNEUMOPHILA SEROGROUP 9 AB TITR PT SER QN IF >1:256
Legionellosis 7957-4 LEGIONELLA SP AB ACNC PT SER QN
Legionellosis 6450-1 LEGIONELLA SP AB TITR PT SER QN IF >1:256
Legionellosis 6451-9 LEGIONELLA SP DNA ACNC PT XXX SQ PROBE Positive
Legionellosis 589-2 LEGIONELLA SP IDENTIFIED PRID PT BRO QL ORGANISM SPECIFIC CULTURE Legionellosis organism list
Legionellosis 590-0 LEGIONELLA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Legionellosis organism list
Legionellosis 593-4 LEGIONELLA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Legionellosis organism list
Legionellosis 5020-3 LEGIONELLA SP RRNA ACNC PT XXX SQ DNA PROBE Positive
Legionellosis 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Legionellosis organism list
Legionellosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Legionellosis organism list
Legionellosis 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Legionellosis organism list
Legionellosis 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Legionellosis organism list
Legionellosis 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Legionellosis organism list
Legionellosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Legionellosis organism list
Legionellosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Legionellosis organism list
Leptospirosis 5239-9 LEPTOSPIRA AB TITR PT SER QN LA
Leptospirosis 7959-0 LEPTOSPIRA AB TITR PT SER QN
Leptospirosis 7960-8 LEPTOSPIRA INTERROGANS AB ACNC PT SER QN HAI
Leptospirosis 6605-0 LEPTOSPIRA INTERROGANS AG ACNC PT TISS SQ IF Positive
Leptospirosis 6452-7 LEPTOSPIRA INTERROGANS AG ACNC PT XXX SQ IF Positive
Leptospirosis 6453-5 LEPTOSPIRA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Leptospirosis organism list
Leptospirosis 6454-3 LEPTOSPIRA SP IDENTIFIED PRID PT CSF QL ORGANISM SPECIFIC CULTURE Leptospirosis organism list
Leptospirosis 6455-0 LEPTOSPIRA SP IDENTIFIED PRID PT UR QL ORGANISM SPECIFIC CULTURE Leptospirosis organism list
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Leptospirosis 594-2 LEPTOSPIRA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Leptospirosis organism list
Leptospirosis 594-2 LEPTOSPIRA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Leptospirosis organism list
Leptospirosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Leptospirosis organism list
Leptospirosis 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Leptospirosis organism list
Leptospirosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Leptospirosis organism list
Leptospirosis 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Leptospirosis organism list
Leptospirosis 10354-9 MICROORGANISM IDENTIFIED PRID PT URT QL URINE CULTURE Leptospirosis organism list
Leptospirosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Leptospirosis organism list
Leptospirosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Leptospirosis organism list
Leptospirosis 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Leptospirosis organism list
Leptospirosis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Leptospirosis organism list
Leptospirosis 6607-6 MICROSCOPIC OBSERVATION PRID PT TISS QL DARK FIELD EXAMINATION Leptospirosis organism list
Leptospirosis 660-1 MICROSCOPIC OBSERVATION PRID PT XXX QL DARK FIELD EXAMINATION Leptospirosis organism list
Listeriosis 13265-4 LEPTOSPIRA AB.IGM TITR PT SER/PLA
S
QN
Listeriosis 11606-1 LEPTOSPIRA INTERROGANS AB ACNC PT SER QN
Listeriosis 5240-7 LISTERIA MONOCYTOGENES AB ACNC PT SER QN Not reportable
Listeriosis 6456-8 LISTERIA MONOCYTOGENES AB TITR PT SER QN CF Not reportable
Listeriosis 5021-1 LISTERIA MONOCYTOGENES RRNA ACNC PT XXX SQ DNA PROBE Positive
Listeriosis 6609-2 LISTERIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Listeria monocytogenes organism list
Listeriosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Listeria monocytogenes organism list
Listeriosis 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Listeria monocytogenes organism list
Listeriosis 625-4 MICROORGANISM IDENTIFIED PRID PT STL QL STOOL CULTURE Listeria monocytogenes organism list
Listeriosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Listeria monocytogenes organism list
Listeriosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Listeria monocytogenes organism list
Listeriosis 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Listeria monocytogenes organism list
Listeriosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Listeria monocytogenes organism list
Lyme disease 11585-7 BORDETELLA PERTUSSIS AB ACNC PT SER QN
Lyme disease 11550-1 BORRELIA BURGDORFERI ACNC PT XXX SQ ORGANISM SPECIFIC CULTURE Lyme disease organism list
Lyme disease 12866-0 BORRELIA BURGDORFERI 18KD AB ACNC PT CSF SQ IB
Lyme disease 12883-5 BORRELIA BURGDORFERI 18KD AB ACNC PT FLU SQ IB
Lyme disease 9588-5 BORRELIA BURGDORFERI 18KD AB.IGG ACNC PT SER SQ IB Positive
Lyme disease 9589-3 BORRELIA BURGDORFERI 23KD AB.IGG ACNC PT SER SQ IB Positive
Lyme disease 9598-4 BORRELIA BURGDORFERI 23KD AB.IGM ACNC PT SER SQ IB Positive
Lyme disease 12864-5 BORRELIA BURGDORFERI 25KD AB ACNC PT CSF SQ IB
Lyme disease 12888-4 BORRELIA BURGDORFERI 25KD AB ACNC PT FLU SQ IB
Lyme disease 12879-3 BORRELIA BURGDORFERI 25KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 9590-1 BORRELIA BURGDORFERI 28KD AB.IGG ACNC PT SER SQ IB Positive
Lyme disease 12865-2 BORRELIA BURGDORFERI 29KD AB ACNC PT CSF SQ IB
Lyme disease 12882-7 BORRELIA BURGDORFERI 29KD AB ACNC PT FLU SQ IB
Lyme disease 12878-5 BORRELIA BURGDORFERI 29KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 12869-4 BORRELIA BURGDORFERI 30KD AB ACNC PT CSF SQ IB
Lyme disease 12889-2 BORRELIA BURGDORFERI 30KD AB ACNC PT FLU SQ IB
Lyme disease 12892-6 BORRELIA BURGDORFERI 30KD AB ACNC PT SER/PLA
S
SQ IB
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Lyme disease 9591-9 BORRELIA BURGDORFERI 30KD AB.IGG ACNC PT SER SQ IB Positive
Lyme disease 12860-3 BORRELIA BURGDORFERI 39KD AB ACNC PT CSF SQ IB
Lyme disease 12884-3 BORRELIA BURGDORFERI 39KD AB ACNC PT FLU SQ IB
Lyme disease 9592-7 BORRELIA BURGDORFERI 39KD AB.IGG ACNC PT SER SQ IB Positive
Lyme disease 9599-2 BORRELIA BURGDORFERI 39KD AB.IGM ACNC PT SER SQ IB Positive
Lyme disease 12863-7 BORRELIA BURGDORFERI 41KD AB ACNC PT CSF SQ IB
Lyme disease 12887-6 BORRELIA BURGDORFERI 41KD AB ACNC PT FLU SQ IB
Lyme disease 12891-8 BORRELIA BURGDORFERI 41KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 9593-5 BORRELIA BURGDORFERI 41KD AB.IGG ACNC PT SER SQ IB
Lyme disease 9587-7 BORRELIA BURGDORFERI 41KD AB.IGM ACNC PT SER SQ IB Positive
Lyme disease 12890-0 BORRELIA BURGDORFERI 45KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 9594-3 BORRELIA BURGDORFERI 45KD AB.IGG ACNC PT SER SQ IB Positive 
Lyme disease 12868-6 BORRELIA BURGDORFERI 47KD AB ACNC PT CSF SQ IB
Lyme disease 12881-9 BORRELIA BURGDORFERI 47KD AB ACNC PT FLU SQ IB
Lyme disease 12877-7 BORRELIA BURGDORFERI 47KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 12867-8 BORRELIA BURGDORFERI 58KD AB ACNC PT CSF SQ IB
Lyme disease 12880-1 BORRELIA BURGDORFERI 58KD AB ACNC PT FLU SQ IB
Lyme disease 12896-7 BORRELIA BURGDORFERI 58KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 9595-0 BORRELIA BURGDORFERI 58KD AB.IGG ACNC PT SER SQ IB Positive 
Lyme disease 12862-9 BORRELIA BURGDORFERI 66KD AB ACNC PT CSF SQ IB
Lyme disease 12886-8 BORRELIA BURGDORFERI 66KD AB ACNC PT FLU SQ IB
Lyme disease 9596-8 BORRELIA BURGDORFERI 66KD AB.IGG ACNC PT SER SQ IB Positive 
Lyme disease 12861-1 BORRELIA BURGDORFERI 88KD AB ACNC PT CSF SQ IB
Lyme disease 12885-0 BORRELIA BURGDORFERI 88KD AB ACNC PT FLU SQ IB
Lyme disease 12873-6 BORRELIA BURGDORFERI 88KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 12874-4 BORRELIA BURGDORFERI 93KD AB ACNC PT SER/PLA
S
SQ IB
Lyme disease 9597-6 BORRELIA BURGDORFERI 93KD AB.IGG ACNC PT SER SQ IB Positive 
Lyme disease 6318-0 BORRELIA BURGDORFERI AB ACNC PT CSF QN EIA Positive 
Lyme disease 6319-8 BORRELIA BURGDORFERI AB ACNC PT FLU QN EIA Positive 
Lyme disease 11006-4 BORRELIA BURGDORFERI AB ACNC PT SER SQ Positive 
Lyme disease 5060-9 BORRELIA BURGDORFERI AB ACNC PT SER QN EIA Positive 
Lyme disease 9586-9 BORRELIA BURGDORFERI AB IMP PT SER QL Positive 
Lyme disease 5061-7 BORRELIA BURGDORFERI AB TITR PT SER QN IF Positive 
Lyme disease 12781-1 BORRELIA BURGDORFERI AB IMP PT SER/PLA
S
SQ IB
Lyme disease 13504-6 BORRELIA BURGDORFERI AB IMP PT SER/PLA
S
QL
Lyme disease 13202-7 BORRELIA BURGDORFERI AB.IGG ACNC PT CSF SQ IB
Lyme disease 13204-3 BORRELIA BURGDORFERI AB.IGG ACNC PT CSF QN IF
Lyme disease 5062-5 BORRELIA BURGDORFERI AB.IGG ACNC PT SER QN EIA Positive 
Lyme disease 6320-6 BORRELIA BURGDORFERI AB.IGG ACNC PT SER SQ IB Positive 
Lyme disease 7817-0 BORRELIA BURGDORFERI AB.IGG ACNC PT SER QN Positive 
Lyme disease 5063-3 BORRELIA BURGDORFERI AB.IGG TITR PT SER QN IF Positive 
Lyme disease 13206-8 BORRELIA BURGDORFERI AB.IGG ACNC PT SNV SQ IB
Lyme disease 13502-0 BORRELIA BURGDORFERI AB.IGG BAND PATTERN IMP PT SER/PLA
S
QL IB
Lyme disease 13203-5 BORRELIA BURGDORFERI AB.IGM ACNC PT CSF SQ IB
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Lyme disease 13205-0 BORRELIA BURGDORFERI AB.IGM ACNC PT CSF QN IF
Lyme disease 5064-1 BORRELIA BURGDORFERI AB.IGM ACNC PT SER QN EIA Positive 
Lyme disease 6321-4 BORRELIA BURGDORFERI AB.IGM ACNC PT SER SQ IB Positive
Lyme disease 7818-8 BORRELIA BURGDORFERI AB.IGM ACNC PT SER QN Positive
Lyme disease 5065-8 BORRELIA BURGDORFERI AB.IGM TITR PT SER QN IF Positive
Lyme disease 13207-6 BORRELIA BURGDORFERI AB.IGM ACNC PT SNV SQ IB
Lyme disease 13503-8 BORRELIA BURGDORFERI AB.IGM BAND PATTERN IMP PT SER/PLA
S
QL IB
Lyme disease 6322-2 BORRELIA BURGDORFERI AG ACNC PT SER QN Positive
Lyme disease 11007-2 BORRELIA BURGDORFERI AG ACNC PT UR QN Positive 
Lyme disease 11551-9 BORRELIA BURGDORFERI DNA ACNC PT CSF SQ AMP/PROBE
Lyme disease 4991-6 BORRELIA BURGDORFERI DNA ACNC PT XXX SQ PCR/PROBE Positive 
Lyme disease 10846-4 BORRELIA BURGDORFERI DNA  ACNC PT BLD SQ AMP/PROBE Positive 
Lyme disease 10847-2 BORRELIA BURGDORFERI DNA  ACNC PT FLU SQ AMP/PROBE Positive 
Lyme disease 6323-0 BORRELIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Lyme disease organism list
Lyme disease 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Lyme disease organism list
Lyme disease 606-4 MICROORGANISM IDENTIFIED PRID PT CSF QL STERILE BODY FLUID CULTURE Lyme disease organism list
Lyme disease 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Lyme disease organism list
Lyme disease 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Lyme disease organism list
Lyme disease 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Lyme disease organism list
Lyme disease 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Lyme disease organism list
Lyme disease 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Lyme disease organism list
Lyme disease 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Lyme disease organism list
Lyme disease 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Lyme disease organism list
Lyme disease 6663-9 MICROSCOPIC OBSERVATION PRID PT TISS QL GIMENEZ STAIN Lyme disease organism list
Lyme disease 6664-7 MICROSCOPIC OBSERVATION PRID PT TISS QL GRAM STAIN Lyme disease organism list
Lyme disease 6665-4 MICROSCOPIC OBSERVATION PRID PT TISS QL HEMATOXYLIN AND EOSIN STAIN Lyme disease organism list
Lyme disease 6681-1 MICROSCOPIC OBSERVATION PRID PT TISS QL WRIGHT STAIN Lyme disease organism list
Lymphogranuloma venereum 557-9 CHLAMYDIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Lymphogranuloma venereum organism list
Lymphogranuloma venereum 6348-7 CHLAMYDIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Lymphogranuloma venereum organism list
Lymphogranuloma venereum 558-7 CHLAMYDIA SP IDENTIFIED PRID PT THRT QL ORGANISM SPECIFIC CULTURE Lymphogranuloma venereum organism list
Lymphogranuloma venereum 559-5 CHLAMYDIA SP IDENTIFIED PRID PT URTH QL ORGANISM SPECIFIC CULTURE Lymphogranuloma venereum organism list
Lymphogranuloma venereum 560-3 CHLAMYDIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Lymphogranuloma venereum organism list
Lymphogranuloma venereum 6353-7 CHLAMYDIA TRACHOMATIS AG ACNC PT TISS SQ IF Positive
Lymphogranuloma venereum 6354-5 CHLAMYDIA TRACHOMATIS AG ACNC PT XXX SQ EIA Positive
Lymphogranuloma venereum 6355-2 CHLAMYDIA TRACHOMATIS AG ACNC PT XXX SQ IF Positive
Lymphogranuloma venereum 6356-0 CHLAMYDIA TRACHOMATIS DNA ACNC PT GEN SQ PCR/PROBE Positive
Lymphogranuloma venereum 6357-8 CHLAMYDIA TRACHOMATIS DNA ACNC PT UR SQ PCR/PROBE Positive
Lymphogranuloma venereum 4993-2 CHLAMYDIA TRACHOMATIS RRNA ACNC PT XXX SQ DNA PROBE Positive
Malaria 637-9 MICROSCOPIC OBSERVATION PRID PT BLD QL MALARIA THICK SMEAR Malaria organism list
Malaria 10355-6 MICROSCOPIC OBSERVATION PRID PT MAR QL WRIGHT GIEMSA STAIN Malaria organism list
Malaria 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Malaria organism list
Malaria 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Malaria organism list
Malaria 6663-9 MICROSCOPIC OBSERVATION PRID PT TISS QL GIMENEZ STAIN Malaria organism list
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Malaria 6664-7 MICROSCOPIC OBSERVATION PRID PT TISS QL GRAM STAIN Malaria organism list
Malaria 6665-4 MICROSCOPIC OBSERVATION PRID PT TISS QL HEMATOXYLIN AND EOSIN STAIN Malaria organism list
Malaria 6670-4 MICROSCOPIC OBSERVATION PRID PT TISS QL MALARIA SMEAR Malaria organism list
Malaria 6681-1 MICROSCOPIC OBSERVATION PRID PT TISS QL WRIGHT STAIN Malaria organism list
Malaria 5278-7 PLASMODIUM FALCIPARUM AB ACNC PT SER QN Not reportable
Malaria 10709-4 PLASMODIUM FALCIPARUM AG ACNC PT BLD QN IF Positive
Malaria 6305-7 PLASMODIUM MALARIAE AB ACNC PT SER QN Not reportable
Malaria 9670-1 PLASMODIUM MALARIAE AB.IGG ACNC PT SER QN Not reportable
Malaria 9671-9 PLASMODIUM MALARIAE AB.IGM ACNC PT SER QN Positive
Malaria 6560-7 PLASMODIUM OVALE AB ACNC PT SER QN Not reportable
Malaria 5279-5 PLASMODIUM SP AB ACNC PT SER QN Not reportable
Malaria 10710-2 PLASMODIUM SP IDENTIFIED PRID PT BLD QL THIN FILM Malaria organism list
Malaria 5280-3 PLASMODIUM VIVAX AB ACNC PT SER QN Not reportable
Malaria 10711-0 PLASMODIUM VIVAX AG ACNC PT BLD QN IF Positive
Marburg 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Marburg organism list
Measles 13283-7 RUBEOLA VIRUS AB.IGM ACNC PT CSF QN
Measles 13328-0 RUBEOLA VIRUS AG ACNC PT SER/PLA
S
SQ
Measles 9565-3 RUBEOLA VIRUS AB TITR PT CSF QN CF Not reportable
Measles 5242-3 RUBEOLA VIRUS AB ACNC PT SER QN EIA Not reportable
Measles 5243-1 RUBEOLA VIRUS AB TITR PT SER QN CF Not reportable
Measles 7961-6 RUBEOLA VIRUS AB ACNC PT SER QN Not reportable
Measles 9566-1 RUBEOLA VIRUS AB.IGG ACNC PT CSF QN EIA Not reportable
Measles 5244-9 RUBEOLA VIRUS AB.IGG ACNC PT SER QN EIA Not reportable
Measles 7962-4 RUBEOLA VIRUS AB.IGG ACNC PT SER QN Not reportable
Measles 5245-6 RUBEOLA VIRUS AB.IGM TITR PT SER QN IF
Measles 7963-2 RUBEOLA VIRUS AB.IGM ACNC PT SER QN Positive
Measles 7964-0 RUBEOLA VIRUS RNA ACNC PT NOS SQ PCR/PROBE Positive
Measles 10737-5 VIRUS IDENTIFIED PRID PT STL QL MICROSCOPY.ELECTRON Measles organism list
Measles 5886-7 VIRUS IDENTIFIED PRID PT STL QL VIRUS CULTURE Measles organism list
Measles 12232-5 MEASLES VIRUS AG PRID PT XXX QL
Meningitis, bacterial 6318-0 BORRELIA BURGDORFERI AB ACNC PT CSF QN EIA Positive
Meningitis, bacterial 6610-0 HAEMOPHILUS INFLUENZAE TYPE A AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6611-8 HAEMOPHILUS INFLUENZAE TYPE B AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6612-6 HAEMOPHILUS INFLUENZAE TYPE C AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6613-4 HAEMOPHILUS INFLUENZAE TYPE D AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6614-2 HAEMOPHILUS INFLUENZAE TYPE E AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6615-9 HAEMOPHILUS INFLUENZAE TYPE F AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6615-9 HAEMOPHILUS INFLUENZAE TYPE F AG ACNC PT CSF SQ IF
Meningitis, bacterial 6454-3 LEPTOSPIRA SP IDENTIFIED PRID PT CSF QL ORGANISM SPECIFIC CULTURE Leptospirosis organism list
Meningitis, bacterial 606-4 MICROORGANISM IDENTIFIED PRID PT CSF QL STERILE BODY FLUID CULTURE Meningitis, Bacterial organism List
Meningitis, bacterial 534-8 MYCOBACTERIUM IDENTIFIED PRID PT CSF QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Meningitis, bacterial 6508-6 NEISSERIA MENINGITIDIS AG ACNC PT CSF SQ Positive
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Meningitis, bacterial 6493-1 NEISSERIA MENINGITIDIS GROUP A AG ACNC PT CSF SQ EIA Positive
Meningitis, bacterial 6494-9 NEISSERIA MENINGITIDIS GROUP A AG ACNC PT CSF SQ LA Positive
Meningitis, bacterial 6496-4 NEISSERIA MENINGITIDIS GROUP B AG ACNC PT CSF SQ EIA Positive
Meningitis, bacterial 6497-2 NEISSERIA MENINGITIDIS GROUP B AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6498-0 NEISSERIA MENINGITIDIS GROUP B AG ACNC PT CSF SQ LA Positive
Meningitis, bacterial 6499-8 NEISSERIA MENINGITIDIS GROUP C AG ACNC PT CSF SQ EIA Positive
Meningitis, bacterial 6500-3 NEISSERIA MENINGITIDIS GROUP C AG ACNC PT CSF SQ LA Positive
Meningitis, bacterial 6503-7 NEISSERIA MENINGITIDIS GROUP Y AG ACNC PT CSF SQ EIA Positive
Meningitis, bacterial 6504-5 NEISSERIA MENINGITIDIS GROUP Y AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6505-2 NEISSERIA MENINGITIDIS GROUP Y AG ACNC PT CSF SQ LA Positive
Meningitis, bacterial 6509-4 NEISSERIA MENINGITIDIS RRNA ACNC PT CSF SQ DNA PROBE Positive
Meningitis, bacterial 6506-0 NEISSERIA MENINGITIDIS W135 AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 6507-8 NEISSERIA MENINGITIDIS W135 AG ACNC PT CSF SQ LA Positive
Meningitis, bacterial 5289-4 REAGIN AB ACNC PT CSF QN FLOC
Meningitis, bacterial 5290-2 REAGIN AB ACNC PT CSF SQ FLOC
Meningitis, bacterial 6553-2 STREPTOCOCCUS PNEUMONIAE AG ACNC PT CSF SQ IF Positive
Meningitis, bacterial 9826-9 TREPONEMA PALLIDUM AB ACNC PT CSF SQ IF Positive
Meningitis, fungal 13193-8 ASPERGILLUS FLAVUS AB ACNC PT CSF QN
Meningitis, fungal 13201-9 BLASTOMYCES DERMATITIDIS AB ACNC PT CSF QN
Meningitis, fungal 5118-5 CRYPTOCOCCUS NEOFORMANS AG TITR PT CSF QN LA Positive
Meningitis, fungal 9817-8 CRYPTOCOCCUS SP AG TITR PT CSF QN EIA Positive
Meningitis, fungal 9819-4 CRYPTOCOCCUS SP AG TITR PT CSF QN LA Positive
Meningitis, fungal 569-4 FUNGUS IDENTIFIED PRID PT CSF QL ROUTINE FUNGAL CULTURE Meningitis, Fungal organism List
Meningitis, fungal 12456-0 HISTOPLASMA CAPSULATUM MYCELIAL AB ACNC PT CSF SQ
Meningitis, fungal 12455-2 HISTOPLASMA CAPSULATUM YEAST AB ACNC PT CSF SQ
Meningitis, fungal 638-7 MICROSCOPIC OBSERVATION PRID PT CSF QL INDIA INK PREPARATION Meningitis, Fungal organism List
Meningitis, fungal 639-5 MICROSCOPIC OBSERVATION PRID PT CSF QL KOH PREPARATION Meningitis, Fungal organism List
Meningitis, fungal 9741-0 TOXOPLASMA SP AB.IGG ACNC PT CSF QN
Meningitis, fungal 13287-8 TOXOPLASMA SP AB.TOTAL ACNC PT CSF QN
Meningitis, fungal 12263-0 TOXOPLASMA SP IDENTIFIED PRID PT CSF QL IF
Meningitis, protozoal 6619-1 ACANTHAMOEBA SP AB ACNC PT CSF SQ IF
Meningitis, protozoal 6620-9 ACANTHAMOEBA SP AB ACNC PT CSF SQ EIA
Meningitis, protozoal 7844-4 CYSTICERCUS AB.IGA ACNC PT CSF SQ
Meningitis, protozoal 6373-5 CYSTICERCUS AB.IGG ACNC PT CSF SQ IB
Meningitis, protozoal 7846-9 CYSTICERCUS AB.IGG ACNC PT CSF SQ
Meningitis, protozoal 7848-5 CYSTICERCUS AB.IGM ACNC PT CSF SQ
Meningitis, protozoal 6624-1 NAEGLERIA FOWLERI AB ACNC PT CSF SQ IF
Meningitis, protozoal 6625-8 NAEGLERIA FOWLERI AB ACNC PT CSF SQ EIA
Meningitis, protozoal 7971-5 NAEGLERIA FOWLERI AB ACNC PT CSF SQ
Meningitis, protozoal 13274-6 TOXOCARA CANIS AB ACNC PT CSF QN
Meningitis, viral 13192-0 ADENOVIRUS AB ACNC PT CSF QN
Meningitis, viral 13232-4 COXSACKIEVIRUS A AB ACNC PT CSF QN
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Meningitis, viral 13295-1 COXSACKIEVIRUS A10 AB ACNC PT CSF QN
Meningitis, viral 9751-9 COXSACKIEVIRUS A10 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 13235-7 COXSACKIEVIRUS A16 AB ACNC PT CSF QN
Meningitis, viral 9752-7 COXSACKIEVIRUS A16 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 13233-2 COXSACKIEVIRUS A2 AB ACNC PT CSF QN
Meningitis, viral 13234-0 COXSACKIEVIRUS A4 AB ACNC PT CSF QN
Meningitis, viral 9756-8 COXSACKIEVIRUS A7 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9758-4 COXSACKIEVIRUS A9 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9759-2 COXSACKIEVIRUS B1 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9760-0 COXSACKIEVIRUS B2 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9761-8 COXSACKIEVIRUS B3 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9762-6 COXSACKIEVIRUS B4 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9763-4 COXSACKIEVIRUS B5 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9764-2 COXSACKIEVIRUS B6 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9514-1 CYTOMEGALOVIRUS AB TITR PT CSF QN CF Not reportable
Meningitis, viral 6921-1 CYTOMEGALOVIRUS AB.IGG ACNC PT CSF QN EIA Not reportable
Meningitis, viral 11008-0 CYTOMEGALOVIRUS AB.IGG TITR PT CSF QN IF Not reportable
Meningitis, viral 13226-6 CYTOMEGALOVIRUS AB.IGM ACNC PT CSF QN
Meningitis, viral 13228-2 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGG ACNC PT CSF QN
Meningitis, viral 10897-7 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGG TITR PT CSF QN IF Not reportable
Meningitis, viral 13229-0 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGM ACNC PT CSF QN
Meningitis, viral 10899-3 EASTERN EQUINE ENCEPHALITIS VIRUS AB.IGM TITR PT CSF QN IF Positive
Meningitis, viral 9516-6 ECHOVIRUS TYPE 11 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9518-2 ECHOVIRUS TYPE 30 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9519-0 ECHOVIRUS TYPE 4 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 9520-8 ECHOVIRUS TYPE 9 AB TITR PT CSF QN CF Not reportable
Meningitis, viral 5839-6 ENTEROVIRUS IDENTIFIED PRID PT CSF QL ORGANISM SPECIFIC CULTURE Meningitis, Viral organism List
Meningitis, viral 11009-8 EPSTEIN-BARR VIRUS VIRAL CAPSID AB.IGG TITR PT CSF QN IF
Meningitis, viral 11010-6 EPSTEIN-BARR VIRUS VIRAL CAPSID AB.IGM TITR PT CSF QN IF
Meningitis, viral 13249-8 HERPES SIMPLEX VIRUS 1&2 AB.IGG ACNC PT CSF QN
Meningitis, viral 9454-0 HERPES SIMPLEX VIRUS AB TITR PT CSF QN CF
Meningitis, viral 9659-4 HERPES SIMPLEX VIRUS AB.IGG ACNC PT CSF QN EIA
Meningitis, viral 5013-8 HERPES SIMPLEX VIRUS DNA ACNC PT CSF SQ PCR/PROBE Positive
Meningitis, viral 13251-4 HERPES SIMPLEX VIRUS TYPE 1 AB.IGM ACNC PT CSF QN
Meningitis, viral 13252-2 HERPES SIMPLEX VIRUS TYPE 2 AB.IGM ACNC PT CSF QN
Meningitis, viral 9531-5 INFLUENZA VIRUS A AB TITR PT CSF QN
Meningitis, viral 9534-9 INFLUENZA VIRUS B AB TITR PT CSF QN
Meningitis, viral 7933-5 JAPANESE ENCEPHALITIS VIRUS AB ACNC PT CSF SQ EIA Not reportable
Meningitis, viral 9538-0 LA CROSSE VIRUS AB TITR PT CSF QN IF Not reportable
Meningitis, viral 9539-8 LA CROSSE VIRUS AB.IGG TITR PT CSF QN IF Not reportable
Meningitis, viral 9540-6 LA CROSSE VIRUS AB.IGM TITR PT CSF QN IF Positive
Meningitis, viral 9564-6 LYMPHOCYTIC CHORIOMENINGITIS VIRUS AB TITR PT CSF QN CF
Meningitis, viral 9766-7 LYMPHOCYTIC CHORIOMENINGITIS VIRUS AB.IGG TITR PT CSF QN IF
Meningitis, viral 9768-3 LYMPHOCYTIC CHORIOMENINGITIS VIRUS AB.IGM TITR PT CSF QN IF Positive
Meningitis, viral 9567-9 MUMPS VIRUS AB TITR PT CSF QN CF
Diane Dwyer, M.D., Rashid Chotani, M.D. M.P.H., Blaine Y. Takesue, M.D., Clement J. McDonald, M.D.
LOINC Names and Codes (c) 1995-1997
Maryland Dept of Health and Mental Hygiene, Regenstrief Inst for Health Care and LOINC Committee 31 of 49 2/10/98
DRAFT Appendix C
Table IV: LOINC List
1
A B C D E F G H I














































Meningitis, viral 13266-2 MUMPS VIRUS AB.IGG ACNC PT CSF QN
Meningitis, viral 13267-0 MUMPS VIRUS AB.IGM ACNC PT CSF QN
Meningitis, viral 7968-1 MUMPS VIRUS RNA ACNC PT CSF SQ PCR/PROBE Positive
Meningitis, viral 6522-7 RABIES VIRUS AB ACNC PT CSF QN Positive
Meningitis, viral 6523-5 RABIES VIRUS AB ACNC PT CSF QN NEUT Positive
Meningitis, viral 9576-0 RUBELLA VIRUS AB ACNC PT CSF QN EIA
Meningitis, viral 9565-3 RUBEOLA VIRUS AB TITR PT CSF QN CF
Meningitis, viral 9566-1 RUBEOLA VIRUS AB.IGG ACNC PT CSF QN EIA
Meningitis, viral 13283-7 RUBEOLA VIRUS AB.IGM ACNC PT CSF QN
Meningitis, viral 8021-8 SAINT LOUIS ENCEPHALITIS VIRUS AB ACNC PT CSF SQ EIA
Meningitis, viral 9577-8 SAINT LOUIS ENCEPHALITIS VIRUS AB TITR PT CSF QN IF
Meningitis, viral 13230-8 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGG ACNC PT CSF QN
Meningitis, viral 13231-6 SAINT LOUIS ENCEPHALITIS VIRUS AB.IGM ACNC PT CSF QN
Meningitis, viral 9636-2 VARICELLA VIRUS AB ACNC PT CSF SQ
Meningitis, viral 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Meningitis, Viral organism List
Meningitis, viral 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Meningitis, Viral organism List
Meningitis, viral 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Meningitis, Viral organism List
Meningitis, viral 9314-6 WESTERN EQUINE ENCEPHALITIS VIRUS AB TITR PT CSF QN IF
Meningitis, viral 9315-3 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGG TITR PT CSF QN IF Not reportable
Meningitis, viral 9316-1 WESTERN EQUINE ENCEPHALITIS VIRUS AB.IGM TITR PT CSF QN IF Not reportable
Meningococcal disease 606-4 MICROORGANISM IDENTIFIED PRID PT CSF QL STERILE BODY FLUID CULTURE Meningococcal organism list
Meningococcal disease 609-8 MICROORGANISM IDENTIFIED PRID PT EYE QL AEROBIC CULTURE Meningococcal organism list
Meningococcal disease 10353-1 MICROORGANISM IDENTIFIED PRID PT NOS QL AEROBIC CULTURE Meningococcal organism list
Meningococcal disease 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Meningococcal organism list
Meningococcal disease 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Meningococcal organism list
Meningococcal disease 6460-0 MICROORGANISM IDENTIFIED PRID PT SPT QL ROUTINE BACTERIAL CULTURE Meningococcal organism list
Meningococcal disease 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Meningococcal organism list
Meningococcal disease 6508-6 NEISSERIA MENINGITIDIS AG ACNC PT CSF SQ Positive
Meningococcal disease 6492-3 NEISSERIA MENINGITIDIS AG ACNC PT XXX SQ IF Positive
Meningococcal disease 6493-1 NEISSERIA MENINGITIDIS GROUP A AG ACNC PT CSF SQ EIA Positive
Meningococcal disease 6494-9 NEISSERIA MENINGITIDIS GROUP A AG ACNC PT CSF SQ LA Positive
Meningococcal disease 6495-6 NEISSERIA MENINGITIDIS GROUP A AG ACNC PT XXX SQ IF Positive
Meningococcal disease 6496-4 NEISSERIA MENINGITIDIS GROUP B AG ACNC PT CSF SQ EIA Positive
Meningococcal disease 6497-2 NEISSERIA MENINGITIDIS GROUP B AG ACNC PT CSF SQ IF Positive
Meningococcal disease 6498-0 NEISSERIA MENINGITIDIS GROUP B AG ACNC PT CSF SQ LA Positive
Meningococcal disease 6499-8 NEISSERIA MENINGITIDIS GROUP C AG ACNC PT CSF SQ EIA Positive
Meningococcal disease 6500-3 NEISSERIA MENINGITIDIS GROUP C AG ACNC PT CSF SQ LA Positive
Meningococcal disease 6501-1 NEISSERIA MENINGITIDIS GROUP C AG ACNC PT XXX SQ IF Positive
Meningococcal disease 6502-9 NEISSERIA MENINGITIDIS GROUP Y AB TITR PT XXX SQ IF Not reportable
Meningococcal disease 7972-3 NEISSERIA MENINGITIDIS GROUP Y AB ACNC PT XXX SQ Not reportable
Meningococcal disease 6503-7 NEISSERIA MENINGITIDIS GROUP Y AG ACNC PT CSF SQ EIA Positive
Meningococcal disease 6504-5 NEISSERIA MENINGITIDIS GROUP Y AG ACNC PT CSF SQ IF Positive
Meningococcal disease 6505-2 NEISSERIA MENINGITIDIS GROUP Y AG ACNC PT CSF SQ LA Positive
Meningococcal disease 6509-4 NEISSERIA MENINGITIDIS RRNA ACNC PT CSF SQ DNA PROBE Positive
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Meningococcal disease 5029-4 NEISSERIA MENINGITIDIS RRNA ACNC PT XXX SQ DNA PROBE Positive
Meningococcal disease 6506-0 NEISSERIA MENINGITIDIS W135 AG ACNC PT CSF SQ IF Positive
Meningococcal disease 6507-8 NEISSERIA MENINGITIDIS W135 AG ACNC PT CSF SQ LA Positive
Mumps 9567-9 MUMPS VIRUS AB TITR PT CSF QN CF Not reportable
Mumps 7965-7 MUMPS VIRUS AB ACNC PT SER QN Not reportable
Mumps 5249-8 MUMPS VIRUS AB TITR PT SER QN CF Not reportable
Mumps 5250-6 MUMPS VIRUS AB TITR PT SER QN IF Not reportable
Mumps 13266-2 MUMPS VIRUS AB.IGG ACNC PT CSF QN
Mumps 6476-6 MUMPS VIRUS AB.IGG ACNC PT SER SQ EIA Not reportable
Mumps 7966-5 MUMPS VIRUS AB.IGG ACNC PT SER QN Not reportable
Mumps 6477-4 MUMPS VIRUS AB.IGG TITR PT SER QN IF Not reportable
Mumps 13267-0 MUMPS VIRUS AB.IGM ACNC PT CSF QN
Mumps 6478-2 MUMPS VIRUS AB.IGM ACNC PT SER SQ EIA Positive
Mumps 7967-3 MUMPS VIRUS AB.IGM ACNC PT SER QN Positive
Mumps 6479-0 MUMPS VIRUS AB.IGM TITR PT SER QN IF Positive
Mumps 6480-8 MUMPS VIRUS AG ACNC PT SER SQ IF Positive
Mumps 12237-4 MUMPS VIRUS AG PRID PT XXX QL IF
Mumps 7968-1 MUMPS VIRUS RNA ACNC PT CSF SQ PCR/PROBE Positive
Mumps 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Mumps organism list
Mumps 5887-5 VIRUS IDENTIFIED PRID PT THRT QL VIRUS CULTURE Mumps organism list
Mumps 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Mumps organism list
Murine typhus 5878-4 RICKETTSIA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Murine typhus organism list
Murine typhus 6544-1 RICKETTSIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Murine typhus organism list
Murine typhus 6545-8 RICKETTSIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Murine typhus organism list
Murine typhus 6546-6 RICKETTSIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Murine typhus organism list
Murine typhus 5324-9 RICKETTSIA TYPHI AB.IGG TITR PT SER QN IF
Murine typhus 8007-7 RICKETTSIA TYPHI AB.IGG ACNC PT SER QN
Murine typhus 5325-6 RICKETTSIA TYPHI AB.IGM TITR PT SER QN IF Positive
Murine typhus 8008-5 RICKETTSIA TYPHI AB.IGM ACNC PT SER QN Positive
Mycobacterium, non-TB 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 620-5 MICROORGANISM IDENTIFIED PRID PT SKN QL AEROBIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 625-4 MICROORGANISM IDENTIFIED PRID PT STL QL STOOL CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 10354-9 MICROORGANISM IDENTIFIED PRID PT URT QL URINE CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 632-0 MICROORGANISM IDENTIFIED PRID PT WND QL AEROBIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 11476-9 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 640-3 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN.KINYOUN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 641-1 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN.KINYOUN MODIFIED Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 642-9 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN.ZIEHL-NEELSEN Non-tuberculosis mycobacterium organism list
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Mycobacterium, non-TB 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 11479-3 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 6655-5 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.KINYOUN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 6656-3 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.KINYOUN MODIFIED Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 6657-1 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.ZIEHL-NEELSEN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 6663-9 MICROSCOPIC OBSERVATION PRID PT TISS QL GIMENEZ STAIN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 6681-1 MICROSCOPIC OBSERVATION PRID PT TISS QL WRIGHT STAIN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 11480-1 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 650-2 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN.KINYOUN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 651-0 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN.KINYOUN MODIFIED Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 652-8 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN.ZIEHL-NEELSEN Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 5022-9 MYCOBACTERIUM AVIUM COMPLEX RRNA ACNC PT XXX SQ DNA PROBE Positive
Mycobacterium, non-TB 5023-7 MYCOBACTERIUM AVIUM RRNA ACNC PT XXX SQ DNA PROBE Positive
Mycobacterium, non-TB 5024-5 MYCOBACTERIUM GORDONAE RRNA ACNC PT XXX SQ DNA PROBE Positive
Mycobacterium, non-TB 532-2 MYCOBACTERIUM IDENTIFIED PRID PT ASP QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 533-0 MYCOBACTERIUM IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 9823-6 MYCOBACTERIUM IDENTIFIED PRID PT BRO QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 534-8 MYCOBACTERIUM IDENTIFIED PRID PT CSF QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 535-5 MYCOBACTERIUM IDENTIFIED PRID PT FLU QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 9824-4 MYCOBACTERIUM IDENTIFIED PRID PT GAST QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 9825-1 MYCOBACTERIUM IDENTIFIED PRID PT ISLT QL Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 536-3 MYCOBACTERIUM IDENTIFIED PRID PT MAR QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 537-1 MYCOBACTERIUM IDENTIFIED PRID PT PRT QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 538-9 MYCOBACTERIUM IDENTIFIED PRID PT SNV QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 539-7 MYCOBACTERIUM IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 540-5 MYCOBACTERIUM IDENTIFIED PRID PT TISS QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 541-3 MYCOBACTERIUM IDENTIFIED PRID PT UR QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 542-1 MYCOBACTERIUM IDENTIFIED PRID PT WND QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 543-9 MYCOBACTERIUM IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Non-tuberculosis mycobacterium organism list
Mycobacterium, non-TB 5025-2 MYCOBACTERIUM INTRACELLULARE RRNA ACNC PT XXX SQ DNA PROBE Positive
Mycobacterium, non-TB 5026-0 MYCOBACTERIUM KANSASII RRNA ACNC PT XXX SQ DNA PROBE Positive
Pertussis 548-8 BORDETELLA PERTUSSIS ACNC PT THRT SQ ORGANISM SPECIFIC CULTURE Positive
Pertussis 549-6 BORDETELLA PERTUSSIS ACNC PT XXX SQ ORGANISM SPECIFIC CULTURE Positive
Pertussis 5059-1 BORDETELLA PERTUSSIS AB ACNC PT SER QN EIA Not reportable
Pertussis 6315-6 BORDETELLA PERTUSSIS AB TITR PT SER QN AGGL Not reportable
Pertussis 6316-4 BORDETELLA PERTUSSIS AB TITR PT SER QN CF Not reportable
Pertussis 6314-9 BORDETELLA PERTUSSIS AB TITR PT XXX QN IF Not reportable
Pertussis 9362-5 BORDETELLA PERTUSSIS AB.IGA ACNC PT SER QN Not reportable
Pertussis 9363-3 BORDETELLA PERTUSSIS AB.IGG ACNC PT SER QN Not reportable
Pertussis 9364-1 BORDETELLA PERTUSSIS AB.IGM ACNC PT SER QN Positive
Pertussis 550-4 BORDETELLA PERTUSSIS AG ACNC PT XXX SQ IF Not reportable
Pertussis 6317-2 BORDETELLA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Pertussis organism list
Pertussis 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Pertussis organism list
Diane Dwyer, M.D., Rashid Chotani, M.D. M.P.H., Blaine Y. Takesue, M.D., Clement J. McDonald, M.D.
LOINC Names and Codes (c) 1995-1997
Maryland Dept of Health and Mental Hygiene, Regenstrief Inst for Health Care and LOINC Committee 34 of 49 2/10/98
DRAFT Appendix C
Table IV: LOINC List
1
A B C D E F G H I














































Pertussis 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Pertussis organism list
Pertussis 10353-1 MICROORGANISM IDENTIFIED PRID PT NOS QL AEROBIC CULTURE Pertussis organism list
Pertussis 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Pertussis organism list
Plague 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Plague organism list
Plague 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Plague organism list
Plague 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Plague organism list
Plague 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Plague organism list
Plague 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Plague organism list
Plague 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Plague organism list
Plague 5411-4 YERSINIA SP AB ACNC PT SER QN
Plague 701-3 YERSINIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Plague organism list
Pneumocystis 648-6 MICROSCOPIC OBSERVATION PRID PT SPT QL GRAM STAIN Pneumocytis organism list
Pneumocystis 6468-3 MICROSCOPIC OBSERVATION PRID PT SPT QL CALCOFLUOR WHITE PREPARATION Pneumocytis organism list
Pneumocystis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Pneumocytis organism list
Pneumocystis 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Pneumocytis organism list
Pneumocystis 6472-5 MICROSCOPIC OBSERVATION PRID PT TISS QL CALCOFLUOR WHITE PREPARATION Pneumocytis organism list
Pneumocystis 6667-0 MICROSCOPIC OBSERVATION PRID PT TISS QL KOH PREPARATION Pneumocytis organism list
Pneumocystis 6675-3 MICROSCOPIC OBSERVATION PRID PT TISS QL PERIODIC ACID-SCHIFF STAIN Pneumocytis organism list
Pneumocystis 6518-5 PNEUMOCYSTIS CARINII AG ACNC PT SER SQ IF Positive
Pneumocystis 6519-3 PNEUMOCYSTIS CARINII AG ACNC PT SPT SQ IF Positive
Pneumocystis 700-5 PNEUMOCYSTIS CARINII AG ACNC PT XXX SQ IF Positive
Pneumocystis 6521-9 PNEUMOCYSTIS CARINII DNA ACNC PT XXX SQ PCR/PROBE Positive
Pneumocystis 10712-8 PNEUMOCYSTIS SP IDENTIFIED PRID PT TLNG QL Pneumocytis organism list
Pneumocystis 13326-4 PNEUMOCYSTIS SP IDENTIFIED PRID PT XXX QL MICROSCOPY.LIGHT
Poliomyelitis 5281-1 POLIO TYPE I VIRUS AB ACNC PT SER QN NEUT Not reportable
Poliomyelitis 5282-9 POLIO TYPE I VIRUS AB TITR PT SER QN CF Not reportable
Poliomyelitis 7985-5 POLIO TYPE I VIRUS AB ACNC PT SER QN Not reportable
Poliomyelitis 5283-7 POLIO TYPE II VIRUS AB ACNC PT SER QN NEUT Not reportable
Poliomyelitis 5284-5 POLIO TYPE II VIRUS AB TITR PT SER QN CF Not reportable
Poliomyelitis 7986-3 POLIO TYPE II VIRUS AB ACNC PT SER QN Not reportable
Poliomyelitis 5285-2 POLIO TYPE III VIRUS AB ACNC PT SER QN NEUT Not reportable
Poliomyelitis 5286-0 POLIO TYPE III VIRUS AB TITR PT SER QN CF Not reportable
Poliomyelitis 7987-1 POLIO TYPE III VIRUS AB ACNC PT SER QN Not reportable
Poliomyelitis 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Poliomyelitis organism list
Poliomyelitis 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Poliomyelitis organism list
Poliomyelitis 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Poliomyelitis organism list
Poliomyelitis 10737-5 VIRUS IDENTIFIED PRID PT STL QL MICROSCOPY.ELECTRON Poliomyelitis organism list
Poliomyelitis 5886-7 VIRUS IDENTIFIED PRID PT STL QL VIRUS CULTURE Poliomyelitis organism list
Poliomyelitis 5887-5 VIRUS IDENTIFIED PRID PT THRT QL VIRUS CULTURE Poliomyelitis organism list
Poliomyelitis 12272-1 VIRUS IDENTIFIED PRID PT XXX QL IF Poliomyelitis organism list
Psittacosis 5079-9 CHLAMYDIA PSITTACI AB TITR PT SER QN CF
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Psittacosis 7822-0 CHLAMYDIA PSITTACI AB ACNC PT SER QN
Psittacosis 6915-3 CHLAMYDIA PSITTACI AB.IGA TITR PT SER QN IF
Psittacosis 5080-7 CHLAMYDIA PSITTACI AB.IGG ACNC PT SER QN
Psittacosis 6916-1 CHLAMYDIA PSITTACI AB.IGG TITR PT SER QN IF
Psittacosis 5081-5 CHLAMYDIA PSITTACI AB.IGM ACNC PT SER QN Positive
Psittacosis 6917-9 CHLAMYDIA PSITTACI AB.IGM TITR PT SER QN IF Positive
Psittacosis 6338-8 CHLAMYDIA PSITTACI AG ACNC PT GEN SQ EIA Positive
Psittacosis 6339-6 CHLAMYDIA PSITTACI AG ACNC PT GEN SQ IF Positive
Psittacosis 6340-4 CHLAMYDIA PSITTACI AG ACNC PT XXX SQ EIA Positive
Psittacosis 6341-2 CHLAMYDIA PSITTACI AG ACNC PT XXX SQ IF Positive
Psittacosis 556-1 CHLAMYDIA SP IDENTIFIED PRID PT CNJT QL ORGANISM SPECIFIC CULTURE Psittacosis organism list
Psittacosis 557-9 CHLAMYDIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Psittacosis organism list
Psittacosis 6348-7 CHLAMYDIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Psittacosis organism list
Psittacosis 558-7 CHLAMYDIA SP IDENTIFIED PRID PT THRT QL ORGANISM SPECIFIC CULTURE Psittacosis organism list
Psittacosis 559-5 CHLAMYDIA SP IDENTIFIED PRID PT URTH QL ORGANISM SPECIFIC CULTURE Psittacosis organism list
Psittacosis 560-3 CHLAMYDIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Psittacosis organism list
Q fever 5100-3 COXIELLA BURNETII AB TITR PT SER QN CF
Q fever 7828-7 COXIELLA BURNETII AB ACNC PT SER QN
Q fever 7829-5 COXIELLA BURNETII AB.IGG PHASE 1 ACNC PT SER QN
Q fever 7830-3 COXIELLA BURNETII AB.IGG PHASE 2 ACNC PT SER QN
Q fever 7831-1 COXIELLA BURNETII AB.IGM PHASE 1 ACNC PT SER QN Positive
Q fever 7832-9 COXIELLA BURNETII AB.IGM PHASE 2 ACNC PT SER QN Positive
Q fever 9706-3 COXIELLA BURNETII PHASE 1 AB.IGA TITR PT SER QN
Q fever 9708-9 COXIELLA BURNETII PHASE 1 AB.IGG TITR PT SER QN
Q fever 9710-5 COXIELLA BURNETII PHASE 1 AB.IGM TITR PT SER QN Positive
Q fever 9707-1 COXIELLA BURNETII PHASE 2 AB.IGA TITR PT SER QN
Q fever 9709-7 COXIELLA BURNETII PHASE 2 AB.IGG TITR PT SER QN
Q fever 9711-3 COXIELLA BURNETII PHASE 2 AB.IGM TITR PT SER QN Positive
Rabies (human) 6522-7 RABIES VIRUS AB ACNC PT CSF QN Positive
Rabies (human) 6523-5 RABIES VIRUS AB ACNC PT CSF QN NEUT
Rabies (human) 5288-6 RABIES VIRUS AB ACNC PT SER QN Positive
Rabies (human) 6524-3 RABIES VIRUS AB ACNC PT SER QN NEUT >1:5
Rabies (human) 6525-0 RABIES VIRUS AB ACNC PT TISS QN NEUT >1:5
Rabies (human) 6526-8 RABIES VIRUS AB ACNC PT XXX QN Positive
Rabies (human) 6527-6 RABIES VIRUS AB ACNC PT XXX QN NEUT >1:5
Rabies (human) 6528-4 RABIES VIRUS AG ACNC PT TISS SQ IF Positive
Rabies (human) 6529-2 RABIES VIRUS AG ACNC PT TISS QN IF Positive
Rabies (human) 6532-6 RABIES VIRUS AG ACNC PT XXX SQ IF Positive
Rabies (human) 6533-4 RABIES VIRUS AG ACNC PT XXX QN IF Positive
Rabies (human) 6536-7 RABIES VIRUS IDENTIFIED PRID PT TISS QL ORGANISM SPECIFIC CULTURE Rabies (human) organism list
Rabies (human) 6539-1 RABIES VIRUS IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Rabies (human) organism list
Rabies (human) 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Rabies (human) organism list
Rabies (human) 10738-3 VIRUS IDENTIFIED PRID PT TISS QL MICROSCOPY.ELECTRON Rabies (human) organism list
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Relapsing fever 6323-0 BORRELIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Relapsing fever organism list
Relapsing fever 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Relapsing fever organism list
Relapsing fever 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Relapsing fever organism list
Relapsing fever 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Relapsing fever organism list
Relapsing fever 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Relapsing fever organism list
Relapsing fever 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Relapsing fever organism list
Relapsing fever 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Relapsing fever organism list
Relapsing fever 6663-9 MICROSCOPIC OBSERVATION PRID PT TISS QL GIMENEZ STAIN Relapsing fever organism list
Relapsing fever 6665-4 MICROSCOPIC OBSERVATION PRID PT TISS QL HEMATOXYLIN AND EOSIN STAIN Relapsing fever organism list
Relapsing fever 6681-1 MICROSCOPIC OBSERVATION PRID PT TISS QL WRIGHT STAIN Relapsing fever organism list
Rickettsial infection 5303-3 RICKETTSIA (PROTEUS OX19) AB ACNC PT SER SQ LA Not reportable
Rickettsial infection 5304-1 RICKETTSIA (PROTEUS OX2) AB ACNC PT SER SQ LA Not reportable
Rickettsial infection 5305-8 RICKETTSIA (PROTEUS OXK) AB ACNC PT SER SQ LA Not reportable
Rickettsial infection 5306-6 RICKETTSIA AB TITR PT SER QN CF >1:16
Rickettsial infection 7994-7 RICKETTSIA AB ACNC PT SER QN
Rickettsial infection 6542-5 RICKETTSIA PROWAZEKII AB ACNC PT SER QN CF >1:16
Rickettsial infection 7995-4 RICKETTSIA PROWAZEKII AB ACNC PT SER QN
Rickettsial infection 7996-2 RICKETTSIA PROWAZEKII RNA ACNC PT SER SQ PCR/PROBE Positive
Rickettsial infection 5309-0 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB ACNC PT SER QN EIA
Rickettsial infection 5310-8 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB ACNC PT SER SQ LA
Rickettsial infection 5311-6 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB TITR PT SER QN IF >1:64
Rickettsial infection 7997-0 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB ACNC PT SER QN
Rickettsial infection 5312-4 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGG
ACNC PT SER QN EIA
Rickettsial infection 5313-2 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGG
TITR PT SER QN IF >1:64
Rickettsial infection 7998-8 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGG
ACNC PT SER QN
Rickettsial infection 5314-0 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGM
ACNC PT SER QN EIA Positive
Rickettsial infection 5315-7 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGM
TITR PT SER QN IF >1:64
Rickettsial infection 7999-6 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGM
ACNC PT SER QN Positive
Rickettsial infection 5307-4 RICKETTSIA RICKETTSII AB.IGG TITR PT SER QN IF >1:64
Rickettsial infection 8003-6 RICKETTSIA RICKETTSII AB.IGG ACNC PT SER QN
Rickettsial infection 5308-2 RICKETTSIA RICKETTSII AB.IGM TITR PT SER QN IF >1:64
Rickettsial infection 8004-4 RICKETTSIA RICKETTSII AB.IGM ACNC PT SER QN Positive
Rickettsial infection 6543-3 RICKETTSIA RICKETTSII AG PRID PT TISS QL IF >1:64
Rickettsial infection 8005-1 RICKETTSIA RICKETTSII RNA ACNC PT SER SQ PCR/PROBE Positive
Rickettsial infection 11482-7 RICKETTSIA RICKETTSII RNA ACNC PT TISS SQ PCR/PROBE Positive
Rickettsial infection 5878-4 RICKETTSIA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Rickettsia organism list
Rickettsial infection 6544-1 RICKETTSIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Rickettsia organism list
Rickettsial infection 6545-8 RICKETTSIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Rickettsia organism list
Rickettsial infection 6546-6 RICKETTSIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Rickettsia organism list
Rickettsial infection 5323-1 RICKETTSIA TSUTSUGAMUCHI AB TITR PT SER QN CF >1:16
Rickettsial infection 8006-9 RICKETTSIA TSUTSUGAMUCHI AB ACNC PT SER QN
Rickettsial infection 5324-9 RICKETTSIA TYPHI AB.IGG TITR PT SER QN IF >1:64
Rickettsial infection 8007-7 RICKETTSIA TYPHI AB.IGG ACNC PT SER QN
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Rickettsial infection 5325-6 RICKETTSIA TYPHI AB.IGM TITR PT SER QN IF >1:64
Rickettsial infection 8008-5 RICKETTSIA TYPHI AB.IGM ACNC PT SER QN Positive
Rickettsial infection 5316-5 RICKETTSIA TYPHUS GROUP AB ACNC PT SER SQ EIA
Rickettsial infection 5317-3 RICKETTSIA TYPHUS GROUP AB ACNC PT SER SQ LA
Rickettsial infection 5318-1 RICKETTSIA TYPHUS GROUP AB TITR PT SER QN IF >1:64
Rickettsial infection 8000-2 RICKETTSIA TYPHUS GROUP AB ACNC PT SER QN
Rickettsial infection 5319-9 RICKETTSIA TYPHUS GROUP AB.IGG ACNC PT SER QN EIA
Rickettsial infection 5320-7 RICKETTSIA TYPHUS GROUP AB.IGG TITR PT SER QN IF >1:64
Rickettsial infection 8001-0 RICKETTSIA TYPHUS GROUP AB.IGG ACNC PT SER QN
Rickettsial infection 5321-5 RICKETTSIA TYPHUS GROUP AB.IGM ACNC PT SER QN EIA Positive
Rickettsial infection 5322-3 RICKETTSIA TYPHUS GROUP AB.IGM TITR PT SER QN IF >1:64
Rickettsial infection 8002-8 RICKETTSIA TYPHUS GROUP AB.IGM ACNC PT SER QN Positive
Rickettsialpox 5878-4 RICKETTSIA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Rickettsialpox organism list
Rickettsialpox 6544-1 RICKETTSIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Rickettsialpox organism list
Rickettsialpox 6545-8 RICKETTSIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Rickettsialpox organism list
Rickettsialpox 6546-6 RICKETTSIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Rickettsialpox organism list
Rocky mountain spotted fever 5309-0 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB ACNC PT SER QN EIA Positive
Rocky mountain spotted fever 5310-8 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB ACNC PT SER SQ LA >1:128
Rocky mountain spotted fever 5311-6 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB TITR PT SER QN IF >1:64
Rocky mountain spotted fever 7997-0 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP AB ACNC PT SER QN Positive
Rocky mountain spotted fever 5312-4 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGG
ACNC PT SER QN EIA
Rocky mountain spotted fever 5313-2 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGG
TITR PT SER QN IF
Rocky mountain spotted fever 7998-8 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGG
ACNC PT SER QN
Rocky mountain spotted fever 5314-0 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGM
ACNC PT SER QN EIA Positive
Rocky mountain spotted fever 5315-7 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGM
TITR PT SER QN IF Positive
Rocky mountain spotted fever 7999-6 RICKETTSIA RICKETTSIAE.SPOTTED FEVER GROUP 
AB.IGM
ACNC PT SER QN Positive
Rocky mountain spotted fever 5307-4 RICKETTSIA RICKETTSII AB.IGG TITR PT SER QN IF
Rocky mountain spotted fever 8003-6 RICKETTSIA RICKETTSII AB.IGG ACNC PT SER QN
Rocky mountain spotted fever 5308-2 RICKETTSIA RICKETTSII AB.IGM TITR PT SER QN IF Positive
Rocky mountain spotted fever 8004-4 RICKETTSIA RICKETTSII AB.IGM ACNC PT SER QN Positive
Rocky mountain spotted fever 6543-3 RICKETTSIA RICKETTSII AG PRID PT TISS QL IF Positive
Rocky mountain spotted fever 8005-1 RICKETTSIA RICKETTSII RNA ACNC PT SER SQ PCR/PROBE Positive
Rocky mountain spotted fever 11482-7 RICKETTSIA RICKETTSII RNA ACNC PT TISS SQ PCR/PROBE Positive
Rocky mountain spotted fever 5878-4 RICKETTSIA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Rocky Mountain spotted fever organism list
Rocky mountain spotted fever 6544-1 RICKETTSIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Rocky Mountain spotted fever organism list
Rocky mountain spotted fever 6545-8 RICKETTSIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Rocky Mountain spotted fever organism list
Rocky mountain spotted fever 6546-6 RICKETTSIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Rocky Mountain spotted fever organism list
Rotavirus 10714-4 ROTAVIRUS PRID PT STL QL MICROSCOPY.ELECTRON Rotavirus organism list
Rotavirus 8011-9 ROTAVIRUS ACNC PT STL SQ MICROSCOPY.ELECTRON Positive
Rotavirus 5328-0 ROTAVIRUS AB ACNC PT SER QN Not reportable
Rotavirus 5329-8 ROTAVIRUS AB ACNC PT SER QN CIE Not reportable
Rotavirus 9575-2 ROTAVIRUS AB TITR PT SER QN CF Not reportable
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Rotavirus 5879-2 ROTAVIRUS AG ACNC PT STL SQ AGGL Positive
Rotavirus 5880-0 ROTAVIRUS AG ACNC PT STL SQ EIA Positive
Rotavirus 8012-7 ROTAVIRUS LITTLE(DS)RNA ACNC PT STL SQ PCR/PROBE Positive
Rotavirus 6547-4 ROTAVIRUS SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Rotavirus organism list
Rubella 9576-0 RUBELLA VIRUS AB ACNC PT CSF QN EIA Not reportable
Rubella 5330-6 RUBELLA VIRUS AB ACNC PT SER QN HAI Not reportable
Rubella 5331-4 RUBELLA VIRUS AB ACNC PT SER SQ HAI Not reportable
Rubella 5332-2 RUBELLA VIRUS AB ACNC PT SER SQ LA Not reportable
Rubella 8013-5 RUBELLA VIRUS AB ACNC PT SER QN Not reportable
Rubella 5333-0 RUBELLA VIRUS AB TITR PT SER QN LA Not reportable
Rubella 13281-1 RUBELLA VIRUS AB.IGG ACNC PT CSF QN
Rubella 5334-8 RUBELLA VIRUS AB.IGG ACNC PT SER QN EIA Not reportable
Rubella 8014-3 RUBELLA VIRUS AB.IGG ACNC PT SER QN Not reportable
Rubella 13279-5 RUBELLA VIRUS AB.IGG^ACUTE SPECIMEN ACNC PT SER/PLA
S
QN





Rubella 13282-9 RUBELLA VIRUS AB.IGM ACNC PT CSF QN
Rubella 5335-5 RUBELLA VIRUS AB.IGM ACNC PT SER QN EIA Positive
Rubella 8015-0 RUBELLA VIRUS AB.IGM ACNC PT SER QN Positive
Rubella 12251-5 RUBELLA VIRUS AG PRID PT XXX QL IF
Rubella 6548-2 RUBELLA VIRUS IDENTIFIED PRID PT SER QL ORGANISM SPECIFIC CULTURE Rubella organism list
Rubella 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Rubella organism list
Rubella 10736-7 VIRUS IDENTIFIED PRID PT CSF QL MICROSCOPY.ELECTRON Rubella organism list
Rubella 5884-2 VIRUS IDENTIFIED PRID PT CSF QL VIRUS CULTURE Rubella organism list
Rubella 5887-5 VIRUS IDENTIFIED PRID PT THRT QL VIRUS CULTURE Rubella organism list
Salmonellosis, non-typhoid 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 6459-2 MICROORGANISM IDENTIFIED PRID PT FOOD QL FOOD CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 625-4 MICROORGANISM IDENTIFIED PRID PT STL QL STOOL CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 10354-9 MICROORGANISM IDENTIFIED PRID PT URT QL URINE CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 632-0 MICROORGANISM IDENTIFIED PRID PT WND QL AEROBIC CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 6462-6 MICROORGANISM IDENTIFIED PRID PT WND QL ROUTINE BACTERIAL CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Non-typhoid salmonellosis organism list
Salmonellosis, non-typhoid 5338-9 SALMONELLA AB TITR PT SER QN LA Not reportable
Salmonellosis, non-typhoid 5339-7 SALMONELLA PARATYPHOID A H AB ACNC PT SER SQ LA Not reportable
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Salmonellosis, non-typhoid 5340-5 SALMONELLA PARATYPHOID A O AB ACNC PT SER SQ LA Not reportable
Salmonellosis, non-typhoid 5341-3 SALMONELLA PARATYPHOID B H AB ACNC PT SER SQ LA Not reportable
Salmonellosis, non-typhoid 5342-1 SALMONELLA PARATYPHOID B O AB ACNC PT SER SQ LA Not reportable
Salmonellosis, non-typhoid 5343-9 SALMONELLA PARATYPHOID C H AB ACNC PT SER SQ LA Not reportable
Salmonellosis, non-typhoid 5344-7 SALMONELLA PARATYPHOID C O AB ACNC PT SER SQ LA Not reportable
Salmonellosis, non-typhoid 11603-8 SALMONELLA SP AB ACNC PT SER QN
Salmonellosis, non-typhoid 9672-7 SALMONELLA SP AB.IGA ACNC PT SER QN Not reportable
Salmonellosis, non-typhoid 9673-5 SALMONELLA SP AB.IGG ACNC PT SER QN Not reportable
Salmonellosis, non-typhoid 9674-3 SALMONELLA SP AB.IGM ACNC PT SER QN
Scrub typhus 5878-4 RICKETTSIA SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Scrub typhus organism list
Scrub typhus 6544-1 RICKETTSIA SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Scrub typhus organism list
Scrub typhus 6545-8 RICKETTSIA SP IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Scrub typhus organism list
Scrub typhus 6546-6 RICKETTSIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Scrub typhus organism list
Scrub typhus 5323-1 RICKETTSIA TSUTSUGAMUCHI AB TITR PT SER QN CF
Scrub typhus 8006-9 RICKETTSIA TSUTSUGAMUCHI AB ACNC PT SER QN
Shigellosis 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Shigellosis organism list
Shigellosis 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Shigellosis organism list
Shigellosis 6459-2 MICROORGANISM IDENTIFIED PRID PT FOOD QL FOOD CULTURE Shigellosis organism list
Shigellosis 625-4 MICROORGANISM IDENTIFIED PRID PT STL QL STOOL CULTURE Shigellosis organism list
Shigellosis 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Shigellosis organism list
Shigellosis 10354-9 MICROORGANISM IDENTIFIED PRID PT URT QL URINE CULTURE Shigellosis organism list
Shigellosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Shigellosis organism list
Shigellosis 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Shigellosis organism list
Shigellosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Shigellosis organism list
Shigellosis 5350-4 SHIGELLA AB ACNC PT SER QN Not reportable
Shigellosis 11602-0 SHIGELLA BOYDII AB ACNC PT SER QN
Shigellosis 9712-1 SHIGELLA BOYDII AB TITR PT SER QN CF Not reportable
Shigellosis 11596-4 SHIGELLA DYSENTERIAE AB ACNC PT SER QN
Shigellosis 9713-9 SHIGELLA DYSENTERIAE AB TITR PT SER QN CF Not reportable
Shigellosis 11600-4 SHIGELLA FLEXNERI AB ACNC PT SER QN
Shigellosis 9714-7 SHIGELLA FLEXNERI AB TITR PT SER QN CF Not reportable
Shigellosis 11611-1 SHIGELLA SONNEI AB ACNC PT SER QN
Shigellosis 9715-4 SHIGELLA SONNEI AB TITR PT SER QN CF Not reportable
Streptococcus pneumoniae 13131-8 STREPTOCOCCUS PNEUMONIAE 1 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9455-7 STREPTOCOCCUS PNEUMONIAE 1 AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13139-1 STREPTOCOCCUS PNEUMONIAE 1 AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13140-9 STREPTOCOCCUS PNEUMONIAE 1 AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13163-1 STREPTOCOCCUS PNEUMONIAE 12 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13135-9 STREPTOCOCCUS PNEUMONIAE 12F AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9456-5 STREPTOCOCCUS PNEUMONIAE 12F AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13153-2 STREPTOCOCCUS PNEUMONIAE 12F AB^BS ACNC PT SER/PLA
S
QN
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Streptococcus pneumoniae 13154-0 STREPTOCOCCUS PNEUMONIAE 12F 




Streptococcus pneumoniae 8027-5 STREPTOCOCCUS PNEUMONIAE 14 AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13155-7 STREPTOCOCCUS PNEUMONIAE 14 AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13156-5 STREPTOCOCCUS PNEUMONIAE 14 




Streptococcus pneumoniae 13136-7 STREPTOCOCCUS PNEUMONIAE 18C AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13157-3 STREPTOCOCCUS PNEUMONIAE 18C AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13158-1 STREPTOCOCCUS PNEUMONIAE 18C AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13165-6 STREPTOCOCCUS PNEUMONIAE 19 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13137-5 STREPTOCOCCUS PNEUMONIAE 19F AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9457-3 STREPTOCOCCUS PNEUMONIAE 19F AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13159-9 STREPTOCOCCUS PNEUMONIAE 19F AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13160-7 STREPTOCOCCUS PNEUMONIAE 19F AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13166-4 STREPTOCOCCUS PNEUMONIAE 23 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13138-3 STREPTOCOCCUS PNEUMONIAE 23F AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9458-1 STREPTOCOCCUS PNEUMONIAE 23F AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13161-5 STREPTOCOCCUS PNEUMONIAE 23F AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13162-3 STREPTOCOCCUS PNEUMONIAE 23F AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 8033-3 STREPTOCOCCUS PNEUMONIAE 3 AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13141-7 STREPTOCOCCUS PNEUMONIAE 3 AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13142-5 STREPTOCOCCUS PNEUMONIAE 3 AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13132-6 STREPTOCOCCUS PNEUMONIAE 4 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9459-9 STREPTOCOCCUS PNEUMONIAE 4 AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13143-3 STREPTOCOCCUS PNEUMONIAE 4 AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13144-1 STREPTOCOCCUS PNEUMONIAE 4 AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13167-2 STREPTOCOCCUS PNEUMONIAE 51 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9611-5 STREPTOCOCCUS PNEUMONIAE 56 AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13168-0 STREPTOCOCCUS PNEUMONIAE 6/26 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9460-7 STREPTOCOCCUS PNEUMONIAE 6A+6B AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13133-4 STREPTOCOCCUS PNEUMONIAE 6B AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13145-8 STREPTOCOCCUS PNEUMONIAE 6B AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13146-6 STREPTOCOCCUS PNEUMONIAE 6B AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 8028-3 STREPTOCOCCUS PNEUMONIAE 7F AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13147-4 STREPTOCOCCUS PNEUMONIAE 7F AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13148-2 STREPTOCOCCUS PNEUMONIAE 7F AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13134-2 STREPTOCOCCUS PNEUMONIAE 8 AB ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 9461-5 STREPTOCOCCUS PNEUMONIAE 8 AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13149-0 STREPTOCOCCUS PNEUMONIAE 8 AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13150-8 STREPTOCOCCUS PNEUMONIAE 8 AB^POST ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 8029-1 STREPTOCOCCUS PNEUMONIAE 9N AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 13151-6 STREPTOCOCCUS PNEUMONIAE 9N AB^BS ACNC PT SER/PLA
S
QN
Streptococcus pneumoniae 13152-4 STREPTOCOCCUS PNEUMONIAE 9N AB^POST ACNC PT SER/PLA
S
QN BLOOD CULTURE
Streptococcus pneumoniae 10717-7 STREPTOCOCCUS PNEUMONIAE AB ACNC PT SER QN LA Not reportable
Streptococcus pneumoniae 6552-4 STREPTOCOCCUS PNEUMONIAE AB ACNC PT SER SQ EIA Not reportable
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Streptococcus pneumoniae 8030-9 STREPTOCOCCUS PNEUMONIAE AB ACNC PT SER SQ Not reportable
Streptococcus pneumoniae 5368-6 STREPTOCOCCUS PNEUMONIAE AB.IGG ACNC PT SER QN EIA Not reportable
Streptococcus pneumoniae 8031-7 STREPTOCOCCUS PNEUMONIAE AB.IGG ACNC PT SER QN Not reportable
Streptococcus pneumoniae 8032-5 STREPTOCOCCUS PNEUMONIAE AB.IGM ACNC PT SER QN
Streptococcus pneumoniae 6553-2 STREPTOCOCCUS PNEUMONIAE AG ACNC PT CSF SQ IF Positive
Streptococcus pneumoniae 11086-6 STREPTOCOCCUS PNEUMONIAE AG ACNC PT SER SQ no method Positive
Streptococcus pneumoniae 6554-0 STREPTOCOCCUS PNEUMONIAE AG ACNC PT SPT SQ IF
Streptococcus pneumoniae 6555-7 STREPTOCOCCUS PNEUMONIAE AG ACNC PT XXX SQ IF Positive
Streptococcus pneumoniae 5035-1 STREPTOCOCCUS PNEUMONIAE RRNA ACNC PT XXX SQ DNA PROBE
Streptococcus, Group A 5133-4 DNASE B AB.STREPTOCOCCAL ACNC PT SER QN Not reportable
Streptococcus, Group A 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Group A streptococcus organism list
Streptococcus, Group A 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Group A streptococcus organism list
Streptococcus, Group A 10352-3 MICROORGANISM IDENTIFIED PRID PT GEN QL AEROBIC CULTURE Not reportable
Streptococcus, Group A 621-3 MICROORGANISM IDENTIFIED PRID PT SNV QL STERILE BODY FLUID CULTURE Group A streptococcus organism list
Streptococcus, Group A 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Not reportable
Streptococcus, Group A 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Not reportable
Streptococcus, Group A 635-3 MICROORGANISM IDENTIFIED PRID PT XXX QL ANAEROBIC CULTURE Not reportable
Streptococcus, Group A 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Not reportable
Streptococcus, Group A 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Not reportable
Streptococcus, Group A 10355-6 MICROSCOPIC OBSERVATION PRID PT MAR QL WRIGHT GIEMSA STAIN Group A streptococcus organism list
Streptococcus, Group A 6819-7 STREPTOCOCCUS AB ACNC PT SER SQ Not reportable
Streptococcus, Group A 6820-5 STREPTOCOCCUS AB TITR PT SER QN Not reportable
Streptococcus, Group A 6556-5 STREPTOCOCCUS PYOGENES AG ACNC PT THRT SQ EIA Not reportable
Streptococcus, Group A 6557-3 STREPTOCOCCUS PYOGENES AG ACNC PT THRT SQ IF Not reportable
Streptococcus, Group A 6558-1 STREPTOCOCCUS PYOGENES AG ACNC PT XXX SQ EIA Not reportable
Streptococcus, Group A 6559-9 STREPTOCOCCUS PYOGENES AG ACNC PT XXX SQ IF Not reportable
Streptococcus, Group A 5172-2 STREPTOCOCCUS PYOGENES ENZYME AB ACNC PT SER SQ LA Not reportable
Streptococcus, Group A 5173-0 STREPTOCOCCUS PYOGENES ENZYME AB TITR PT SER QN LA Not reportable
Streptococcus, Group A 5036-9 STREPTOCOCCUS PYOGENES RRNA ACNC PT XXX SQ DNA PROBE Not reportable
Streptococcus, Group A 546-2 STREPTOCOCCUS.BETA-HEMOLYTIC ACNC PT THRT QL ORGANISM SPECIFIC CULTURE Not reportable
Streptococcus, Group A 547-0 STREPTOCOCCUS.BETA-HEMOLYTIC ACNC PT XXX QL ORGANISM SPECIFIC CULTURE Not reportable
Streptococcus, Group B 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Group B streptococcus organism list
Streptococcus, Group B 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Group B streptococcus organism list
Streptococcus, Group B 10352-3 MICROORGANISM IDENTIFIED PRID PT GEN QL AEROBIC CULTURE Not reportable
Streptococcus, Group B 621-3 MICROORGANISM IDENTIFIED PRID PT SNV QL STERILE BODY FLUID CULTURE Group B streptococcus organism list
Streptococcus, Group B 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Not reportable
Streptococcus, Group B 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Group B streptococcus organism list
Streptococcus, Group B 628-8 MICROORGANISM IDENTIFIED PRID PT TISS QL ANAEROBIC CULTURE Group B streptococcus organism list
Streptococcus, Group B 632-0 MICROORGANISM IDENTIFIED PRID PT WND QL AEROBIC CULTURE Not reportable
Streptococcus, Group B 633-8 MICROORGANISM IDENTIFIED PRID PT WND QL ANAEROBIC CULTURE Not reportable
Streptococcus, Group B 6462-6 MICROORGANISM IDENTIFIED PRID PT WND QL ROUTINE BACTERIAL CULTURE Not reportable
Streptococcus, Group B 9786-5 MICROSCOPIC OBSERVATION PRID PT BLD/MAR QL PERIODIC ACID-SCHIFF STAIN Group B streptococcus organism list
Streptococcus, Group B 6551-6 STREPTOCOCCUS AGALACTIAE AG ACNC PT THRT SQ IF Not reportable
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Streptococcus, Group B 581-9 STREPTOCOCCUS AGALACTIAE IDENTIFIED PRID PT CVX QL ORGANISM SPECIFIC CULTURE Not reportable
Streptococcus, Group B 582-7 STREPTOCOCCUS AGALACTIAE IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Not reportable
Streptococcus, Group B 583-5 STREPTOCOCCUS AGALACTIAE IDENTIFIED PRID PT GENL QL ORGANISM SPECIFIC CULTURE Not reportable
Streptococcus, Group B 584-3 STREPTOCOCCUS AGALACTIAE IDENTIFIED PRID PT GENV QL ORGANISM SPECIFIC CULTURE Not reportable
Streptococcus, Group B 585-0 STREPTOCOCCUS AGALACTIAE IDENTIFIED PRID PT THRT QL ORGANISM SPECIFIC CULTURE Not reportable
Streptococcus, Group B 586-8 STREPTOCOCCUS AGALACTIAE IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Group B streptococcus organism list
Streptococcus, Group B 5034-4 STREPTOCOCCUS AGALACTIAE RRNA ACNC PT XXX SQ DNA PROBE Positive
Strongyloides 10671-6 HELMINTH IDENTIFIED PRID PT XXX QL Strongyloides organism list
Strongyloides 10672-4 HELMINTH/ARTHROPOD IDENTIFIED PRID PT XXX QL Strongyloides organism list
Strongyloides 5373-6 STRONGYLOIDES SP AB ACNC PT SER QN HAI Not reportable
Strongyloides 8034-1 STRONGYLOIDES SP AB ACNC PT SER QN Not reportable
Strongyloides 10718-5 STRONGYLOIDES SP AB ACNC PT SER/PLAS QN EIA Not reportable
Strongyloides 6632-4 STRONGYLOIDES STERCORALIS AB.IGG ACNC PT SER SQ EIA Not reportable
Strongyloides 8035-8 STRONGYLOIDES STERCORALIS AB.IGG ACNC PT SER SQ Not reportable
Syphilis 6471-7 MICROSCOPIC OBSERVATION PRID PT TISS QL Syphilis organism list
Syphilis 6607-6 MICROSCOPIC OBSERVATION PRID PT TISS QL DARK FIELD EXAMINATION Syphilis organism list
Syphilis 6664-7 MICROSCOPIC OBSERVATION PRID PT TISS QL GRAM STAIN Syphilis organism list
Syphilis 6665-4 MICROSCOPIC OBSERVATION PRID PT TISS QL HEMATOXYLIN AND EOSIN STAIN Syphilis organism list
Syphilis 5289-4 REAGIN AB ACNC PT CSF QN FLOC Positive
Syphilis 5290-2 REAGIN AB ACNC PT CSF SQ FLOC Positive
Syphilis 11084-1 REAGIN AB TITR PT SER QN Positive
Syphilis 5291-0 REAGIN AB ACNC PT SER/PLAS QN FLOC Positive
Syphilis 5292-8 REAGIN AB ACNC PT SER/PLAS SQ FLOC Positive
Syphilis 13288-6 TREPONEMA PALLIDUM AB ACNC PT BLD QN IF
Syphilis 9826-9 TREPONEMA PALLIDUM AB ACNC PT CSF SQ IF Positive
Syphilis 5392-6 TREPONEMA PALLIDUM AB ACNC PT SER QN IMMOBILIZATION Positive
Syphilis 5393-4 TREPONEMA PALLIDUM AB ACNC PT SER SQ IF Positive
Syphilis 8041-6 TREPONEMA PALLIDUM AB ACNC PT SER SQ HAI Positive
Syphilis 11597-2 TREPONEMA PALLIDUM AB ACNC PT SER QN
Syphilis 5394-2 TREPONEMA PALLIDUM AB TITR PT SER QN LA Positive
Syphilis 6561-5 TREPONEMA PALLIDUM AB.IGG ACNC PT SER SQ Positive
Syphilis 6562-3 TREPONEMA PALLIDUM AB.IGM ACNC PT SER SQ Positive
Tetanus 5092-2 CLOSTRIDIUM TETANI AB ACNC PT SER QN Not reportable
Tetanus 5093-0 CLOSTRIDIUM TETANI AB ACNC PT SER SQ Not reportable
Tetanus 6367-7 CLOSTRIDIUM TETANI AB.IGG ACNC PT SER QN EIA Not reportable
Tetanus 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Tetanus organism list
Tetanus 628-8 MICROORGANISM IDENTIFIED PRID PT TISS QL ANAEROBIC CULTURE Tetanus organism list
Toxoplasmosis 5387-6 TOXOPLASMA GONDII AB ACNC PT SER SQ DYE TEST
Toxoplasmosis 11598-0 TOXOPLASMA GONDII AB ACNC PT SER QN
Toxoplasmosis 10723-5 TOXOPLASMA GONDII AB.IGA ACNC PT SER/PLAS QN EIA
Toxoplasmosis 10724-3 TOXOPLASMA GONDII AB.IGE ACNC PT SER/PLAS QN EIA
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Toxoplasmosis 5388-4 TOXOPLASMA GONDII AB.IGG ACNC PT SER QN EIA
Toxoplasmosis 8039-0 TOXOPLASMA GONDII AB.IGG ACNC PT SER QN
Toxoplasmosis 5389-2 TOXOPLASMA GONDII AB.IGG TITR PT SER QN IF
Toxoplasmosis 12261-4 TOXOPLASMA GONDII AB.IGG TITR PT SER QN MEIA





Toxoplasmosis 5390-0 TOXOPLASMA GONDII AB.IGM ACNC PT SER QN EIA
Toxoplasmosis 8040-8 TOXOPLASMA GONDII AB.IGM ACNC PT SER QN
Toxoplasmosis 5391-8 TOXOPLASMA GONDII AB.IGM TITR PT SER QN IF
Toxoplasmosis 12262-2 TOXOPLASMA GONDII AB.IGM TITR PT SER QN MEIA
Toxoplasmosis 10725-0 TOXOPLASMA GONDII DNA ACNC PT FLU QN AMP/PROBE
Toxoplasmosis 9741-0 TOXOPLASMA SP AB.IGG ACNC PT CSF QN
Toxoplasmosis 13287-8 TOXOPLASMA SP AB.TOTAL ACNC PT CSF QN
Toxoplasmosis 12263-0 TOXOPLASMA SP IDENTIFIED PRID PT CSF QL IF
Toxoplasmosis 10726-8 TOXOPLASMA SP IDENTIFIED PRID PT TISS QL GIEMSA STAIN
Toxoplasmosis 10727-6 TOXOPLASMA SP IDENTIFIED PRID PT TISS QL
Trachoma 556-1 CHLAMYDIA SP IDENTIFIED PRID PT CNJT QL ORGANISM SPECIFIC CULTURE Trachoma organism list
Trachoma 6350-3 CHLAMYDIA TRACHOMATIS AG ACNC PT CNJT SQ EIA Positive
Trachoma 6351-1 CHLAMYDIA TRACHOMATIS AG ACNC PT CNJT SQ IF Positive
Trachoma 13217-5 CHLAMYDIA TRACHOMATIS TYPE B AB ACNC PT SER/PLA
S
QN
Trachoma 13223-3 CHLAMYDIA TRACHOMATIS TYPE B AB.TOTAL ACNC PT SER/PLA
S
QN
Trachoma 13218-3 CHLAMYDIA TRACHOMATIS TYPE C AB ACNC PT SER/PLA
S
QN
Trachoma 13220-9 CHLAMYDIA TRACHOMATIS TYPE C AB.IGM ACNC PT SER/PLA
S
QN
Trachoma 13222-5 CHLAMYDIA TRACHOMATIS TYPE C AB.TOTAL ACNC PT SER/PLA
S
QN
Trachoma 13219-1 CHLAMYDIA TRACHOMATIS TYPE G+F+K AB ACNC PT SER/PLA
S
QN
Trachoma 13221-7 CHLAMYDIA TRACHOMATIS TYPE G+F+K AB.IGM ACNC PT SER/PLA
S
QN
Trachoma 13224-1 CHLAMYDIA TRACHOMATIS TYPE G+F+K AB.TOTAL ACNC PT SER/PLA
S
QN
Trichinosis 10671-6 HELMINTH IDENTIFIED PRID PT XXX QL Trichinosis organism list
Trichinosis 10672-4 HELMINTH/ARTHROPOD IDENTIFIED PRID PT XXX QL Trichinosis organism list
Trichinosis 5395-9 TRICHINELLA SPIRALIS AB TITR PT SER QN LA
Trichinosis 8042-4 TRICHINELLA SPIRALIS AB ACNC PT SER QN
Trichinosis 6563-1 TRICHINELLA SPIRALIS AB.IGG ACNC PT SER SQ EIA
Trichinosis 8043-2 TRICHINELLA SPIRALIS AB.IGG ACNC PT SER SQ
Trichomonas 10728-4 TRICHOMONAS SP IDENTIFIED PRID PT GEN QL ORGANISM SPECIFIC CULTURE Trichomonas organism list
Trichomonas 6564-9 TRICHOMONAS VAGINALIS ACNC PT GEN SQ CF
Trichomonas 6565-6 TRICHOMONAS VAGINALIS PRID PT GEN QL WET PREPARATION Trichomonas organism list
Trichomonas 6566-4 TRICHOMONAS VAGINALIS AG ACNC PT GEN SQ EIA Not reportable
Trichomonas 6567-2 TRICHOMONAS VAGINALIS AG ACNC PT GEN SQ IF Not reportable
Trichomonas 6568-0 TRICHOMONAS VAGINALIS RRNA ACNC PT GEN SQ DNA PROBE Not reportable
Tuberculosis 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Tuberculosis organism list
Tuberculosis 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Tuberculosis organism list
Tuberculosis 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Tuberculosis organism list
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Tuberculosis 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Tuberculosis organism list
Tuberculosis 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Tuberculosis organism list
Tuberculosis 6460-0 MICROORGANISM IDENTIFIED PRID PT SPT QL ROUTINE BACTERIAL CULTURE Tuberculosis organism list
Tuberculosis 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Tuberculosis organism list
Tuberculosis 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Tuberculosis organism list
Tuberculosis 10354-9 MICROORGANISM IDENTIFIED PRID PT URT QL URINE CULTURE Tuberculosis organism list
Tuberculosis 632-0 MICROORGANISM IDENTIFIED PRID PT WND QL AEROBIC CULTURE Tuberculosis organism list
Tuberculosis 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Tuberculosis organism list
Tuberculosis 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Tuberculosis organism list
Tuberculosis 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Tuberculosis organism list
Tuberculosis 9786-5 MICROSCOPIC OBSERVATION PRID PT BLD/MAR QL PERIODIC ACID-SCHIFF STAIN Tuberculosis organism list
Tuberculosis 6465-9 MICROSCOPIC OBSERVATION PRID PT DUFL QL TRICHROME STAIN Tuberculosis organism list
Tuberculosis 11476-9 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN Tuberculosis organism list
Tuberculosis 640-3 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN.KINYOUN Tuberculosis organism list
Tuberculosis 641-1 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN.KINYOUN MODIFIED Tuberculosis organism list
Tuberculosis 642-9 MICROSCOPIC OBSERVATION PRID PT GAST QL ACID FAST STAIN.ZIEHL-NEELSEN Tuberculosis organism list
Tuberculosis 645-2 MICROSCOPIC OBSERVATION PRID PT SPT QL ACID FAST STAIN.KINYOUN Tuberculosis organism list
Tuberculosis 646-0 MICROSCOPIC OBSERVATION PRID PT SPT QL ACID FAST STAIN.KINYOUN MODIFIED Tuberculosis organism list
Tuberculosis 647-8 MICROSCOPIC OBSERVATION PRID PT SPT QL ACID FAST STAIN.ZIEHL-NEELSEN Tuberculosis organism list
Tuberculosis 11477-7 MICROSCOPIC OBSERVATION PRID PT SPT QL ACID FAST STAIN Tuberculosis organism list
Tuberculosis 11479-3 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN Tuberculosis organism list
Tuberculosis 6655-5 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.KINYOUN Tuberculosis organism list
Tuberculosis 6656-3 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.KINYOUN MODIFIED Tuberculosis organism list
Tuberculosis 6657-1 MICROSCOPIC OBSERVATION PRID PT TISS QL ACID FAST STAIN.ZIEHL-NEELSEN Tuberculosis organism list
Tuberculosis 6662-1 MICROSCOPIC OBSERVATION PRID PT TISS QL GIEMSA STAIN Tuberculosis organism list
Tuberculosis 6663-9 MICROSCOPIC OBSERVATION PRID PT TISS QL GIMENEZ STAIN Tuberculosis organism list
Tuberculosis 6664-7 MICROSCOPIC OBSERVATION PRID PT TISS QL GRAM STAIN Tuberculosis organism list
Tuberculosis 6665-4 MICROSCOPIC OBSERVATION PRID PT TISS QL HEMATOXYLIN AND EOSIN STAIN Tuberculosis organism list
Tuberculosis 6681-1 MICROSCOPIC OBSERVATION PRID PT TISS QL WRIGHT STAIN Tuberculosis organism list
Tuberculosis 11480-1 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN Tuberculosis organism list
Tuberculosis 650-2 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN.KINYOUN Tuberculosis organism list
Tuberculosis 651-0 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN.KINYOUN MODIFIED Tuberculosis organism list
Tuberculosis 652-8 MICROSCOPIC OBSERVATION PRID PT UR QL ACID FAST STAIN.ZIEHL-NEELSEN Tuberculosis organism list
Tuberculosis 654-4 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN.KINYOUN Tuberculosis organism list
Tuberculosis 655-1 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN.KINYOUN MODIFIED Tuberculosis organism list
Tuberculosis 656-9 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN.ZIEHL-NEELSEN Tuberculosis organism list
Tuberculosis 11545-1 MICROSCOPIC OBSERVATION PRID PT XXX QL ACID FAST STAIN Tuberculosis organism list
Tuberculosis 532-2 MYCOBACTERIUM IDENTIFIED PRID PT ASP QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 533-0 MYCOBACTERIUM IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 9823-6 MYCOBACTERIUM IDENTIFIED PRID PT BRO QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 534-8 MYCOBACTERIUM IDENTIFIED PRID PT CSF QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 535-5 MYCOBACTERIUM IDENTIFIED PRID PT FLU QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 9824-4 MYCOBACTERIUM IDENTIFIED PRID PT GAST QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 9825-1 MYCOBACTERIUM IDENTIFIED PRID PT ISLT QL Tuberculosis organism list
Tuberculosis 536-3 MYCOBACTERIUM IDENTIFIED PRID PT MAR QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
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Tuberculosis 537-1 MYCOBACTERIUM IDENTIFIED PRID PT PRT QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 538-9 MYCOBACTERIUM IDENTIFIED PRID PT SNV QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 539-7 MYCOBACTERIUM IDENTIFIED PRID PT SPT QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 540-5 MYCOBACTERIUM IDENTIFIED PRID PT TISS QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 541-3 MYCOBACTERIUM IDENTIFIED PRID PT UR QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 542-1 MYCOBACTERIUM IDENTIFIED PRID PT WND QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 543-9 MYCOBACTERIUM IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Tuberculosis organism list
Tuberculosis 5027-8 MYCOBACTERIUM TUBERCULOSIS RRNA ACNC PT XXX SQ DNA PROBE Positive
Tularemia 5166-4 FRANCISELLA TULARENSIS AB ACNC PT SER SQ LA
Tularemia 5167-2 FRANCISELLA TULARENSIS AB TITR PT SER QN LA
Tularemia 7888-1 FRANCISELLA TULARENSIS AB ACNC PT SER SQ
Tularemia 7889-9 FRANCISELLA TULARENSIS AB.IGG ACNC PT SER SQ
Tularemia 6407-1 FRANCISELLA TULARENSIS AB.IGM ACNC PT SER SQ LA
Tularemia 7890-7 FRANCISELLA TULARENSIS AB.IGM ACNC PT SER SQ Positive
Tularemia 6408-9 FRANCISELLA TULARENSIS AG ACNC PT XXX SQ IF Positive
Tularemia 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Tularemia organism list
Tularemia 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Tularemia organism list
Tularemia 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Tularemia organism list
Tularemia 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Tularemia organism list
Tularemia 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Tularemia organism list
Tularemia 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Tularemia organism list
Tularemia 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Tularemia organism list
Tularemia 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Tularemia organism list
Typhoid fever 597-5 MICROORGANISM IDENTIFIED PRID PT ASP QL AEROBIC CULTURE Typhoid fever organism list
Typhoid fever 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Typhoid fever organism list
Typhoid fever 604-9 MICROORGANISM IDENTIFIED PRID PT BRO QL AEROBIC CULTURE Typhoid fever organism list
Typhoid fever 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Typhoid fever organism list
Typhoid fever 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Typhoid fever organism list
Typhoid fever 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Typhoid fever organism list
Typhoid fever 6459-2 MICROORGANISM IDENTIFIED PRID PT FOOD QL FOOD CULTURE Typhoid fever organism list
Typhoid fever 621-3 MICROORGANISM IDENTIFIED PRID PT SNV QL STERILE BODY FLUID CULTURE Typhoid fever organism list
Typhoid fever 622-1 MICROORGANISM IDENTIFIED PRID PT SPT QL AEROBIC CULTURE Typhoid fever organism list
Typhoid fever 623-9 MICROORGANISM IDENTIFIED PRID PT SPT QL CYSTIC FIBROSIS RESPIRATORY CULTURE Typhoid fever organism list
Typhoid fever 624-7 MICROORGANISM IDENTIFIED PRID PT SPT QL RESPIRATORY CULTURE Typhoid fever organism list
Typhoid fever 6460-0 MICROORGANISM IDENTIFIED PRID PT SPT QL ROUTINE BACTERIAL CULTURE Typhoid fever organism list
Typhoid fever 625-4 MICROORGANISM IDENTIFIED PRID PT STL QL STOOL CULTURE Typhoid fever organism list
Typhoid fever 626-2 MICROORGANISM IDENTIFIED PRID PT THRT QL THROAT CULTURE Typhoid fever organism list
Typhoid fever 627-0 MICROORGANISM IDENTIFIED PRID PT TISS QL AEROBIC CULTURE Typhoid fever organism list
Typhoid fever 630-4 MICROORGANISM IDENTIFIED PRID PT UR QL URINE CULTURE Typhoid fever organism list
Typhoid fever 10354-9 MICROORGANISM IDENTIFIED PRID PT URT QL URINE CULTURE Typhoid fever organism list
Typhoid fever 632-0 MICROORGANISM IDENTIFIED PRID PT WND QL AEROBIC CULTURE Typhoid fever organism list
Typhoid fever 6462-6 MICROORGANISM IDENTIFIED PRID PT WND QL ROUTINE BACTERIAL CULTURE Typhoid fever organism list
Typhoid fever 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Typhoid fever organism list
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Typhoid fever 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Typhoid fever organism list
Typhoid fever 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Typhoid fever organism list
Typhoid fever 5345-4 SALMONELLA TYPHI H AB ACNC PT SER SQ LA Not reportable
Typhoid fever 13284-5 SALMONELLA TYPHI H AB GROUP D ACNC PT SER/PLA
S
SQ
Typhoid fever 5346-2 SALMONELLA TYPHI O AB ACNC PT SER SQ LA Not reportable
Typhoid fever 13285-2 SALMONELLA TYPHI O AB GROUP D ACNC PT SER/PLA
S
SQ
Vibrio cholerae, non-O1 6578-9 VIBRIO SP IDENTIFIED PRID PT BLD QL ORGANISM SPECIFIC CULTURE Non-O1 vibrio cholerae organism list
Vibrio cholerae, non-O1 6579-7 VIBRIO SP IDENTIFIED PRID PT STL QL ORGANISM SPECIFIC CULTURE Non-O1 vibrio cholerae organism list
Vibrio cholerae, non-O1 6580-5 VIBRIO SP IDENTIFIED PRID PT WAT QL ORGANISM SPECIFIC CULTURE Non-O1 vibrio cholerae organism list
Vibrio cholerae, non-O1 6581-3 VIBRIO SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Non-O1 vibrio cholerae organism list
Yellow fever 5883-4 VIRUS IDENTIFIED PRID PT BLD QL VIRUS CULTURE Yellow fever organism list
Yellow fever 6587-0 YELLOW FEVER VIRUS AB TITR PT SER QN CF
Yellow fever 6588-8 YELLOW FEVER VIRUS AB ACNC PT SER QN HAI
Yellow fever 6589-6 YELLOW FEVER VIRUS AB TITR PT SER QN IF
Yellow fever 6590-4 YELLOW FEVER VIRUS AB TITR PT SER QN LA
Yellow fever 6591-2 YELLOW FEVER VIRUS AB ACNC PT SER QN NEUT
Yellow fever 8054-9 YELLOW FEVER VIRUS AB ACNC PT SER QN
Yellow fever 6592-0 YELLOW FEVER VIRUS AB.IGG ACNC PT SER QN EIA
Yellow fever 8055-6 YELLOW FEVER VIRUS AB.IGG ACNC PT SER QN
Yellow fever 6593-8 YELLOW FEVER VIRUS AB.IGM ACNC PT SER QN EIA Positive
Yellow fever 8056-4 YELLOW FEVER VIRUS AB.IGM ACNC PT SER QN Positive
Yellow fever 8057-2 YELLOW FEVER VIRUS RNA ACNC PT SER SQ PCR/PROBE Positive
Yersiniosis, non-plague 600-7 MICROORGANISM IDENTIFIED PRID PT BLD QL BLOOD CULTURE Non-plague yersiniosis organism list
Yersiniosis, non-plague 605-6 MICROORGANISM IDENTIFIED PRID PT CNL QL AEROBIC CULTURE Non-plague yersiniosis organism list
Yersiniosis, non-plague 610-6 MICROORGANISM IDENTIFIED PRID PT FLU QL AEROBIC CULTURE Non-plague yersiniosis organism list
Yersiniosis, non-plague 611-4 MICROORGANISM IDENTIFIED PRID PT FLU QL STERILE BODY FLUID CULTURE Non-plague yersiniosis organism list
Yersiniosis, non-plague 634-6 MICROORGANISM IDENTIFIED PRID PT XXX QL AEROBIC CULTURE Non-plague yersiniosis organism list
Yersiniosis, non-plague 636-1 MICROORGANISM IDENTIFIED PRID PT XXX QL STERILE BODY FLUID CULTURE Non-plague yersiniosis organism list
Yersiniosis, non-plague 6463-4 MICROORGANISM IDENTIFIED PRID PT XXX QL ROUTINE BACTERIAL CULTURE Non-plague yersiniosis organism list
Yersiniosis, non-plague 5407-2 YERSINIA ENTEROCOLITICA 03 AB ACNC PT SER QN Not reportable
Yersiniosis, non-plague 6959-1 YERSINIA ENTEROCOLITICA 03 AB TITR PT SER QN Not reportable
Yersiniosis, non-plague 6960-9 YERSINIA ENTEROCOLITICA 05 AB TITR PT SER QN Not reportable
Yersiniosis, non-plague 5408-0 YERSINIA ENTEROCOLITICA 08 AB ACNC PT SER QN Not reportable
Yersiniosis, non-plague 6961-7 YERSINIA ENTEROCOLITICA 08 AB TITR PT SER QN Not reportable
Yersiniosis, non-plague 5409-8 YERSINIA ENTEROCOLITICA 09 AB ACNC PT SER QN Not reportable
Yersiniosis, non-plague 6962-5 YERSINIA ENTEROCOLITICA 09 AB TITR PT SER QN Not reportable
Yersiniosis, non-plague 6963-3 YERSINIA ENTEROCOLITICA AB TITR PT SER QN Not reportable
Yersiniosis, non-plague 6964-1 YERSINIA ENTEROCOLITICA AB.IGA ACNC PT SER QN EIA Not reportable
Yersiniosis, non-plague 6965-8 YERSINIA ENTEROCOLITICA AB.IGG ACNC PT SER QN EIA Not reportable
Yersiniosis, non-plague 6966-6 YERSINIA ENTEROCOLITICA AB.IGM ACNC PT SER QN EIA Positive
Yersiniosis, non-plague 5410-6 YERSINIA PSEUDOTUBERCULOSIS AB ACNC PT SER QN Not reportable
Yersiniosis, non-plague 6967-4 YERSINIA PSEUDOTUBERCULOSIS AB TITR PT SER QN Not reportable
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Yersiniosis, non-plague 5411-4 YERSINIA SP AB ACNC PT SER QN Not reportable
Yersiniosis, non-plague 701-3 YERSINIA SP IDENTIFIED PRID PT XXX QL ORGANISM SPECIFIC CULTURE Non-plague yersiniosis organism list
Acute Pesticide Poisoning 9681-8 1-NAPTHOL MCNC PT SER QN
Acute Pesticide Poisoning 5638-2 DIAZINON MCNC PT BLD QN
Acute Pesticide Poisoning 5680-4 MALATHION MCNC PT SER QN
Acute Pesticide Poisoning 9694-1 PROPOXUR MCNC PT SER QN
Lead Exposure 5933-7 LEAD MCNC PT DIAF QN
Lead Exposure 5675-4 LEAD ACNC PT UR SQ
Lead Exposure 5671-3 LEAD MCNC PT BLD QN
Lead Exposure 5672-1 LEAD MCNC PT BLD SQ
Lead Exposure LEAD MCNC PT BLD SQN Fingerstick
Lead Exposure 5674-7 LEAD MCNC PT RBC QN
Lead Exposure 5676-2 LEAD MCNC PT UR QN
Lead Exposure 9436-7 LEAD MCNC PT FLU QN
Lead Exposure 9477-1 LEAD MCNC PT WAT QN Not reportable
Lead Exposure 5673-9 LEAD MFR PT HAR QN
Lead Exposure 8202-4 LEAD MFR PT NAIL QN
Lead Exposure 5677-0 LEAD MRAT 24H UR QN
Carboxyhemoglobin levels 2030-5 CARBON MONOXIDE.HEMOGLOBIN NFR PT BLDA QN
Carboxyhemoglobin levels 2031-3 CARBON MONOXIDE.HEMOGLOBIN NFR PT BLDC QN
Carboxyhemoglobin levels 2032-1 CARBON MONOXIDE.HEMOGLOBIN NFR PT BLDV QN
Carboxyhemoglobin levels 2029-7 CARBON MONOXIDE.HEMOGLOBIN SFR PT RBC SQ
Sickle cell disease 4561-7 HEMOGLOBIN C SFR PT BLD QN ELECTROPHORESIS PH 6.3
Sickle cell disease 4562-5 HEMOGLOBIN C SFR PT BLD QN ELECTROPHORESIS PH 8.9
Sickle cell disease 4563-3 HEMOGLOBIN C SFR PT BLD QN
Sickle cell disease 4621-9 HEMOGLOBIN S ACNC PT BLD SQ
Sickle cell disease 4622-7 HEMOGLOBIN S ACNC PT BLD SQ ELECTROPHORESIS PH 6.3
Sickle cell disease 4623-5 HEMOGLOBIN S ACNC PT BLD SQ ELECTROPHORESIS PH 8.9
Sickle cell disease 4624-3 HEMOGLOBIN S MCNC PT BLD SQ
Sickle cell disease 4620-1 HEMOGLOBIN S SFR PT BLD QN
Sickle cell disease 4625-0 HEMOGLOBIN S SFR PT BLD QN
Sickle cell disease 801-1 SICKLE CELLS ACNC PT BLD SQ MICROSCOPY.LIGHT
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Primary Lymphoid Hyperplasia 
and/or Lymphoid Interstitial 
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A B C D E F G
Condition Name Organism Set Element SNOMED SNOMED Name IUPAC IUPAC Name
Amebiasis Amebiasis organism list Entamoeba histolytica L-51511 MSH95D004748
Amebiasis Amebiasis organism list Entamoeba histolytica trophozoites
Anthrax Anthrax organism list Bacillus anthracis L-12202 ATCC14578
Arbovirus Arbovirus organism list California encephalitis virus L-33841
Arbovirus Arbovirus organism list Eastern equine encephalitis virus L-32207
Arbovirus Arbovirus organism list Inkoo virus L-33842
Arbovirus Arbovirus organism list Jamestown Canyon encephalitis virus L-33843
Arbovirus Arbovirus organism list Japanese encephalitis virus L-32329
Arbovirus Arbovirus organism list LaCrosse encephalitis virus L-33846
Arbovirus Arbovirus organism list Saint Louis encephalitis virus L-32352
Arbovirus Arbovirus organism list Snowshoe hare encephalitis virus
Arbovirus Arbovirus organism list Tahyna virus L-33851
Arbovirus Arbovirus organism list Western equine encephalitis virus L-32224
Babesiosis Babesiosis organism list Babesia microti L-52B02 MI0151
Bartonellosis Bartonellosis organism list Bartonella bacilliformis L-2A401 ATCC35685
Bartonellosis Bartonellosis organism list Bartonella henselae
Bartonellosis Bartonellosis organism list Bartonella quintana
Blastomycosis Blastomycosis organism list Blastomyces dermatitidis L-44171 MI0236
Botulism Botulism organism list Clostridium botulinum L-14118 ATCC25763
Brucellosis Brucellosis organism list Brucella abortus L-13202 ATCC23448
Brucellosis Brucellosis organism list Brucella canis L-13206 ATCC23365
Brucellosis Brucellosis organism list Brucella melitensis L-13201 ATCC23456
Brucellosis Brucellosis organism list Brucella suis L-13203 ATCC23444
Campylobacteriosis Campylobacteriosis organism list Campylobacter coli L-13501 ATCC33559
Campylobacteriosis Campylobacteriosis organism list Campylobacter concisus L-13509 ATCC33237
Campylobacteriosis Campylobacteriosis organism list Campylobacter fetus L-13502 MI0302
Campylobacteriosis Campylobacteriosis organism list Campylobacter fetus ss. fetus L-13503 ATCC27324
Campylobacteriosis Campylobacteriosis organism list Campylobacter jejuni L-13505 MI0304
Campylobacteriosis Campylobacteriosis organism list Campylobacter jejuni ss. jejuni L-13505 ATCC33560
Campylobacteriosis Campylobacteriosis organism list Campylobacter laridis L-13511 MI0305
Campylobacteriosis Campylobacteriosis organism list Campylobacter sp. L-13500 Campylobacter, NOS MSH94D002167 Campylobacter species
Campylobacteriosis Campylobacteriosis organism list Campylobacter sputorum L-13506 MI0308
Campylobacteriosis Campylobacteriosis organism list Campylobacter upsaliensis ATCC43954
Chanchroid Chanchroid organism list Haemophilus ducreyi L-1F710 ATCC33940
Chickenpox Chickenpox organism list Varicella-zoster virus L-36401
Chlamydial infection Chlamydia organism list Chlamydia pneumoniae ATCCVR 2282
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Chlamydial infection Chlamydia organism list Chlamydia psittaci L-2A902 ATCCVR 125
Chlamydial infection Chlamydia organism list Chlamydia psittaci var. bovis L-2A904 ATCCVR 125
Chlamydial infection Chlamydia organism list Chlamydia psittaci var. felis L-2A905 ATCCVR 125
Chlamydial infection Chlamydia organism list Chlamydia psittaci var. ovis L-2A906 ATCCVR 125
Chlamydial infection Chlamydia organism list Chlamydia trachomatis L-2A901 ATCCVR 571
Chlamydial infection Chlamydia organism list Chlamydia sp. L-2A900 Chlamydia, NOS MSH94D002689 Chlamydia species
Chlamydial infection Chlamydia organism list Intracellular elementary bodies
Cholera Cholerae organism list Vibrio cholerae, classical L-26204
Cholera Cholerae organism list Vibrio cholerae, El tor L-26205
Coccidiodomycosis Coccidiodomycosis organism list Coccidioides immitis L-44181 MI0406
Coccidiodomycosis Coccidiodomycosis organism list Coccidioides sp. L-44180 Coccidioides, NOS MSH95D003045 Coccidioides
Colorado tick fever Colorado tick fever organism list Colorado tick fever virus subgroup sp. L-31850 Colorado tick fever virus subgroup, NOS
Colorado tick fever Colorado tick fever organism list Colorado tick fever virus L-31851
Cryptococcosis Cryptococcus organism list Cryptococcus neoformans L-43165 MSH95D003455
Cryptosproridiosis Cryptosporidium organism list Cryptosporidium parvum L-52408 MI0453
Cryptosproridiosis Cryptosporidium organism list Cryptosporidium sp. L-52400 Cryptosporidium, NOS MI0452 Cryptosporidium
Cyclospora Cyclospora organism list Cyclospora cayetanensis
Cysticercosis Cysticercosis organism list Taenia solium L-5B101 MI1467
Cytomegalovirus Cytomegalovirus organism list Cytomegalovirus sp. L-36500 Cytomegalovirus, NOS MI0472 Cytomegalovirus
Dengue fever Dengue fever organism list Dengue virus sp. L-32320 Dengue virus, NOS
Dengue fever Dengue fever organism list Dengue virus, type 1 L-32321
Dengue fever Dengue fever organism list Dengue virus, type 2 L-32322
Dengue fever Dengue fever organism list Dengue virus, type 3 L-32323
Dengue fever Dengue fever organism list Dengue virus, type 4 L-32324
Diphtheria Diphtheria organism list Corynebacterium diphtheriae L-14401 ATCC27010
Ebola Ebola virus organism list Ebola virus L-38712
Echinococciasis Echinococciasis organism list Echinococcus sp. L-5B140 Echinococcus, NOS MSH95D004446
Echinococciasis Echinococciasis organism list Echinococcus granulosus L-5B141 MI0510
Echinococciasis Echinococciasis organism list Echinococcus multilocularis L-5B142 MI0511
Echinococciasis Echinococciasis organism list Echinococcus vogeli L-5B143 MI0512
Ehrlichiosis Ehrlichiosis organism list Ehrlichia sp. L-2A600 Ehrlichia, NOS MI0518
Ehrlichiosis Ehrlichiosis organism list Ehrlichia canis L-2A601 MI0519
Ehrlichiosis Ehrlichiosis organism list Ehrlichia chaffeensis L-2A611 ATCC 
CRL10679
Ehrlichiosis Ehrlichiosis organism list Ehrlichia equi L-2A603 MI0520
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Ehrlichiosis Ehrlichiosis organism list Ehrlichia phagocytophila L-2A602 MI0521
Ehrlichiosis Ehrlichiosis organism list Ehrlichia risticii L-2A605 MI0522
Ehrlichiosis Ehrlichiosis organism list Ehrlichia sennetsu L-2A604 ATCC VR 367
Endemic typhus Endemic typhus organism list Rickettsia typhi L-2A002 MI1268
Enterococcus Enterococcus organism list Enterococcus sp. L-1E600 Enterococcus, NOS
Enterococcus Enterococcus organism list Enterococcus avium L-1E603 ATCC14025
Enterococcus Enterococcus organism list Enterococcus casseliflavus L-1E604 ATCC25788
Enterococcus Enterococcus organism list Enterococcus cecorum ATCC43198
Enterococcus Enterococcus organism list Enterococcus durans L-1E605 ATCC19432
Enterococcus Enterococcus organism list Enterococcus faecalis L-1E601 ATCC19433
Enterococcus Enterococcus organism list Enterococcus faecium L-1E602 ATCC19434
Enterococcus Enterococcus organism list Enterococcus gallinarum L-1E606 ATCC35038
Enterococcus Enterococcus organism list Enterococcus hirae L-1E608 ATCC08043
Enterococcus Enterococcus organism list Enterococcus malodoratus L-1E607 MI0561
Enterococcus Enterococcus organism list Enterococcus mundtii L-1E609 MI0562
Enterococcus Enterococcus organism list Enterococcus pseudoavium MI0563
Enterococcus Enterococcus organism list Enterococcus raffinosus MI0564
Enterococcus Enterococcus organism list Enterococcus saccharolyticus ATCC43076
Enterococcus Enterococcus organism list Enterococcus seriolicida ATCC49156
Enterococcus Enterococcus organism list Enterococcus solitarius MI0565
Epidemic typhus Epidemic typhus organism list Rickettsia prowazekii L-2A001 MI1262
Escherichia coli O157:H7 infection Esherichia coli O157:H7 organism list Escherichia coli O157:H7 L-15602 Escherichia coli, enteropathogenic strain
Fifth's disease Fifth's disease organism list Parvovirus B19
Filariasis Filariasis organism list Brugia malayi L-56D11 MSH95D017178
Filariasis Filariasis organism list Brugia timori L-56D13 MI0285
Genital warts Genital warts organism list Human papillomavirus group, NOS L-35610 Human papillomavirus group, NOS
Genital warts Genital warts organism list Human papillomavirus type 1 L-35621
Genital warts Genital warts organism list Human papillomavirus type 2 L-35622
Genital warts Genital warts organism list Human papillomavirus type 3 L-35623
Genital warts Genital warts organism list Human papillomavirus type 4 L-35624
Genital warts Genital warts organism list Human papillomavirus type 5 L-35625
Genital warts Genital warts organism list Human papillomavirus type 6 L-35626
Genital warts Genital warts organism list Human papillomavirus type 7 L-35627
Genital warts Genital warts organism list Human papillomavirus type 8 L-35628
Genital warts Genital warts organism list Human papillomavirus type 9 L-35629
Genital warts Genital warts organism list Human papillomavirus sp. L-35620 Human papillomavirus, NOS
Giardiasis Giardiasis organism list Giardia lamblia L-50701 MSH95D016829
Gonorrhea Gonorrhoeae organism list Gram-negative diplococcus L-10028
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Gonorrhea Gonorrhoeae organism list Neisseria gonorrhoeae L-22201 ATCC19424
Granuloma inguinale Granuloma inguinale organism list Calymmatobacterium granulomatis L-13401 MI0295
Granuloma inguinale Granuloma inguinale organism list Donovan bodies
Haemophilis influenzae Haemophilus influenzae organism list Haemophilus influenzae sp. L-1F701 Haemophilus influenzae ATCC33391
Haemophilis influenzae Haemophilus influenzae organism list Haemophilus influenzae, type A
Haemophilis influenzae Haemophilus influenzae organism list Haemophilus influenzae, type B
Haemophilis influenzae Haemophilus influenzae organism list Haemophilus influenzae, type C
Haemophilis influenzae Haemophilus influenzae organism list Haemophilus influenzae, type D
Haemophilis influenzae Haemophilus influenzae organism list Haemophilus influenzae, type E
Haemophilis influenzae Haemophilus influenzae organism list Haemophilus influenzae, type F
Hantavirus Hantavirus organism list Hanta virus L-34401 Hantaan virus MI0699
Hantavirus Hantavirus organism list Hanta virus L-34400 Hantanvirus group, NOS
Hepatitis A Hepatitis A organism list Hepatitis A virus L-30605
Hepatitis B Hepatitis B organism list Hepatitis B virus L-38601
Hepatitis C Hepatitis C organism list Hepatitis C virus L-38806
Hepatitis D Hepatitis D organism list Hepatitis D virus L-38815
Herpes simplex Herpes simplex organism list Herpes simplex sp. L-36210 Human herpes simplex virus, NOS
Herpes simplex Herpes simplex organism list Herpes simplex type 1 L-36211 Human herpes simplex virus type 1
Herpes simplex Herpes simplex organism list Herpes simplex type 2 L-36212 Human herpes simplex virus type 2
Histoplasmosis HIstoplasmosis organism list Histoplasma sp. L-44220 Histoplasma, NOS - (L-41300) MSH95D006658 Histoplasma
Histoplasmosis HIstoplasmosis organism list Histoplasma capsulatum L-44221 MI0715
Human immunodeficiency virus Human immunodeficiency virus organism list Human immunodeficiency virus sp. L-35210 Human immunodeficiency virus, NOS
Human immunodeficiency virus Human immunodeficiency virus organism list Human immunodeficiency virus type 1 L-35211
Human immunodeficiency virus Human immunodeficiency virus organism list Human immunodeficiency virus type 2 L-35212
Human T-lymphotrophic virus Human T-lymphotrophic virus organism list Human T-lymphotropic virus, type I L-34803
Human T-lymphotrophic virus Human T-lymphotrophic virus organism list Human T-lymphotropic virus, type II L-34804
Human T-lymphotrophic virus Human T-lymphotrophic virus organism list Human T-lymphotropic virus, type V L-34805
Influenza Influenza virus organism list Influenzavirus sp. L-32800 Influenzavirus, NOS CC9811 Influenza virus
Influenza Influenza virus organism list Influenzavirus A L-32801
Influenza Influenza virus organism list Influenzavirus B L-32802
Influenza Influenza virus organism list Influenzavirus C L-32803
Isosporiasis Isosproriasis organism list Isospora L-52500 Isospora, NOS MSH95D007549
Isosporiasis Isosproriasis organism list Isospora belli L-52501 MI0728
Lassa fever Lassa fever virus organism list Lassa virus L-35302
Legionellosis Legionellosis organism list Legionella sp. L-20400 Legionella, NOS MSH94D007875 Legionella species
Legionellosis Legionellosis organism list Legionella adelaidensis ATCC49625
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Legionellosis Legionellosis organism list Legionella anisa L-20422 MI0767
Legionellosis Legionellosis organism list Legionella birminghamensis L-20424 MI0768
Legionellosis Legionellosis organism list Legionella bozemanii L-20403 MI0769
Legionellosis Legionellosis organism list Legionella brunensis ATCC43878
Legionellosis Legionellosis organism list Legionella cherrii L-20419 ATCC35252
Legionellosis Legionellosis organism list Legionella cincinnatiensis L-20425 ATCC43753
Legionellosis Legionellosis organism list Legionella dumoffii L-20404 MI0773
Legionellosis Legionellosis organism list Legionella erythra L-20415 ATCC35303
Legionellosis Legionellosis organism list Legionella fairfieldensis ATCC49588
Legionellosis Legionellosis organism list Legionella feeleii L-20410 ATCC35072
Legionellosis Legionellosis organism list Legionella geestiana ATCC49504
Legionellosis Legionellosis organism list Legionella gormanii L-20405 MI0776
Legionellosis Legionellosis organism list Legionella gratiana ATCC49413
Legionellosis Legionellosis organism list Legionella hackeliae L-20416 ATCC35250
Legionellosis Legionellosis organism list Legionella israelensis L-20423 MI0778
Legionellosis Legionellosis organism list Legionella jamestowniensis L-20413 ATCC35298
Legionellosis Legionellosis organism list Legionella jordanis L-20407 MI0780
Legionellosis Legionellosis organism list Legionella lansingensis ATCC49751
Legionellosis Legionellosis organism list Legionella londiniensis ATCC49505
Legionellosis Legionellosis organism list Legionella longbeachae L-20406 MI0781
Legionellosis Legionellosis organism list Legionella maceachernii L-20412 MI0782
Legionellosis Legionellosis organism list Legionella micdadei L-20402 MI0783
Legionellosis Legionellosis organism list Legionella moravica ATCC43877
Legionellosis Legionellosis organism list Legionella nautarum ATCC49506
Legionellosis Legionellosis organism list Legionella oakridgensis L-20408 MI0785
Legionellosis Legionellosis organism list Legionella parisiensis L-20418 ATCC35299
Legionellosis Legionellosis organism list Legionella pneumophila ss. fraseri ATCC33156
Legionellosis Legionellosis organism list Legionella pneumophila ss. pascullei ATCC33737
Legionellosis Legionellosis organism list Legionella pneumophila ss. pneumophila ATCC33152
Legionellosis Legionellosis organism list Legionella quinlivanii ATCC43830
Legionellosis Legionellosis organism list Legionella rubrilucens L-20414 ATCC35304
Legionellosis Legionellosis organism list Legionella sainthelensi L-20411 MI0790
Legionellosis Legionellosis organism list Legionella santicrucis L-20421 ATCC35301
Legionellosis Legionellosis organism list Legionella shakespearei ATCC49655
Legionellosis Legionellosis organism list Legionella species L-20400 Legionella, NOS MSH94D007875
Legionellosis Legionellosis organism list Legionella spiritensis L-20417 ATCC35249
Legionellosis Legionellosis organism list Legionella steigerwaltii L-20420 ATCC35302
Legionellosis Legionellosis organism list Legionella tucsonensis ATCC49180
Legionellosis Legionellosis organism list Legionella wadsworthii L-20409 MI0795
Legionellosis Legionellosis organism list Legionella worsleiensis ATCC49507
Legionellosis Legionellosis organism list Legionellaceae MI0796
Leprosy Leprosy organism list Mycobacterium leprae L-21827 MI0938
Leptospirosis Leptospirosis organism list Leptospira interrogans biflexa MI0815
Leptospirosis Leptospirosis organism list Leptospira interrogans interrogans ATCC23581 Leptospira interrogans
Leptospirosis Leptospirosis organism list Leptospira interrogans var. australis L-20504 Leptospira interrogans, serogroup australis
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Leptospirosis Leptospirosis organism list Leptospira interrogans var. autumnalis L-20505 Leptospira interrogans, serogroup autumnalis
Leptospirosis Leptospirosis organism list Leptospira interrogans var. ballum L-20506 Leptospira interrogans, serogroup balhum
Leptospirosis Leptospirosis organism list Leptospira interrogans var. bataviae L-20507 Leptospira interrogans, serogroup bataviae
Leptospirosis Leptospirosis organism list Leptospira interrogans var. bufonis
Leptospirosis Leptospirosis organism list Leptospira interrogans var. canicola L-20508 Leptospira interrogans, serogroup canicola
Leptospirosis Leptospirosis organism list Leptospira interrogans var. celledoni L-20509 Leptospira interrogans, serogroup celledoni
Leptospirosis Leptospirosis organism list Leptospira interrogans var. cynopteri L-20510 Leptospira interrogans, serogroup cynopteri
Leptospirosis Leptospirosis organism list Leptospira interrogans var. grippotyphosa L-20512 Leptospira interrogans, serogroup grippotyphosa
Leptospirosis Leptospirosis organism list Leptospira interrogans var. hebdomadis L-20513 Leptospira interrogans, serogroup hebdomadis
Leptospirosis Leptospirosis organism list Leptospira interrogans var. 
icterohemorrhagiae
L-20503 Leptospira interrogans, serogroup 
icterohaemorrhagiae
Leptospirosis Leptospirosis organism list Leptospira interrogans var. javanica L-20514 Leptospira interrogans, serogroup javanica
Leptospirosis Leptospirosis organism list Leptospira interrogans var. panama L-20517 Leptospira interrogans, serogroup panama
Leptospirosis Leptospirosis organism list Leptospira interrogans var. pomona L-20518 Leptospira interrogans, serogroup pomona
Leptospirosis Leptospirosis organism list Leptospira interrogans var. pyogenes L-20519 Leptospira interrogans, serogroup pyrogenes
Leptospirosis Leptospirosis organism list Leptospira interrogans var. ranarum
Leptospirosis Leptospirosis organism list Leptospira interrogans var. shermani L-20521 Leptospira interrogans, serogroup shermani
Leptospirosis Leptospirosis organism list Leptospira interrogans var. tarassovi L-20522 Leptospira interrogans, serogroup tarassovi
Listeriosis Listeriosis organism list Listeria monocytogenes L-20901 ATCC15313
Lyme disease Lyme disease organism list Borrelia burgdorferi L-12921 ATCC35210
Lymphogranuloma venereum Lymphogranuloma venereum organism list Chlamydia trachomatis L-2A901 ATCCVR 571
Malaria Malaria organism list Plasmodium falciparum L-52901 MSH95D010963
Malaria Malaria organism list Plasmodium malariae L-52902 MSH95D010965
Malaria Malaria organism list Plasmodium ovale L-52903 MI1132
Malaria Malaria organism list Plasmodium vivax L-52904 MSH95D010966
Malaria Malaria organism list Plasmodium sp. L-52900 Plasmodium, NOS
Marburg Marburg virus organism list Marburg virus L-38711
Measles Measles virus organism list Measles virus L-33001
Meningitis, bacterial Meningitis, bacterial organism list Acinetobacter calcoaceticus L-10501 ATCC23055
Meningitis, bacterial Meningitis, bacterial organism list Actinomyces sp. L-10800 Actinomyces, NOS MSH94D000190 Actinomyces species
Meningitis, bacterial Meningitis, bacterial organism list Actinomyces bovis L-10801 ATCC13683
Meningitis, bacterial Meningitis, bacterial organism list Bacterium sp. L-10000 Bacterium, NOS MSH95D00609? Bacterium
Meningitis, bacterial Meningitis, bacterial organism list Bacteriodes sp. L-12400 Bacteroides, NOS MSH94D001439 Bacteroides species
Meningitis, bacterial Meningitis, bacterial organism list Clostridium perfringens L-14210 ATCC13124
Meningitis, bacterial Meningitis, bacterial organism list Enterobacter aerogenes L-15802 ATCC13048
Meningitis, bacterial Meningitis, bacterial organism list Enterobacter cloacae L-15801 ATCC13047
Meningitis, bacterial Meningitis, bacterial organism list Escherichia coli L-15601 ATCC11775
Meningitis, bacterial Meningitis, bacterial organism list Haemophilus influenzae L-1F701 ATCC33391
Meningitis, bacterial Meningitis, bacterial organism list Klebsiella oxytoca L-16002 ATCC13182
Meningitis, bacterial Meningitis, bacterial organism list Klebsiella pneumoniae L-16001
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Meningitis, bacterial Meningitis, bacterial organism list Klebsiella pneumoniae ss ozaenae L-16001 Klebsiella pneumoniae ATCC11296
Meningitis, bacterial Meningitis, bacterial organism list Klebsiella pneumoniae ss pneumoniae L-16001 Klebsiella pneumoniae ATCC13883
Meningitis, bacterial Meningitis, bacterial organism list Klebsiella pneumoniae ss rhinoscleromatis L-16001 Klebsiella pneumoniae ATCC13884 Klebsiella pneumoniae, ssp. 
rhinoscleromatis
Meningitis, bacterial Meningitis, bacterial organism list Listeria monocytogenes L-20901 ATCC15313
Meningitis, bacterial Meningitis, bacterial organism list Mycobacterium sp. L-21800 Mycobacterium, NOS MSH94D009161 Mycobacterium species
Meningitis, bacterial Meningitis, bacterial organism list Neisseria meningitidis L-22202 ATCC13077
Meningitis, bacterial Meningitis, bacterial organism list Pseudomonas aeruginosa L-23401 ATCC10145
Meningitis, bacterial Meningitis, bacterial organism list Proteus mirabilis L-16802 ATCC29906
Meningitis, bacterial Meningitis, bacterial organism list Salmonella choleraesuis ss. arizonae ATCC13314
Meningitis, bacterial Meningitis, bacterial organism list Salmonella choleraesuis ss. choleraesuis L-17518 ATCC13312
Meningitis, bacterial Meningitis, bacterial organism list Serratia marcescens L-1E001 ATCC13880
Meningitis, bacterial Meningitis, bacterial organism list Staphylococcus aureus L-24801 ATCC12600 Staphylococcus aureus ss 
aureus
Meningitis, bacterial Meningitis, bacterial organism list Staphylococcus epidermidis L-24802 ATCC14990
Meningitis, bacterial Meningitis, bacterial organism list Streptococcus pneumoniae L-25116 ATCC33400
Meningitis, bacterial Meningitis, bacterial organism list Streptococcus agalactiae L-25107 ATCC13813
Meningitis, bacterial Meningitis, bacterial organism list Enterococcus faecalis L-1E601 ATCC19433
Meningitis, bacterial Meningitis, bacterial organism list Mycobacterium tuberculosis L-21801 Mycobacterium tuberculosis hominis ATCC27294
Meningitis, bacterial Meningitis, bacterial organism list Borrelia burgdorferi L-12921 ATCC35210
Meningitis, bacterial Meningitis, bacterial organism list Leptospira L-20500 205 LEPTOSPIRA ATCC23581 Leptospira interrogans
Meningitis, bacterial Meningitis, bacterial organism list Treponema pallidum L-25901 MI1497
Meningitis, bacterial Meningitis, bacterial organism list Rickettsia rickettsii L-2A003 MI1265
Meningitis, bacterial Meningitis, bacterial organism list Rickettsia conorii L-2A005 MI1257
Meningitis, bacterial Meningitis, bacterial organism list Rickettsia prowazekii L-2A001 MI1262
Meningitis, bacterial Meningitis, bacterial organism list Rickettsia typhi L-2A002 MI1268
Meningitis, bacterial Meningitis, bacterial organism list Rickettsia tsutsugamushi L-2A010 MI1267 Rickettsia tsutsugamishi
Meningitis, bacterial Meningitis, bacterial organism list Rickettsia sp. L-2A000 Rickettsia, NOS
Meningitis, fungal Meningitis, fungal organism list Aspergillus sp. L-44130 Aspergillus, NOS
Meningitis, fungal Meningitis, fungal organism list Aspergillus candidus L-44148 MI0121
Meningitis, fungal Meningitis, fungal organism list Aspergillus carneus L-44152 MI0122 Aspergillus cerneus
Meningitis, fungal Meningitis, fungal organism list Aspergillus clavatus L-44133 MI0123
Meningitis, fungal Meningitis, fungal organism list Aspergillus deflectus L-44153 MI0125
Meningitis, fungal Meningitis, fungal organism list Aspergillus fischeri L-44156 MI0126
Meningitis, fungal Meningitis, fungal organism list Aspergillus flavipes L-44134 MI0127
Meningitis, fungal Meningitis, fungal organism list Aspergillus flavus L-44135 MSH95D001231
Meningitis, fungal Meningitis, fungal organism list Aspergillus fumigatus L-44136 MSH95D001232
Meningitis, fungal Meningitis, fungal organism list Aspergillus nidulans L-44138 MSH95D001233
Meningitis, fungal Meningitis, fungal organism list Aspergillus niger L-44139 MSH95D001234
Meningitis, fungal Meningitis, fungal organism list Aspergillus ochraceus L-44141 MSH95D001235
Meningitis, fungal Meningitis, fungal organism list Aspergillus oryzae L-44142 MSH95D001236
Meningitis, fungal Meningitis, fungal organism list Aspergillus parasiticus L-44147 MI0135
Meningitis, fungal Meningitis, fungal organism list Aspergillus restrictus L-44144 MI0137
Meningitis, fungal Meningitis, fungal organism list Aspergillus syndowi L-44149 MI0138
Meningitis, fungal Meningitis, fungal organism list Aspergillus terreus L-44145 MI0139
Meningitis, fungal Meningitis, fungal organism list Aspergillus ustus L-44151 MI0140
Meningitis, fungal Meningitis, fungal organism list Aspergillus versicolor L-44146 MI0141
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Meningitis, fungal Meningitis, fungal organism list Blastomyces dermatitidis L-44171 MI0236
Meningitis, fungal Meningitis, fungal organism list Candida albicans L-43131 MSH95D002176
Meningitis, fungal Meningitis, fungal organism list Candida sp. L-43130 Candida, NOS - (L-41010) (L-42040) MSH95D002175
Meningitis, fungal Meningitis, fungal organism list Candida tropicalis L-43141 MI0322
Meningitis, fungal Meningitis, fungal organism list Candida glabrata L-43222 MI1484 Torulopsis glabrata
Meningitis, fungal Meningitis, fungal organism list Coccidioides immitis L-44181 MI0406
Meningitis, fungal Meningitis, fungal organism list Cryptococcus neoformans L-43165 MSH95D003455
Meningitis, fungal Meningitis, fungal organism list Histoplasma capsulatum L-44221 MI0715
Meningitis, fungal Meningitis, fungal organism list Nocardia sp. L-22300 Nocardia, NOS MSH94D009615 Nocardia species
Meningitis, protozoal Meningitis, protozoal organism list Naegleria fowleri
Meningitis, protozoal Meningitis, protozoal organism list Angiostrongylus cantonensis
Meningitis, protozoal Meningitis, protozoal organism list Strongyloides stercoralis
Meningitis, viral Meningitis, viral organism list Herpesvirus L-36210 Herpesvirus, NOS MI0710 Herpesviridae
Meningitis, viral Meningitis, viral organism list Alphaherpesvirus L-36200 362-364 ALPHAHERPESVIRUS GROUP
Meningitis, viral Meningitis, viral organism list Varicella-zoster virus
Meningitis, viral Meningitis, viral organism list Betaherpesvirus L-36500 365 BETAHERPESVIRUS GROUP
Meningitis, viral Meningitis, viral organism list Cytomegalovirus
Meningitis, viral Meningitis, viral organism list Gammaherpesvirus L-36800 368 GAMMAHERPESVIRUS GROUP
Meningitis, viral Meningitis, viral organism list Epstein-Barr virus
Meningitis, viral Meningitis, viral organism list Human herpesvirus 6
Meningitis, viral Meningitis, viral organism list Arbovirus L-32200 Arbovirus, NOS
Meningitis, viral Meningitis, viral organism list Alphavirus L-32200 Alphavirus, NOS MSH95D000524
Meningitis, viral Meningitis, viral organism list Togavirus L-32200 322-326 TOGAVIRUS GROUP MI1481 Togaviridae
Meningitis, viral Meningitis, viral organism list Eastern equine encephalitis virus L-32207
Meningitis, viral Meningitis, viral organism list Venezuelan equine encephalitis virus L-32223
Meningitis, viral Meningitis, viral organism list Western equine encephalitis virus L-32224
Meningitis, viral Meningitis, viral organism list Flavivirus L-32300 323 FLAVIVIRUS MI0627 Flavivirus
Meningitis, viral Meningitis, viral organism list Japanese encephalitis virus L-32329
Meningitis, viral Meningitis, viral organism list St. Louis encephalitis virus L-32352
Meningitis, viral Meningitis, viral organism list Bunyavirus L-33800 338-339 BUNYAVIRUS MI0289
Meningitis, viral Meningitis, viral organism list Jamestown Canyon encephalitis virus L-33843 Jamestown Canyon virus
Meningitis, viral Meningitis, viral organism list La Crosse virus L-33846
Meningitis, viral Meningitis, viral organism list Enterovirus L-30200 302 ENTEROVIRUS
Meningitis, viral Meningitis, viral organism list Coxsackievirus A sp. L-30300 Human coxsackievirus A, NOS
Meningitis, viral Meningitis, viral organism list Coxsackievirus A1 L-30301 Human coxsackievirus A1
Meningitis, viral Meningitis, viral organism list Coxsackievirus A10 L-30310 Human coxsackievirus A10
Meningitis, viral Meningitis, viral organism list Coxsackievirus A11 L-30311 Human coxsackievirus A11
Meningitis, viral Meningitis, viral organism list Coxsackievirus A12 L-30312 Human coxsackievirus A12
Meningitis, viral Meningitis, viral organism list Coxsackievirus A13 L-30313 Human coxsackievirus A13
Meningitis, viral Meningitis, viral organism list Coxsackievirus A14 L-30314 Human coxsackievirus A14
Meningitis, viral Meningitis, viral organism list Coxsackievirus A15 L-30315 Human coxsackievirus A15
Meningitis, viral Meningitis, viral organism list Coxsackievirus A16 L-30316 Human coxsackievirus A16
Meningitis, viral Meningitis, viral organism list Coxsackievirus A17 L-30317 Human coxsackievirus A17
Meningitis, viral Meningitis, viral organism list Coxsackievirus A18 L-30318 Human coxsackievirus A18
Meningitis, viral Meningitis, viral organism list Coxsackievirus A19 L-30319 Human coxsackievirus A19
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Meningitis, viral Meningitis, viral organism list Coxsackievirus A2 L-30302 Human coxsackievirus A2
Meningitis, viral Meningitis, viral organism list Coxsackievirus A20 L-30320 Human coxsackievirus A20
Meningitis, viral Meningitis, viral organism list Coxsackievirus A21 L-30321 Human coxsackievirus A21
Meningitis, viral Meningitis, viral organism list Coxsackievirus A22 L-30322 Human coxsackievirus A22
Meningitis, viral Meningitis, viral organism list Coxsackievirus A23 L-30509 Human coxsackievirus A23
Meningitis, viral Meningitis, viral organism list Coxsackievirus A24 L-30323 Human coxsackievirus A24
Meningitis, viral Meningitis, viral organism list Coxsackievirus A3 L-30303 Human coxsackievirus A3
Meningitis, viral Meningitis, viral organism list Coxsackievirus A4 L-30304 Human coxsackievirus A4
Meningitis, viral Meningitis, viral organism list Coxsackievirus A5 L-30305 Human coxsackievirus A5
Meningitis, viral Meningitis, viral organism list Coxsackievirus A6 L-30306 Human coxsackievirus A6
Meningitis, viral Meningitis, viral organism list Coxsackievirus A7 L-30307 Human coxsackievirus A7
Meningitis, viral Meningitis, viral organism list Coxsackievirus A8 L-30308 Human coxsackievirus A8
Meningitis, viral Meningitis, viral organism list Coxsackievirus A9 L-30309 Human coxsackievirus A9
Meningitis, viral Meningitis, viral organism list Coxsackievirus B sp. L-30400 Human coxsackievirus B, NOS
Meningitis, viral Meningitis, viral organism list Coxsackievirus B1 L-30401 Human coxsackievirus B1
Meningitis, viral Meningitis, viral organism list Coxsackievirus B2 L-30402 Human coxsackievirus B2
Meningitis, viral Meningitis, viral organism list Coxsackievirus B3 L-30403 Human coxsackievirus B3
Meningitis, viral Meningitis, viral organism list Coxsackievirus B4 L-30404 Human coxsackievirus B4
Meningitis, viral Meningitis, viral organism list Coxsackievirus B5 L-30405 Human coxsackievirus B5
Meningitis, viral Meningitis, viral organism list Coxsackievirus B6 L-30406 Human coxsackievirus B6
Meningitis, viral Meningitis, viral organism list Coxsackievirus sp. L-30220 Human coxsackievirus, NOS
Meningitis, viral Meningitis, viral organism list Echovirus 1 L-30501 Human echovirus 1
Meningitis, viral Meningitis, viral organism list Echovirus 11 L-30510 Human echovirus 11
Meningitis, viral Meningitis, viral organism list Echovirus 12 L-30511 Human echovirus 12
Meningitis, viral Meningitis, viral organism list Echovirus 13 L-30512 Human echovirus 13
Meningitis, viral Meningitis, viral organism list Echovirus 14 L-30513 Human echovirus 14
Meningitis, viral Meningitis, viral organism list Echovirus 15 L-30514 Human echovirus 15
Meningitis, viral Meningitis, viral organism list Echovirus 16 L-30515 Human echovirus 16
Meningitis, viral Meningitis, viral organism list Echovirus 17 L-30516 Human echovirus 17
Meningitis, viral Meningitis, viral organism list Echovirus 18 L-30517 Human echovirus 18
Meningitis, viral Meningitis, viral organism list Echovirus 19 L-30518 Human echovirus 19
Meningitis, viral Meningitis, viral organism list Echovirus 2 L-30502 Human echovirus 2
Meningitis, viral Meningitis, viral organism list Echovirus 20 L-30519 Human echovirus 20
Meningitis, viral Meningitis, viral organism list Echovirus 21 L-30520 Human echovirus 21
Meningitis, viral Meningitis, viral organism list Echovirus 22 L-30521 Human echovirus 22
Meningitis, viral Meningitis, viral organism list Echovirus 23 L-30522 Human echovirus 23
Meningitis, viral Meningitis, viral organism list Echovirus 24 L-30523 Human echovirus 24
Meningitis, viral Meningitis, viral organism list Echovirus 25 L-30524 Human echovirus 25
Meningitis, viral Meningitis, viral organism list Echovirus 26 L-30525 Human echovirus 26
Meningitis, viral Meningitis, viral organism list Echovirus 27 L-30526 Human echovirus 27
Meningitis, viral Meningitis, viral organism list Echovirus 29 L-30527 Human echovirus 29
Meningitis, viral Meningitis, viral organism list Echovirus 3 L-30503 Human echovirus 3
Meningitis, viral Meningitis, viral organism list Echovirus 30 L-30528 Human echovirus 30
Meningitis, viral Meningitis, viral organism list Echovirus 31 L-30529 Human echovirus 31
Meningitis, viral Meningitis, viral organism list Echovirus 32 L-30530 Human echovirus 32
Meningitis, viral Meningitis, viral organism list Echovirus 33 L-30531 Human echovirus 33
Meningitis, viral Meningitis, viral organism list Echovirus 34 L-30532 Human echovirus 34
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Meningitis, viral Meningitis, viral organism list Echovirus 4 L-30504 Human echovirus 4
Meningitis, viral Meningitis, viral organism list Echovirus 5 L-30505 Human echovirus 5
Meningitis, viral Meningitis, viral organism list Echovirus 6 L-30506 Human echovirus 6
Meningitis, viral Meningitis, viral organism list Echovirus 7 L-30507 Human echovirus 7
Meningitis, viral Meningitis, viral organism list Echovirus 8 L-30508 Human echovirus 8
Meningitis, viral Meningitis, viral organism list Echovirus 9 L-30509 Human echovirus 9
Meningitis, viral Meningitis, viral organism list Echovirus sp. L-30500 Human echovirus, NOS
Meningitis, viral Meningitis, viral organism list Lentivirus L-35200 Subfamily lentivirinae, NOS MI0808
Meningitis, viral Meningitis, viral organism list Lyssavirus L-33300 333 LYSSAVIRUS MI0841
Meningitis, viral Meningitis, viral organism list Papovavirus L-35600 Papovavirus, NOS
Meningitis, viral Meningitis, viral organism list Paramyxovirus L-32900 329 PARAMYXOVIRUS MI1048
Meningitis, viral Meningitis, viral organism list Picornavirus L-30200 302-315 PICORNAVIRUS
Meningitis, viral Meningitis, viral organism list Polyomavirus L-35740 Polyomavirus, NOS MI1144
Meningitis, viral Meningitis, viral organism list Retrovirus L-34600 346 RETROVIRUS
Meningitis, viral Meningitis, viral organism list Rhabdovirus L-334A0 Rhabdovirus, NOS MI1232
Meningitis, viral Meningitis, viral organism list Rubivirus L-32500 325 RUBIVIRUS MI1283
Meningitis, viral Meningitis, viral organism list Lymphocytic choriomeningitis virus L-35301 Lymphocytic choriomeningitis virus
Meningitis, viral Meningitis, viral organism list Human immunodeficiency virus sp. L-35210 Human immunodeficiency virus, NOS
Meningitis, viral Meningitis, viral organism list Human immunodeficiency virus type 1 L-35211
Meningitis, viral Meningitis, viral organism list Human immunodeficiency virus type 2 L-35212
Meningitis, viral Meningitis, viral organism list Adenovirus L-35800 358 ADENOVIRUS
Meningitis, viral Meningitis, viral organism list Colorado tick fever virus L-31851
Meningitis, viral Meningitis, viral organism list California encephalitis virus L-33841
Meningitis, viral Meningitis, viral organism list Mumps virus L-32903
Meningitis, viral Meningitis, viral organism list Human poliovirus sp. L-30210 Human poliovirus, NOS
Meningitis, viral Meningitis, viral organism list Human poliovirus 1 L-30211
Meningitis, viral Meningitis, viral organism list Human poliovirus 2 L-30212
Meningitis, viral Meningitis, viral organism list Human poliovirus 3 L-30213
Meningococcal disease Meningococcal organism list Neisseria meningitidis L-22202 ATCC13077
Microsporidia Microsporidia organism list Microsporidia sp.
Microsporidia Microsporidia organism list Encephalitozoon sp. L-54020 Encephalitozoon, NOS MI0528 Encephalitozoon
Microsporidia Microsporidia organism list Nosema sp. L-54000 Nosema, NOS MSH95D016818 Nosema
Microsporidia Microsporidia organism list Pleistophora MI1135
Microsporidia Microsporidia organism list Enterocytozoon sp. L-54040 Enterocytozoon, NOS MI0566 Enterocytozoon
Microsporidia Microsporidia organism list Enterocytozoon bienusi L-54041 MI0567
Mumps Mumps virus organism list Mumps virus L-32903
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium abscessus ATCC19977
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium asiaticum L-21854 MI0927
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium avium ss. avium ATCC25291
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium avium ss. paratuberculosis ATCC19698
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium avium-intracellulare MI0928
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium celatum ATCC51131
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium chelonae L-21823 ATCC35752
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Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium fortuitum L-21822 ATCC6841
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium fortuitum-chelonae MI0932
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium genavense ATCC51234
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium gordonae L-21812 MI0934
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium haemophilum L-21831 MI0935
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium intracellulare L-21814 ATCC13950
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium kansasii L-21805 ATCC12478
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium malmonense L-21830 ATCC29571 Mycobacterium malmoense
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium marinum L-21806 ATCC00927
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium scrofulaceum L-21813 MI0947
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium shimoidei L-21853
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium simiae L-21807 MI0948
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium smegmatis L-21820 ATCC19420
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium szulgai L-21829 MI0950
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium ulcerans L-21817 MI0954
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium xenopi L-21816 MI0955
Mycobacterium, non-TB Non-tuberculosis mycobacterium organism list Mycobacterium sp. L-21800 Mycobacterium, NOS MSH94D009161 Mycobacterium species
Pertussis Pertussis organism list Bordetella pertussis L-12801 ATCC9797
Plague Plague organism list Yersinia pestis L-1E401 ATCC19428
Pneumocystis carinii Pneumocystis carinii organism list Pneumocystis carinii L-50F00 MSH95D011010
Poliomyelitis Poliomyelitis organism list Human poliovirus sp. L-30210 Human poliovirus, NOS
Poliomyelitis Poliomyelitis organism list Human poliovirus 1 L-30211
Poliomyelitis Poliomyelitis organism list Human poliovirus 2 L-30212
Poliomyelitis Poliomyelitis organism list Human poliovirus 3 L-30213
Psittacosis Psittacosis organism list Chlamydia psittaci L-2A902 ATCCVR 125
Psittacosis Psittacosis organism list Chlamydia psittaci var. bovis L-2A904
Psittacosis Psittacosis organism list Chlamydia psittaci var. felis L-2A905
Psittacosis Psittacosis organism list Chlamydia psittaci var. ovis L-2A906
Q fever Q fever organism list Coxiella burnetii L-2A301 MI0443
Rabies (animal) Rabies (animal) organism list Rabies virus group sp. L-33300 Rabies virus group, NOS
Rabies (animal) Rabies (animal) organism list Rabies virus L-33301
Rabies (human) Rabies (human) organism list Rabies virus group sp. L-33300 Rabies virus group, NOS
Rabies (human) Rabies (human) organism list Rabies virus L-33301
Relapsing fever Relapsing fever organism list Borrelia caucasica L-12910 MI0251
Relapsing fever Relapsing fever organism list Borrelia crocidurae L-12914 MI0253
Relapsing fever Relapsing fever organism list Borrelia dipodilli MI0254
Relapsing fever Relapsing fever organism list Borrelia duttonii L-12905 MI0255
Relapsing fever Relapsing fever organism list Borrelia hermsii L-12904 MI0257
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Relapsing fever Relapsing fever organism list Borrelia hispanica L-12903 MI0258
Relapsing fever Relapsing fever organism list Borrelia latyschewii L-12915 MI0259
Relapsing fever Relapsing fever organism list Borrelia mazzottii L-12908 MI0260
Relapsing fever Relapsing fever organism list Borrelia merionesi MI0261
Relapsing fever Relapsing fever organism list Borrelia microti L-12922 MI0262
Relapsing fever Relapsing fever organism list Borrelia parkeri L-12906 MI0263
Relapsing fever Relapsing fever organism list Borrelia persica L-12909 MI0264
Relapsing fever Relapsing fever organism list Borrelia recurrentis L-12902 MI0266
Relapsing fever Relapsing fever organism list Borrelia turicatae L-12919 MI0269
Relapsing fever Relapsing fever organism list Borrelia venezuelensis L-12907 MI0270
Rickettsial infection Rickettsia organism list Rickettsia sp. L-2A000 Rickettsia, NOS
Rickettsial infection Rickettsia organism list Rickettsia akari L-2A007 MI1253
Rickettsial infection Rickettsia organism list Rickettsia prowazekii L-2A001 MI1262
Rickettsial infection Rickettsia organism list Rickettsia rickettsii L-2A003 MI1265
Rickettsial infection Rickettsia organism list Rickettsia tsutsugamishi L-2A010 MI1267 Rickettsia tsutsugamishi
Rickettsial infection Rickettsia organism list Rickettsia typhi L-2A002 MI1268
Rickettsialpox Rickettsialpox organism list Rickettsia akari L-2A007 MI1253
Rocky Mountain Spotted Fever Rocky Mountain Spotted Fever organism list Rickettsia rickettsii L-2A003 MI1265
Rotavirus Rotavirus organism list Rotavirus L-32100 321 ROTAVIRUS MI1280
Rubella Rubella organism list Rubella virus L-32501
Salmonellosis, non-typhoid Non-typhoid salmonellosis organism list Salmonella choleraesuis ss. arizonae ATCC13314
Salmonellosis, non-typhoid Non-typhoid salmonellosis organism list Salmonella choleraesuis ss. choleraesuis ATCC13312
Salmonellosis, non-typhoid Non-typhoid salmonellosis organism list Salmonella enterica ATCC43971
Salmonellosis, non-typhoid Non-typhoid salmonellosis organism list Salmonella enteritidis L-18128 ATCC13076
Salmonellosis, non-typhoid Non-typhoid salmonellosis organism list Salmonella sp. L-17100 Salmonella, NOS MSH94D012475 Salmonella species
Scrub typus Scrub typhus organism list Rickettsia tsutsugamushi L-2A010 MI1267 Rickettsia tsutsugamishi
Shigellosis Shigellosis organism list Shigella boydii L-1E103 ATCC8700
Shigellosis Shigellosis organism list Shigella dysenteriae L-1E101 ATCC13313
Shigellosis Shigellosis organism list Shigella flexneri L-1E102 ATCC29903
Shigellosis Shigellosis organism list Shigella sonnei L-1E104 ATCC29930
Shigellosis Shigellosis organism list Shigella sp. L-1E100 Shigella, NOS MSH94D012760 Shigella species
Staphylococcus Staphlococcus organism list Staphylococcus aureus L-24801 ATCC12600 Staphylococcus aureus ss 
aureus
Staphylococcus Staphlococcus organism list Staphylococcus auricularis L-24822 ATCC33753
Staphylococcus Staphlococcus organism list Staphylococcus capitis ss. ureolyticus
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Staphylococcus Staphlococcus organism list Staphylococcus capitis ss. capitis ATCC27840 Staphylococcus capitis 
subsp. capitis
Staphylococcus Staphlococcus organism list Staphylococcus caprae L-24820 MI1391
Staphylococcus Staphlococcus organism list Staphylococcus cohnii ss. cohnii ATCC29974
Staphylococcus Staphlococcus organism list Staphylococcus cohnii ss. urealyticum ATCC49330
Staphylococcus Staphlococcus organism list Staphylococcus epidermidis L-24802 ATCC14990
Staphylococcus Staphlococcus organism list Staphylococcus haemolyticus L-24805 ATCC29970
Staphylococcus Staphlococcus organism list Staphylococcus hominis L-24804 ATCC27844
Staphylococcus Staphlococcus organism list Staphylococcus lugdunensis MI1406
Staphylococcus Staphlococcus organism list Staphylococcus pasteuri ATCC51129
Staphylococcus Staphlococcus organism list Staphylococcus saccharolyticus L-24821 MI1408
Staphylococcus Staphlococcus organism list Staphylococcus saprophyticus L-24803 ATCC15305
Staphylococcus Staphlococcus organism list Staphylococcus schleiferi ss. schleiferi ATCC43808
Staphylococcus Staphlococcus organism list Staphylococcus simulans L-24806 ATCC27848
Staphylococcus Staphlococcus organism list Staphylococcus warneri L-24813 ATCC27836
Staphylococcus Staphlococcus organism list Staphylococcus xylosus L-24812 ATCC29971
Streptococcus pneumoniae Streptococcus pneumoniae organism list Streptococcus pneumoniae L-25116 ATCC33400
Streptococcus, Group A Group A streptococcus organism list Streptococcus pyogenes L-25102 ATCC12344
Streptococcus, Group A Group A streptococcus organism list Streptococcus, Group A L-25128 Streptococcus, group A
Streptococcus, Group B Group B streptococcus organism list Streptococcus agalactiae L-25107 ATCC13813
Strongyloides Strongyloides organism list Strongyloides stercoralis L-55301 MI1455
Syphilis Syphilis organism list Treponema pallidum L-25901 MI1497
Tetanus Tetanus organism list Clostridium tetani L-14158 MI0403
Toxoplasmosis Toxoplasmosis organism list Toxoplasma gondii L-52801 MSH95D014122
Trachoma Trachoma organism list Chlamydia trachomatis L-2A901 ATCCVR 571
Trichinellosis Trichinellosis organism list Trichinella spiralis L-57181 MSH95D017160
Trichomoniasis Trichomoniasis organism list Trichomonas vaginalis L-50901 MSH95D014246
Tuberculosis Tuberculosis organism list Mycobacterium tuberculosis L-21801 Mycobacterium tuberculosis hominis ATCC27294
Tularemia Tularemia organism list Francisella tularensis L-1F201
Tularemia Tularemia organism list Francisella tularensis ss. tularensis L-1F202 ATCC06223
Typhoid fever Typhoid fever organism list Salmonella typhi L-18122 ATCC19430
Typhoid fever Typhoid fever organism list Salmonella paratyphi A L-17201
Typhoid fever Typhoid fever organism list Salmonella paratyphi B L-17309
Typhoid fever Typhoid fever organism list Salmonella paratyphi C L-17517
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Typhoid fever Typhoid fever organism list Salmonella typhimurium L-17354 ATCC13311
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio cholerae, non-01 L-26203
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio alginolyticus L-26210 ATCC17749
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio carchariae L-26235 ATCC35084
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio cincinnatiensis L-26236 ATCC35912
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio damsela L-26239 MI1566
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio fluvialis L-26215 ATCC33809
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio furnissii L-26228 MI1568
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio hollisae L-26223 ATCC33564
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio metschnikovii L-26212 NCTC8443
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio mimicus L-26213 ATCC33653
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio parahemolyticus ATCC17802
Vibrio cholerae, non-O1 Non-O1 vibrio cholerae organism list Vibrio vulnificus L-26211 ATCC27562
Visceral larva migrans Visceral larva migrans organism list Bayliascaris procyonis L-56262
Visceral larva migrans Visceral larva migrans organism list Toxocara canis L-56221
Yellow fever Yellow fever organism list Yellow fever virus L-32301
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia aldovae L-1E405 ATCC35236
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia bercovieri ATCC43970
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia enterocolitica L-1E403 ATCC09610
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia frederiksenii L-1E407 ATCC33641
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia intermedia L-1E404 ATCC29909
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia kristensenii L-1E408 ATCC33638
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia mollaretii ATCC43969
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia pseudotuberculosis L-1E402 ATCC29833
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia rohdei L-1E409 ATCC43380
Yersiniosis, non-plague Non-plague yersiniosis organism list Yersinia sp. L-1E400 Yersinia, NOS MSH94D015007 Yersinia species
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